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Autophagy is a cell renovation system that directs almost any type of cell contents for 
lysosomal degradation and recycling of building blocks. It is fundamental for cellular 
homeostasis and for determining cell fate in response to stress. Hence, understanding the 
regulation of autophagy-related proteins is of great importance. This study focuses on the effect 
of posttranslational modifications on the autophagy proteins LC3B and TP53INP2, and 
importance of molecular interactions for ATG4B mediated cleavage and delipidation of the 
ATG8 family proteins. 
 In the first paper, we shed light on the effect of phosphorylation of LC3B on selective 
autophagy. LC3B is the most recognized member of the ATG8 family proteins and is used as a 
readout for autophagy activity. LC3B is enriched in the growing autophagosomal membrane, 
where it recruits cargo and cargo receptors to the autophagosomes via direct LC3 interacting 
region (LIR)-LC3 docking site (LDS) interactions. We identified four serine-threonine kinases 
that phosphorylate LC3B at the threonine 50 (T50) residue. In vivo and in vitro data show that 
they interact with LC3B via LIR-LDS mediated interactions. The LC3B T50 residue is adjacent 
to the LDS motif in LC3B. Importantly, we found that the phospho-mimicking LC3B T50E 
mutant inhibited the interaction of LC3B with core autophagy proteins and negatively regulated 
selective autophagy. We showed that NEK9 phosphorylate LC3B T50 and that depletion of 
NEK9 facilitated autophagic flux. This study thus points to NEK9 as a regulator of selective 
autophagic flux via phosphorylation of LC3B T50.  
In the second paper, we show that subcellular localization of the autophagy protein 
TP53INP2 is regulated by acetylation. TP53INP2 is previously recognized as a regulator of 
autophagy, providing nuclear export of LC3B and autophagosome formation by interactions 
with the ATG8s and VMP1. Here we show that upon mTOR inactivation, nuclear import of 
TP53INP2 is impaired via acetylation of K187, while its degradation is facilitated by acetylation 
of K165 and K204. Hence, mTOR dependent re-localization of TP53INP2 is due to enhanced 
nuclear degradation and cytoplasmic retention. 
The functional role of the cysteine protease ATG4B for cleavage and delipidation of 
ATG8 homologues are well known. In the third paper, we unravel essential residues involved 
in the ATG4B-ATG8s functional interactions. We identified a canonical LIR motif at C- 
terminal part of ATG4B and solved the crystal structure of GABARAPL1 in complex with a 
peptide containing this LIR motif. Our in vivo and in vitro data showed that the ATG4B C- 
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Proteostasis is an essential requirement for the maintenance of healthy cells. The cells 
have a complex network of cellular mechanisms that tightly controls protein stability, folding, 
its rate of synthesis and degradation.  The disturbance of proteostasis has detrimental 
consequences resulting in accumulation of unfolded proteins, misfolded proteins or damaged 
proteins that affects cellular functions leading to aging and age-related diseases, cancers, 
immunological disorders and several other metabolic diseases (Balch et al., 2008).  To maintain 
proteostasis, cells are equipped with a complex protein quality control system, which constantly 
regulates cellular proteomes via tracking each nascent protein from synthesis to degradation. 
Each process from mRNA transcription, translation, transportation, and degradation need 
constant surveillance (Schubert et al., 2000). During mRNA transcription, abnormal mRNA 
transcripts are degraded before translation. During protein translation, nascent protein requires 
correct folding which is often mediated by chaperones. Such chaperones also facilitate the 
degradation of misfolded proteins (McClellan et al., 2005). In addition, cells are exposed to 
several internal and external stresses, which may lead to the accumulation of protein aggregates. 
Such protein aggregates are removed by two major complementary degradation systems called 
the ubiquitin-proteasome system (UPS) and the autophagy-lysosome system. 
 
Ubiquitin Proteasome system (UPS) 
Every protein within the cell has a defined half-live ranging from a few minutes to 
several days, which is tightly regulated. Proteins that are destined to be degraded are first 
modified by ubiquitin in an ATP dependent manner and later subjected to degradation by a 
large proteolytic complex called the 26S proteasome (Raynes et al., 2016) (Figure 1A). 
Ubiquitin is a 76 amino acid protein, which is activated by ubiquitin-activating enzymes known 
as E1 and transferred to the Ub conjugating enzymes E2. Finally, ubiquitin molecules carried 
by E2 are conjugated to specific substrates by ubiquitin E3 ligase enzymes. Ubiquitin contains 
internal lysine residues, which can be repeatedly conjugated to another ubiquitin leading to the 
formation of polyubiquitin chains. The specificity in the process is determined by the E3 ligases 
(Buetow and Huang, 2016). The E3 ligase recognizes a degradative signal or ‘‘degron’’, which 
are either basic or hydrophobic residues in the N-terminal part of a protein. Such residues in the 
N-terminal part of a protein tend to destabilize it, leading to recognition by E3 enzymes (Ravid 
and Hochstrasser, 2008). The specificity of E3 ligases is also facilitated by chaperones such as 




protein is subjected to degradation by the 26S proteasome. The proteasome is a large multi-
subunit protease complex, approximately 2.5MDa, composed of two subcomplexes: the 
catalytic 20S core particle (CP) and 19S regulatory particle (RP) which are attached to either 
end of the barrel-shaped 20S CP (Voges et al., 1999) (Figure 1B). The 20S CP consists of 28 
subunits arranged in two outer α-rings and two inner β-rings. The α-rings act as gates for 
substrate entry into the catalytic chamber formed by the β-rings. These β-ring subunits are 
associated with caspase-like, trypsin-like, and chymotrypsin-like activities, which digest the 
substrate protein into peptides ranging from 2-24 amino acids. The 19S RP is composed of lid 
and base substructures. The base is composed of six AAA’ ATPase subunits (Rpt 1-6) which 
provide ATP energy source for deubiquitinating and unfolding of the substrate. This is essential 
for the transport of the substrate to the core proteolytic chamber of CP (Smith et al., 2007).  In 
addition to the ATPase subunits, the RP base also contains non-ATPase proteins (Rpn 1, 2, 10, 
12 and 13). The Rpn10 and Rpn13 function as receptors for ubiquitinated substrates via their 
ubiquitin-binding domains (Finley, 2009). Besides recognition of ubiquitinated substrates by 
Rpn10 and Rpn13, there are also shuttling factors such as Rad23, Dsk2, Ddil and p62 that 
mediate delivery of ubiquitinated proteins to the proteasome (Finley, 2009). Hence, the delivery 
of ubiquitinated substrates to the proteasome is a sequential process where first the substrate is 
recognized by proteasome receptors followed by protein unfolding in an ATPase dependent 






Ub and finally delivery of unfolded proteins into the core proteolytic chamber for cleavage into 
short peptides. 
Figure 1: The Ubiquitin-Proteasome pathway 
(UPS): (A) The proteasomal degradation of 
misfolded protein by UPS. (B) The 26S proteasome 
is composed of a 20S core and 19S regulatory core 
particles. The substrate recognition is mediated by 
19S regulatory subunit whereas substrate 
proteolysis is carried out by β-ring subunits of 20S 
core particles.  
The modes of ubiquitination determine 
different degradation fates of proteins. The 
ubiquitin molecules can be linked at K6, 
K11, K27, K29, K33, K48 and K68 lysine 
residues, generating seven various ubiquitin chains. In addition, heterogeneous 
polyubiquitination chains can be formed (Swatek and Komander, 2016). These homo- and 
heterogeneous ubiquitin linkages generate different binding surfaces and thereby specificity 
towards ubiquitin-binding proteins (Hicke et al., 2005; Swatek and Komander, 2016), which 
may lead to different modes of degradation. Furthermore, ubiquitin chains can be of varying 
length varying from single ubiquitin (monoubiquitination) or multiple residues 
(polyubiquitination). For a protein to be directed to proteasomal degradation, the ubiquitin chain 
must contain a minimum of four ubiquitins (Hicke et al., 2005). The K48 and K11 ubiquitin 
linkages serve as potent proteasomal degradation signals (Jin et al., 2008; Xu et al., 2009), 
although a study has also shown specificity towards K29 and K63 linkages (Swatek and 
Komander, 2016). 
It is becoming increasingly clear that proteins also can be subjected to proteasomal 
degradation in an ubiquitin-independent manner by both the 26S and the 20S core proteasomes 
(Asher et al., 2005; Hwang et al., 2011). The substrates for such a degradation pathway are 
native proteins with intrinsically disorder regions (IDRs)(van der Lee et al., 2014). Proteins 
involved in cell cycle progression, growth and oncogenesis are found to be degraded by this 
pathway (Dyson and Wright, 2005). It is shown that the same protein can be degraded by both 





The role of the proteasome is not limited to the clearance of proteins within cytoplasm 
but also extends to the regulation of gene expression. The first evidence of the presence of 
proteasome systems within the nucleus leads to the identification of several nuclear proteins as 
substrates for proteasomal degradation (Kleinschmidt et al., 1983). The nuclear proteasomal 
degradation pathway is associated with regulation of transcription, replication, DNA repair and 
nuclear protein quality control (Floyd et al., 2001; Krogan et al., 2004; Mendez et al., 2002). 
Like cytoplasmic proteasomal degradation pathway, studies have shown that the nuclear 
proteasomal pathway can degrade substrates both by ubiquitin-dependent and-independent 
pathways. In addition, there is now growing evidence for the existence of a nucleolar ubiquitin-
independent proteasomal degradation pathway (Maehama et al., 2014; Murai et al., 2018).  
 
Autophagy 
The genesis of the word autophagy started five-decades ago. Christian de Duve and 
colleagues identified acid phosphatase and other hydrolytic enzymes within membranous 
structures in the cell. Later, he named these unique organelles lysosome for their lytic function 
(De Duve et al., 1955). Novikoff working in Christian de Duve’s research group further 
identified organelles such as mitochondria, endoplasmic reticulum, and ribosomes within the 
acid phosphatase containing membranous compartments (Novikoff et al., 1956). Following 
studies showed that some membranous compartments contained cellular organelles but not 
hydrolytic enzymes, indicating the formation of autophagosomes which later fuse with 
lysosomes (Arstila and Trump, 1968). C de Duve defined this process of delivery of 
cytoplasmic contents to lysosomes for degradation as ‘‘autophagy’’(Hanada et al., 2007). The 
word autophagy is derived from Greek meaning self-eating. 
The process of degradation of cytoplasmic contents in lysosomes is subdivided into 
three categories: microautophagy, chaperone-mediated autophagy (CMA) and 
macroautophagy. Microautophagy involves the engulfment of cytoplasmic content by direct 
invagination of the lysosomal membrane (Figure 2). The microautophagy pathway is well 
studied in yeast but studies in mammalian cells are limited. Although several techniques have 
been developed to study microautophagy, morphological analysis of lysosomal structures by 
electron microscopy has been the main choice of method (de Waal et al., 1986; Mortimore et 
al., 1988). This method has some limitations and requires extra caution for interpretation of 
results. In yeast, microautophagy is constitutively active but can be further induced by Target 




process (Li et al., 2012). The selective degradation of mitochondria (Kissova et al., 2007), 
peroxisomes (Sakai et al., 1998) and nucleus (Krick et al., 2009) is shown to be mediated via 
microautophagy. No homologous process is identified in mammalian cells. However, recently 
in mammalian, a degradation pathway similar to yeast microautophagy was identified. In such 
pathway, cytosolic proteins are rapidly degraded in late endosomes or multivesicular bodies 
(MVB) instead of lysosome and pathway are termed as endosomal microautophagy (Mejlvang 
et al., 2018; Sahu et al., 2011). The pathway depends on proteins associated with endosomal 
sorting complexes required for transport machinery (ESCRT)(Sahu et al., 2011). The 
endosomal microautophagy involves bulk degradation of cytosolic protein and selective 
degradation of proteins mediated by HSP70 (Sahu et al., 2011). 
 
Figure 2: The three autophagy pathways microautophagy, CMA and macroautophagy. Microautophagy involves 
direct invagination of the lysosomal membrane for engulfment of cytoplasmic contents and its degradation. 
Endosomal microautophagy involves degradation of cytosolic proteins in late endosomal vesicles.  CMA involves 
lysosomal degradation of its substrate protein via recognition of a specific motif. Macroautophagy involves 
sequestration of cargo within the double-membrane structure called autophagosome which fuses with the lysosome 





CMA involves selective delivery of substrate proteins with a specific recognition motif for 
lysosomal degradation, mediated by chaperone Heat shock cognate (HSC70) (Figure 2). The 
CMA recognition motif contains one or two positive residues (K or R), one or two hydrophobic 
residues (F, L, I or V), one negatively charged residue (E or D) and finally, this motif is flanked 
on one of the sides by glutamine (Tekirdag and Cuervo, 2018). About 40% of the mammalian 
proteome contains such a canonical KFERQ like motif. HSC70 recognizes misfolded proteins 
with KFERQ motifs and targets them to the lysosomal membrane via interaction with the 
cytosolic tail of LAMP2A (lysosome-associated membrane protein type 2A)(Kaushik and 
Cuervo, 2018). Subsequently, the proteins are unfolded and thereby translocated into the 
lysosomal lumen. The transportation of substrates through the lysosomal membrane requires 
multimerization of LAMP2A and formation of a complex with luminal HSC70 and HSC90 
(Kaushik and Cuervo, 2018). CMA occurs at basal level, but can also be induced by different 
stresses such as starvation (Cuervo et al., 1995), DNA damage (Park et al., 2015), oxidative 
stress (Kiffin et al., 2004) and hypoxia (Dohi et al., 2012).  
In contrast to CMA and microautophagy, macroautophagy (hereafter autophagy) involves 
sequestration of cytoplasmic cargo within double-membrane structures called autophagosomes 
and delivery of cargo into lysosomes for degradation. Initial genetic screening in yeast led to 
the identification of genes regulating the autophagy pathway (named ATG proteins). This 
provided mechanistic insight into the core autophagic pathway (Tsukada and Ohsumi, 1993). 
There are 41 autophagy-related genes identified to regulate the autophagy pathway in yeast 
(Wen and Klionsky, 2016).  
 
Autophagosome biogenesis: Initiation, elongation, closure, and fusion 
Autophagy initiation starts with activation of the initiation complex comprising ULK1/2 
(Unc-51-like kinase), FIP200 /RB1CC1 (FAK family interacting protein of 200 kDa, RB1-
inducible coiled-coil protein 1), ATG101 and ATG13 (Ganley et al., 2009; Hosokawa et al., 
2009a; Jung et al., 2009). In Saccharomyces cerevisiae, the initiation complex is pentameric 
consisting of Atg1 (ULK1), Atg13, Atg17, Atg29 and Atg31 (He and Klionsky, 2009). Human 
has two atg1 homologous genes encoding the ULK1 and ULK2 proteins. The functional roles 
of ULK1 are well characterized compared to ULK2. To initiate autophagy, ULK1 has to be 
switched on via phosphorylation events, recruited to the site of phagophore formation and 
finally scaffolding essential proteins at the site of autophagosome formation (Zachari and 




formation (Hara et al., 2008). ATG13 and ATG101 contain HORMA (Hop/Rev7/Mad2) 
domains that heterodimerize with each other (Qi et al., 2015; Suzuki et al., 2015). Such 
dimerization of ATG13 with ATG101 stabilizes ATG13 by preventing it from proteasomal 
degradation (Hosokawa et al., 2009b; Mercer et al., 2009). In addition to the ATG101 
interaction, ATG13 interacts with FIP200 and ULK1 via two other motifs and thereby holds 
four proteins in a complex (Alers et al., 2014) (Figure 3).  
 
Figure 3: Yeast and mammalian initiation 
complex. (A) Yeast initiation complex 
comprises Atg1, Atg13, Atg17, Atg31, and 
Atg29. (B) Mammals have a tetrameric 
initiation complex with ULK1, ATG13, 
ATG101, and FIP200. ATG13 holds the 
components of the initiation complex 
together. 
The initiation of autophagy is regulated by two major kinases, mTORC1 and AMPK. 
Under nutrient-rich conditions, mTOR is activated by the small GTPase Rheb (Inoki et al., 
2003a). Activation of mTOR leads to inactivation of ULK1 by mTOR mediated 
phosphorylation of the two serine residues S638 and S758 (Kim et al., 2011; Shang et al., 2011) 
(Figure 4). mTOR also phosphorylates ATG13 at S258 (Puente et al., 2016). This 
phosphorylation of ULK1 and ATG13 inhibit direct AMPK-dependent activation of autophagy, 
resulting in subsequent inhibition of autophagy. Under nutrient deficient conditions, AMPK 
senses the reduced ATP/AMP ratio in the cell and stimulates autophagy by mTOR inactivation 
and ULK1 activation. AMPK mediates mTOR inactivation by direct phosphorylation of 
RAPTOR (a subunit of the mTORC1 complex) and TSC2, an inhibitor of Rheb (Gwinn et al., 
2008; Inoki et al., 2003b). Furthermore, AMPK phosphorylates both ULK1 and ATG13 at 
specific sites important for the initiation of autophagy (Puente et al., 2016; Shang et al., 2011) 
(Figure 4). ULK1 activity can also be regulated by ubiquitination. The AMBRA-TRAF6 
dependent Lys-63-linked polyubiquitination of ULK1 leads to its stabilization, dimerization, 
and activation (Nazio et al., 2013). 
Activation of ULK1 is followed by translocation of ULK1 initiation complexes to 
subdomains of the endoplasmic reticulum (ER) called omegasomes, a phosphatidylinositol 3-









translocation of the initiation complex to the autophagosome nucleation site and the protein 
complexes involved is not well understood. Recently, it was shown that the nucleation site is 
marked by ATG9 vesicles (Karanasios et al., 2016) and that translocation of the ULK1 complex 
to the nucleation site is mediated by the Rab1 effector C9orf72 (Webster et al., 2016). 
Furthermore, the ER proteins VAPA and VAPB are shown to be recruited to the site of 
autophagosome nucleation and initiate autophagosome formation via direct interaction with 
FIP200 and ULK1 (Zhao et al., 2018). After activation and recruitment of the initiation 
complex, it is stabilized by membrane association of ULK1 and ATG13. The membrane 
interaction of ULK1 is mediated by its EAT domain in the C-terminal part (Chan et al., 2009; 
Hurley and Young, 2017). In the case of ATG13, the electrostatic interaction between the N-
terminal basic residues of ATG13 
 Figure 4: Regulation of 
initiation complex in (A) 
Nutrient-rich condition and (B) 
Starvation. Under the nutrient-
rich condition, mTOR induced 
phosphorylation of ULK1 and 
ATG13 inhibits autophagy. 
Under starvation, AMPK 
induced phosphorylation of 
ULK1 and ATG13 leads to 
stimulation of autophagy. In 
addition to phosphorylation-mediated activation of ULK1, polyubiquitination of ULK1 via TRAF6 also 
leads to activation of autophagy. 
and acidic phospholipids present within the ER membrane mediates such interaction 
(Karanasios et al., 2013). The association of the initiation complex with omegasomes is further 
stabilized by LC3 interaction regions (LIR). Both ULK1 and ATG13 contain LIR motifs which 
mediate interactions with phosphatidylethanolamine conjugated ATG8 proteins in the 
omegasomes membrane, and thereby further enhances retention of the initiation complex at 
omegasomes (Alemu et al., 2012; Kraft et al., 2012). Following the stabilization of the initiation 
complex, the class III PI3K complex is recruited to the site. The class III PI3K complex forms 






complex I (PI3KC3-C1) consists of VPS34 (Vacuolar Protein Sorting 34), VPS15 (Vacuolar 
Protein Sorting 15), ATG14L (Autophagy-related protein 14-Like protein (Atg14 in yeast) and 
Beclin-1 (BECN1) (Vps30 in yeast)(Backer, 2016). PI3KC3-C2 contains UVRAG (UV 
Radiation Resistance- Associated Gene 
protein; Vps38 in yeast) instead of 
ATG14L(Backer, 2016) (Figure 5). The PI3K 
complex I is known to facilitate phagophore 
formation whereas PI3K complex II is 
involved in endosome and autophagosome 
maturation (Backer, 2016). 
Figure 5: Complex structure of yeast Class III 
PI3KC3-C2 (PDB: 5DFZ)(Rostislavleva et al., 
2015). The BARA domain of VPS30, N-terminal 
part of VPS15, C-terminal Kα12 helix and activation loop of VPS15 is actively involved in membrane 
interaction at omegasomes. 
Each component of the PI3KC1 complex associates with lipid membranes and contributes to 
the stabilization of the complex. Association of ATG14L with membrane structures and 
recruitment of  PI3KC1 complex is mediated by its ER targeting sequence, its N-terminal 
cysteine-rich domain and its BATS (Barkor/ATG14L autophagosome targeting sequence) 
domain which interacts with both PI3P and phosphatidylinositol 3,4 bisphosphate (Fan et al., 
2011; Matsunaga et al., 2010). The C-terminal BARA domain of BECN1 directly associates 
with lipid membranes using three aromatic residues Y359/Y360/W361 (Huang et al., 2012). 
VPS34 stabilizes the complex via its Kα12 helix and activation loops interacting with the 
membrane (Miller et al., 2010). Finally, the N-terminal part of VPS15 is involved in membrane 
association (Stack et al., 1995). Recently, VPS34, BECN1, and ATG14 were found to interact 
preferentially with GABARAP for efficient recruitment of complex to membrane structure 
(Birgisdottir et al., 2019).VPS34 is a protein kinase, phosphorylating phosphatidylinositol to 
generate PI3P. The generation of PI3P by VPS34 at omegasomes leads to recruitment of 
downstream PI3P effector proteins. The first effector protein to be recruited is DFCP1 (double 
FYVE domain-containing protein 1) which binds to PI3P through its two FYVE motifs (Axe et 
al., 2008). In addition to DFCP1, WIPIs (WD-repeat domain phosphoinositide-interacting 
proteins) are PI3P effector proteins that are essential for phagophore formation. There are four 




omegasomes via their FRRG motifs interacting with PI3P (Gaugel et al., 2012; Polson et al., 
2010). 
 The recruitment and stabilization of the PI3KC1 complex are proceeded by elongation 
of the phagophore. This process, in both yeasts and mammals, is achieved by two conjugation 
systems involving the ubiquitin-like proteins: ATG12-ATG5-ATG16 and ATG8/LC3 
conjugation system (Nakatogawa, 2013; Ohsumi and Mizushima, 2004) (Figure 6). The 
ubiquitin-like protein ATG12 is covalently conjugated to ATG5 by the E1-like enzyme ATG7 
(Kim et al., 1999) and E2-Like enzyme ATG10 (Shintani et al., 1999). First, ATG12 is activated 
by ATG7 and transferred to the E2-like enzyme ATG10 for conjugation of ATG12 to ATG5. 
Contrary to ubiquitin conjugation systems, the ATG12-ATG5 conjugation is irreversible and 
does not require an E3 ligase (Geng and Klionsky, 2008). After the conjugation of ATG12 to 
ATG5, ATG16L1 interacts with ATG5 and subsequently homodimerizes with itself to form a 
large stable ATG12-ATG5: ATG16L1 complex which later functions as an E3 Ligase for the 
ATG8 conjugation system (Kuma et al., 2002). The ATG8 conjugation system starts with the 
processing of ATG8 family proteins by the ATG4 cysteine proteases (Kirisako et al., 2000). 
Yeast has only one ATG4 protein and one ATG8 protein compared to mammals which have 
four ATG4 (ATG4A-D) and seven ATG8 proteins. The ATG8s are cleaved at the C-terminal 
by ATG4 leading to exposure of a glycine residue (Kirisako et al., 2000). The E1-Like ATG7 
activates the processed ATG8 protein and transfers it to the E2-like enzyme ATG3 (Ichimura 
et al., 2000). Finally, the ATG12-ATG5-ATG16L1 E3 ligase conjugates 
phosphatidylethanolamine (PE) at the C-terminal glycine residue of ATG8 (Hanada et al., 2007; 
Ichimura et al., 2000). The PE-conjugated ATG8 leads to association with the inner and outer 
sides of the growing phagophore and later, outer side ATG8-PE is released to the cytoplasm by 
ATG4 mediated cleavage (Kirisako et al., 2000). 






Figure 6: The two conjugation systems: The ATG12-ATG5-ATG16 conjugation system produces an 
E3 Ligase for the ATG8 conjugation system. In the ATG8 conjugation system, proATG8 protein is 
processed by ATG4 to expose C-terminal glycine residue. The processed ATG8 is transferred by ATG7 
to ATG3, an E2 activating enzyme. The activated ATG8-I is conjugated to phosphatidylethanolamine 
(PE) at the C-terminal glycine residue by ATG12-ATG5-ATG16, E3 ligase. The PE-conjugated ATG8 
is recruited to phagophore. 
In addition, to the two conjugation systems, ATG9 is essential for phagophore 
elongation. ATG9 is a transmembrane protein containing six highly conserved transmembrane 
domains spanning the membrane (Noda, 2017). Under nutrient-rich conditions, ATG9 is 
localized within the trans-Golgi network and endosomes. Upon induction of autophagy via 
nutrient deprivation, ATG9 vesicles shuttle around the phagophore and transiently interact for 




Young et al., 2006). Such trafficking of ATG9 vesicles around the phagophore is regulated by 
the ULK1 kinase and depletion of it leads to inhibition of ATG9 trafficking (Orsi et al., 2012). 
Phosphorylation of ATG9 at S14 by ULK1 is essential for both ATG9 trafficking and 
autophagy induction (Zhou et al., 2017). Also, WIPI2 (WD repeat domain phosphoinositide-
interacting protein 2) is shown to regulate ATG9 vesicles during autophagy initiation (Orsi et 
al., 2012). 
The extensive studies on yeast models have helped to better understand the mechanisms 
involved in the activation of autophagy and the formation of autophagosomes. However, the 
mechanisms involved in the closure of the autophagosome and its subsequent fusion with late 
endosomes/lysosomes are still elusive. Its prerequisite is that only closed autophagosomes can 
fuse with lysosomes. Previous studies have shown that the ATG conjugation systems are 
essential for the closure of autophagosomes and degradation of the inner autophagy membrane 
(Fujita et al., 2008; Kishi-Itakura et al., 2014; Sou et al., 2008; Tsuboyama et al., 2016). In 
contrast, another study showed that KO of all 6 human ATG8 family proteins did not affect 
formation and closure of autophagosomes but affected fusion of the autophagosome with 
lysosomes (Nguyen et al., 2016). The closed autophagosomes are transported towards late 
endosomes/lysosomes present at the perinuclear region. The transport towards the perinuclear 
region is mediated by dynein-dynactin complexes, whereas kinesins are involved in transport 
towards the cell periphery (Gross et al., 2007). For efficient transport of autophagosomes 
towards perinuclear lysosomes, these motor proteins are essential, and their activity is 
facilitated by interactions with the small GTPase Rab7 (Gutierrez et al., 2004). Rab7 is a 
molecular switch which is activated by specific guanine nucleotide exchange factors (GEFs). 
Upon GTP binding, Rab7 undergoes conformational changes which lead to interaction with its 
downstream effector proteins (Hyttinen et al., 2013). The kinesin-driven movement towards the 
cell periphery is achieved by Rab7 interacting with FYCO1 (Pankiv et al., 2010), while dynein-
dynactin mediated movement towards the perinuclear region is mediated by Rab7 interactions 
with RILP (Rab-interacting lysosomal protein) and ORPL1 (oxysterol-binding protein-related 
protein 1)(Jordens et al., 2001; Wijdeven et al., 2016). A complex interaction involving three 
major sets of protein families: Rab GTPase, membrane-tethering complex and soluble N-
ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) is known to be 
implicated in autophagosome-lysosome fusion.  The Rab7 protein is essential in the recruitment 
of the HOPS complex (tethering factor) and SNAREs at the autophagosome lysosomes fusion 




PLEKHM1 and RILP, which bind the VPS39 and VPS41 components of the HOPS complex, 
respectively (Wijdeven et al., 2016). PLEKHM1 facilitates autophagosome-lysosome fusion 
via direct interaction with ATG8s bound to closed autophagosomes (McEwan et al., 2015). In 
addition, Rab7 recruits another effector protein and tethering factor called Ectopic P granules 
protein 5 (EPG5) which stabilizes the STX17-SNAP29-VAMP8 complex via direct interaction 
with each component of the complex (Wang et al., 2016b). Furthermore, EPG5 interacts 
directly with the ATG8s via LIR-LDS binding, which most likely promotes the 
autophagosome-lysosome fusion process (Wang et al., 2016b). 
 
ATG8 and its LDS and UDS binding surfaces 
The extensive studies in yeast led to the identification of at least 41 autophagy-related 
proteins that are found to be functionally conserved in eukaryotes. Among these proteins is the 
ATG8 family of proteins. In yeast there is only one ATG8 gene compared to mammals which 
have six functional ATG8 orthologs: microtubules associated protein 1 light chain 3α 
(MAP1LC3A), β (MAP1LC3B),γ (MAP1LC3C), GABA type A receptor-associated protein 
(GABARAP), GABARAP-like 1(GABARAPL1) and GABARAP like 2 (GABARAP2/GATE 
16)(Schaaf et al., 2016). They share high sequence similarity and have a conserved C-terminal 
glycine residue for cleavage by cysteine protease ATG4 (Kirisako et al., 2000). In addition to 
amino acid sequence similarity, the LC3/GABARAP (Noda et al., 2009) proteins share 
structure similarity with two N-terminal α-helices (α1 and α2) and a C-terminal ubiquitin core 
(Sugawara et al., 2004) (Figure 7).  The amino terminals of the LC3/GABARAPs show 
differences in their electrostatic surfaces, which is hypothesized to be a factor for determining 
their specific functional roles. The first α1 of LC3B is basic compared to α1 of GABARAP and 
GABARAPL2 which are more acidic, while α2 of LC3B is acidic whereas α2 of GABARAP 
and GABARAPL2 are basic and neutral, respectively (Noda et al., 2009). The C-terminal 
ubiquitin core contains two α helices (α3 and α4) and a four-stranded central β -sheet(β1-β4). 
The two central β strands are parallel to each other whereas the two outer β strands are 
antiparallel to the central strands. Although the C-terminal ubiquitin core of the ATG8s is 
similar structurally to the ubiquitin protein, the amino acids sequence similarity is very low 





Figure 7: Structure of ATG8s homologues and Ubiquitin: Ribbon representation of GABARAPL2 
(PDB code 1EO6), GABARAP (PDB code 1GNU), LC3B (PDB code 1UGM) and Ubiquitin (PDB 
code 1UBI). 
Several proteins interact with mammalian LC3B/GABARAPs via a conserved motif called LC3 
interaction region (LIR) or ATG8 interacting motif (AIM) in yeast. The canonical core LIR 
consensus sequences contain [W/F/Y] XX [L/I/V] residues, where X denotes any amino acid 
(Birgisdottir et al., 2013). The LIR motif docks into two hydrophobic pockets (HP1 and HP2) 
present on the ATG8s structural surfaces (Figure 8). The HP1 pocket accommodates 
hydrophobic aromatic residues whereas the HP2 pocket accommodates hydrophobic aliphatic 
residues. The core LIR motifs are often preceded by acidic residues (E, D, S, T), which are 
involved in electrostatic interactions with basic residues present in the N-terminal helices of the 
ATG8s (Birgisdottir et al., 2013). The binding affinity between ATG8s and their interaction 
partners is often regulated by phosphorylation of S or T residues flanking the core LIR motif 
(Birgisdottir et al., 2013; Di Rita et al., 2018; Hamacher-Brady and Brady, 2016).   In contrast 
to the canonical LIR motif, non-canonical LIR (CLIR) motifs contain three stretches of the 
aliphatic residues L-V-V (in case of NDP52) and lack hydrophobic aromatic residues. These 
hydrophobic LVV residues interact with a complementary hydrophobic surface on the HP2 
pocket of LC3C (von Muhlinen et al., 2012).  
Recently, a novel binding surface was identified in Arabidopsis thaliana ATG8s. This 
binding site interacts with proteins containing a ubiquitin-interacting motif (UIM) like sequence 
and is called UIM docking site (UDS)(Marshall et al., 2019) (Figure 8B). The Arabidopsis 
RPN10 uses a UIM motif to interact with the ATG8 UDS site instead of the LDS site (Marshall 
et al., 2019). In addition to RPN10, several proteins belonging to the Arabidopsis UBX 
(Ubiquitin regulatory domain X) domain containing family interacts with ATG8s via UIM-




Figure 8: Structural representation of ATG8s LDS and UDS 
sites: (A) Surface representation of p62 LIR peptide bound 
to LC3B. The hydrophobic aromatic amino acid (tryptophan) 
of p62 docks into hydrophobic pocket 1 (HP1) whereas 
another hydrophobic aliphatic residue (leucine) docks into 
hydrophobic pocket 2 (HP2).  The acidic residues preceding the LIR motif are involved in electrostatic 
interactions with basic residues at N-terminal helices of LC3B. (B) ATG8 interacts with proteins 
containing Ubiquitin interacting motif (UIM) like sequence via its non-LDS site called UDS (UIM 
docking site). 
The structural similarity of ATG8s homologues suggests functional redundancy. 
However, studies have shown that the ATG8s have differential roles in the autophagy pathway. 
The LC3s were found to play an essential role in the early stage of autophagosome biogenesis, 
whereas GABARAPs are important in later stages during autophagosome maturation 
(Weidberg et al., 2010). In contrast to the human cell line studies, genetic analysis in 
Caenorhabditis elegans identified the GABARAP homolog LGG1 to be essential in the early 
stage of autophagosome formation while the LC3B homologue LGG2 was essential for 
autophagosome maturation (Manil-Segalen et al., 2014). LC3B and GABARAP seem to be 
redundant in the autophagic degradation of long-lived proteins, but LC3B is indispensable for 
degradation of the selective autophagy receptor p62 (Maruyama et al., 2014). Recently, it has 
been shown that in cell lines that are genetically KO for all ATG8s, autophagosome biogenesis 
still occur. The essential role of the ATG8s is restricted to mediate autophagosome-lysosome 
fusion (Nguyen et al., 2016). In agreement, another study showed that only GABARAPs play 
a role in the LDH degradation assay, indicating that the GABARAPs are the main players in 
autophagosome-lysosome fusion (Szalai et al., 2015). Both studies state importance for the 
interaction of GABARAPs with PLEKHM1 as essential for autophagosome lysosomal fusion 





Additional to the autophagic roles of the ATG8s, other non-autophagic roles have been 
reported (Sanjuan et al., 2007). For example, LC3B is shown to be recruited to phagosome 
membranes and thereby enhance phagosome-lysosome fusion leading to efficient clearance of 




The mammalian genome contains four independent genes encoding proteins 
homologous to the yeast ATG4 protein: ATG4A, ATG4B, ATG4C, and ATG4D. ATG4 
belongs to the C54 endopeptidase family. Initially, it cleaves the ATG8s at a C-terminal glycine 
residue and later it delipidates ATG8s located at the outer membrane of autophagosomes. 
ATG4B cleaves all the ATG8s homologues, but LC3B seems to be its main substrate (Li et al., 
2011; Tanida et al., 2004). Efforts are made to determine the sensitivity and specificity of the 
various ATG4 homologues towards the ATG8 homologues. ATG4A is shown to cleave 
GABARAPL2, whereas ATG4D cleavages GABARAPL1 and this cleavage is shown to 
enhanced by Caspase3 cleavage at the N terminus (Betin and Lane, 2009; Scherz-Shouval et 
al., 2003). An in vitro assay showed that ATG4A cleavage activity towards GABARAPL2 was 
increased in the presence of the reducing agent DTT (Scherz-Shouval et al., 2003). This led to 
the speculations that redox potential might regulate ATG4A activity in vivo. Later, it was shown 
that starvation-induced ROS production affects cysteine residue C81 (close to active cysteine 
residue C74) and thereby negatively regulate ATG4A activity (Scherz-Shouval et al., 2007).  
The negative regulation is restricted to defined sites with high ROS, like in the vicinity of the 
mitochondria where autophagosome formation is initiated. At subcellular areas with lower 
ROS, such as at autophagosome maturation sites, ATG4A activity is facilitated and can carry 
out delipidation of membrane-bound ATG8s for efficient fusion with lysosomes (Scherz-
Shouval et al., 2007). In addition to ROS, ATG4B activity is also regulated by an E3 ubiquitin 
ligase called RNF5. RNF5 mediated ubiquitination of ATG4B leads to degradation of 
membrane-associated ATG4B, and KO of RNF5 enhanced autophagy flux and clearance of 
bacterial pathogens (Kuang et al., 2012).  Overexpression of catalytic deficient ATG4B inhibits 
lipidation of LC3B and autophagic degradation. This inhibitory effect was due to sequestration 
of unlipidated LC3B into stable complexes together with the ATG4B mutant, and thereby limit 
the availability of LC3B for phagophore elongation (Fujita et al., 2008). ATG4C is shown to 




KO of ATG4C seems to have minor phenotypic defects compared to KO of ATG4B (Marino 
et al., 2010; Marino et al., 2007).  
The structure of the ATG4B-LC3B complex solved by x-ray crystallography revealed 
that the ATG4B interaction with the ATG8s is mediated by two mechanisms: via its N-terminal 
LIR motif and via its kinase domain (Satoo et al., 2009). In addition, a novel C-terminal ATG4B 
LIR motif plays an important role in both binding and cleavage of its ATG8 substrate (discussed 
in paper III). The functional role of ATG4 for cleavage and activation of the ATG8s for 
conjugation to lipid moieties is well understood, while the functional relevance of the de-
lipidation step is unclear.  It is shown that yeast Atg4 mediates Atg8 de-lipidation at the outer 
membrane of the autophagosome, and this has two essential functions: to provide an adequate 
supply of un-lipidated ATG8 for autophagosome formation and to facilitate efficient fusion of 
the mature autophagosomes with lysosomes (Yu et al., 2012). In addition, ATG4 de-lipidation 
compensates intrinsic defects in the lipidation system that constitutively and non-selectively 
produces ATG8-PE at different intracellular membrane structures (Nair et al., 2012). Hence, 
Atg4 plays an essential role in delipidating these Atg8-PEs and thereby provides a large enough 
pool of un-lipidated Atg8s for autophagosome formation (Nair et al., 2012).  
Autophagy has an essential role in the clearance of intracellular bacteria. In response to 
host defense mechanisms, pathogens have developed strategies to manipulate the host cell 
machinery for their survival. Recently it was shown that Legionella pneumophila interfere with 
autophagy via its effector protein RavZ (Choy et al., 2012). RavZ displays preferential binding 
to high curvature membranes via its PI3P binding domain and functions as a cysteine protease 
by uncoupling lipidated ATG8 attached to autophagosome membranes. RavZ cleaves the amide 
bond between the C-terminal glycine and the preceding aromatic residue in ATG8, leading to 
the generation of ATG8s with no glycine residues for lipidation (Choy et al., 2012). 
Interestingly, RavZ interacts with the host ATG8s via two LIR motifs (Kwon et al., 2017). 
 
TP53INP1 and TP53INP2 
Tumor protein p53-inducible nuclear proteins 1 and 2 (TP53INP1 and TP53INP2) are 
described as bifunctional proteins acting as nuclear coactivators and as regulators of autophagy 
(Sancho et al., 2012; Seillier et al., 2012). Phylogenetic analysis shows that TP53INP1 is the 
ancestral gene and that TP53INP2 is a result of gene duplication (Nowak et al., 2009). 




TP53INP1 interacts with a kinase that phosphorylates p53 at S46, leading to transcriptional 
activation of apoptotic protein p53AIP1 (Oda et al., 2000). Later two kinases, homeodomain 
interacting protein kinase 2 (HIPK2) and proapoptotic PKC δ were found to mediate 
phosphorylation of p53 S46 during genotoxic stress (Tomasini et al., 2003; Yoshida et al., 
2006). Additional to its role in apoptosis, TP53INP1 is shown to interact with the ATG8 family 
proteins via an LIR motif and positively regulate autophagy (Seillier et al., 2012). Human 
TP53INP1 and TP53INP2 show 30% sequence identity and 45% similarity.TP53INP2 was first 
published as a transcription coactivator of the thyroid hormone receptor, thereby regulating its 
function (Baumgartner et al., 2007). The identification of TP53INP2 gene within chromosome 
20q11.22, loci associated with human obesity leads to the nomenclature of TP53INP2 as DOR 
(Diabetes- and Obesity Regulated)(Baumgartner et al., 2007). Recently, TP53INP2 was found 
to negatively regulate adipogenesis by promoting sequestration of GSK3β in an ESCRT 
dependent pathway (Romero et al., 2018). Similarly, to TP53INP1, TP53INP2 is reported to be 
implicated both in apoptosis and autophagy. It promotes death receptor-induced apoptosis via 
TRAF6 dependent ubiquitination of caspase-8 (Ivanova et al., 2019). Furthermore, TP53INP2 
regulates autophagosome formation via acting as a scaffold protein recruiting ATG8s to the site 
of phagophore formation via interactions with VMP1 and the BECN1 complex (Nowak et al., 
2009). TP53INP2 is a nuclear protein under normal conditions, but under mTOR inactivation, 
it translocate from the nucleus to autophagic structures in the cytoplasm (Nowak et al., 2009; 
Seillier et al., 2012). Moreover, TP53INP2 acts as a chaperone by translocating nuclear-
deacetylated LC3B to cytoplasmic autophagosome structures (Huang et al., 2015). Here it 
contributes to autophagosome biogenesis by promoting LC3-ATG7 interactions (You et al., 
2019). TP523INP2 is also reported to have a functional role in nutrient-rich conditions, 
enhancing rDNA transcription via the assembly of the rDNA transcription complex at the rDNA 
promoter (Xu et al., 2016). Hence, TP53INP2 has roles both when mTOR is inactive and when 
mTOR is active, as a facilitator of autophagy and by promoting ribosome biogenesis, 
respectively.  
Regulation of autophagy: Posttranslational modifications 
Posttranslational modifications (PTMs) regulate the stability, localization, and function 
of several proteins. The major types of PTMs include phosphorylation, ubiquitination, 
glycosylation, methylation, acetylation, SUMOylating, lipidation and proteolysis. These PTMs 
play essential roles in the regulation of each step of the autophagic pathway from the formation 




Several protein kinases, E1/E2/E3 ligases, and acetyltransferases have been identified to 
regulate autophagy by PTMs of autophagy proteins (Wani et al., 2015; Xie et al., 2015). 
Figure 9: Overview of the regulation of autophagy by posttranslational modifications. Acetylations 
(ac.), phosphorylations (P) and ubiquitinations (Ub) are indicated. 
ULK1, the key component of the autophagy initiation complex, is heavily regulated by 
PTMs. mTORC1 inhibits autophagy via phosphorylation of ULK1 at S758 and S638 (Shang et 
al., 2011). AMPK promotes autophagy by phosphorylation of ULK1 at S317 and S777 (Kim et 
al., 2011). The additional AMPK mediated phosphorylation of ULK1 (S467, S555, T574, S637) 
are identified to be essential in mitophagy (Egan et al., 2011). Also, PKA and AKT are 
implicated in phosphorylation ULK1 leading to inhibition of autophagy (Bach et al., 2011; 
Dorsey et al., 2009). Upon serum deprivation, acetylation of ULK1 at K162 by KAT5/TIP60 is 
found to be essential for the induction of autophagy (Lin et al., 2012). Moreover, K63-linked 




ULK1 stability and its function in autophagy (Nazio et al., 2013). ULK1 itself is a kinase and 
is associated with regulation of autophagy via phosphorylation of FIP200 and ATG13 
(Hosokawa et al., 2009a; Jung et al., 2009). 
Also, the downstream PIK3C3 complex responsible for the production of PtdIns3P is 
tightly regulated by PTMs. The BECN1 interaction with its negative regulator (BCL2) is 
increased upon epidermal growth factor receptor-mediated phosphorylation on the three 
residues Y229, Y233, and Y352 (Wei et al., 2013). This increases the association of BECN1 
with BCL2, and thereby negatively regulates the induction of autophagy. The interaction of 
BECN1 with BCL2 is mediated by the BH3 domain, and phosphorylation of the T119 residue 
within the BH3 domain leads to dissociation of BECN1 from its negative regulator and induces 
autophagy (Zalckvar et al., 2009). In addition to phosphorylation, TRAF6 mediated 
ubiquitination of lysine residue 117 within the BH3 domain induces autophagy by affecting the 
interaction of BECN1 with BCL2 (Shi and Kehrl, 2010). ULK1 mediated phosphorylation of 
BECN1 at S14 leads to initiation of autophagy by activation of the ATG14 bound VPS34 
complex (Russell et al., 2013). In mTOR dependent manner, ULK1 also directly phosphorylates 
ATG14 at serine 29 residues and positively regulates ATG14-VPS34 activity (Wold et al., 
2016). VPS34, another component of the PI3KC3 complex, is phosphorylated by CDK1 and 
CDK5 which inhibits its interaction with BECN1 and thereby inhibits autophagy (Furuya et al., 
2010). p300 mediated acetylation of VPS34 at K771 and K29 negatively regulates VPS34 
activity. The acetylation at K771 reduces VPS34’s affinity for phosphatidylinositol leading to 
reduced production of PI3P, while the acetylation at K29 affects the formation of the BECN1-
VPS34 complex (Su et al., 2017). TRIM28, an E3 ligase, positively regulates autophagy by 
increasing VPS34 activity via SUMOylation of K840 (Yang et al., 2013). 
The core proteins of the conjugation system, the ATG8s family proteins, are regulated 
by both phosphorylation and acetylation in addition to proteolysis. LC3B S12 phosphorylation 
mediated by protein kinase A (PKA) inhibits autophagy via reduced recruitment of LC3B to 
the phagophore (Cherra et al., 2010). PMA induced activation of protein kinase C leads to 
increased phosphorylation of LC3B at T6 and T29 (Jiang et al., 2010), but no effect on 
autophagy was detected. Recently, STK3/STK4 was found to phosphorylate LC3B T50, a site 
near the LDS.  The phosphorylation of LC3B T50 enhanced autophagosome-lysosome fusion 
(Wilkinson et al., 2015). Two residues within the LDS site, K49, and K51 are regulated by p300 
mediated acetylation. Under the nutrient-rich condition, p300 acetylates nuclear LC3B at K49 




Upon starvation, SIRT1 deacetylates LC3B. Deacetylated LC3B is shuttled out of the nucleus 
by TP53INP2 to the autophagosome formation sites in the cytoplasm (Huang et al., 2015). P300 
also inhibits autophagy by acetylation of proteins associated with the conjugating system such 
as ATG12, ATG5, and ATG7 (Lee and Finkel, 2009).  
Autophagy is also regulated at the transcription level, and several transcription factors 
regulating autophagy have been identified. The localization and activity of many transcription 
factors are regulated by PTMs. For example, the FOXO family regulates the expression of 
several genes associated with autophagy. Starvation-induced dephosphorylation of FOXO1 and 
FOXO3 results in shuttling from the cytoplasm to the nucleus where they induce expression of 
autophagy-related genes (Sengupta et al., 2009). FOXO1 also regulate autophagy in a 
transcriptional independent manner by direct interaction with ATG7. Serum deprivation or 
oxidative stress induced acetylation of FOXO1 is required for this interaction, which promotes 
autophagy (Zhao et al., 2010). The transcription factor EB (TFEB) is a master regulator of 
lysosomal function and autophagy. Under nutrient-rich conditions, TFEB is cytoplasmic and 
inactive. Under nutrient deficient conditions, dephosphorylation of TFEB at S142 and S211 
leads to nuclear localization, activation and subsequent transcription of its target genes 
(Roczniak-Ferguson et al., 2012; Settembre et al., 2011).     
Regulation of autophagy by serine-threonine kinases  
STK3/STK4 
The mammalian sterile 20-like kinases MST1(STK4) and MST2(STK3) are closely 
related protein serine-threonine kinases and are orthologues of the Drosophila Hippo kinase. 
They share ~ 75% sequence identity and >95% sequence identity within their catalytic domains. 
They were identified in a search for protein kinases with catalytic domains related to the 
Saccharomyces cerevisiae kinase Ste20 (hence mammalian Ste20 related)(Creasy and 
Chernoff, 1995). STK3/STK4 contain an N-terminal kinase domain followed by an 
autoinhibitory domain and a C-terminal SARAH domain (Figure 10) (Creasy et al., 1996).  The 
coiled-coil SARAH domain mediates homo- and heterodimerization. SARAH domains are ~50 
amino acids long and are named due to similar homologues structures within three gene families 
of SAV1/WW45 (Drosophila ortholog Salvador), RASSF 1-6, and Hippo (Drosophila 






Figure 10: Schematic diagrams of STK3 domain structure comprising N-terminal kinase domain and 
C-terminal SARAH domain. 
Activation of STK3/STK4 requires phosphorylation of a threonine residue within the activation 
loop (T183 in STK4  and T180 in STK3)(Praskova et al., 2004). Deletion of the autoinhibitory 
domain enhances the kinase activity whereas deletion of the SARAH domain reduces its 
activity due to the failure of the kinase to form homodimers (Praskova et al., 2004). In the Hippo 
pathway, STK3 and STK4 form a complex with their regulatory protein SAV1/WW45 and 
phosphorylate the downstream substrate LATS1/LATS2. In addition, STK3/STK4 also 
phosphorylate the LATS1/2 regulatory subunits MOB1A/MOB1B. The phosphorylation of the 
LATS1/2-MOB1A/B complex leads to its activation, which in turn phosphorylates the 
transcriptional co-activators YAP and TAZ. The phosphorylations lead to inhibition of YAP 
and TAZ transcriptional activity by preventing their nuclear translocation and enhancing their 
proteasomal degradation in the cytoplasm. These transcriptional co-activators regulate 
transcription of target genes associated with cell proliferation and survival (Meng et al., 2016). 
Besides the role of STK3/STK4 in the Hippo pathway, they are shown to interact with ATG8 
family proteins and negatively regulate autophagy (Behrends et al., 2010). There are several 
contradictory results regarding the role of STK4 in autophagy. On one hand, STK3/STK4 was 
identified as a kinase that phosphorylates LC3B at T50 leading to enhanced autophagosome-
lysosome fusion (Wilkinson et al., 2015). Another study showed that STK4 acts as a negative 
regulator of autophagy by phosphorylation of BECN1 leading to increased interaction with its 
negative regulator BCL2 (Maejima et al., 2013). 
 
PKCζ 
In mammals, the Protein Kinase C (PKC) superfamily consists of 10 related serine-
threonine kinases. The PKC superfamily is classified into three subfamilies based on their 
regulatory domains and physiological activators: classical, novel and atypical. The Classical 
PKCs contains three members (α, β, and γ) and their activity depends on the level of intracellular 
calcium, diacylglycerol (DAG), and phosphatidylserine (PS). The novel PKCs comprises four 




calcium. In contrast to the classical and novel PKCs, atypical PKC does not require DAG and 
calcium for their activation(Spitaler and Cantrell, 2004).  
The atypical PKCs consist of two members, PKCζ and PKCλ/I. The human PKC and 
mouse PKCλ are orthologs and share 98% amino acid sequence identity and thus referred to as 
PKCλ/ι. Moreover, amino acid sequence identity within PKCζ and PKCλ/ι is 86%.  Both PKCζ 
and PKCλ/ι contain an N-terminal PB1 domain, pseudosubstrate sequence, a cysteine-rich zinc 
finger domain, kinase domain and hydrophobic motif at C-terminal region. (Figure 11) (Suzuki 
et al., 2003). The kinase domain of PKCζ comprises an ATP binding region and an activation 
loop whereas AGC-kinase C-terminal domain contains a turn motif and a hydrophobic motif.  
 
Figure 11: Schematic diagram of PKCζ domain structure comprising N-terminal PB1 domain followed 
by pseudosubstrate sequence (PS), zinc finger domain, kinase domain and hydrophobic motif. 
Activation of PKCζ requires two sequential events: the first release of the 
pseudosubstrate from the substrate binding pocket and second phosphorylation of its kinase 
domain(Newton, 2001). Several lipid components such as phosphatidylinositols, phosphatidic 
acid, arachidonic acid, and ceramide are found to activate PKCζ (Limatola et al., 1994; Muller 
et al., 1995; Nakanishi et al., 1993).  Activation of PKCζ by enzymatically synthesized 
phosphatidylinositol 3,4,5 triphosphate (PIP3) suggested that it may be regulated by PI3K, a 
kinase which produces PIP3 in response to several growth factors (Nakanishi et al., 1993). 
Pleckstrin homology domain containing proteins such as AKT and PDK1 (3’-PI-dependent 
protein kinase 1) are activated by direct binding to PIP3. Activated PDK1 interacts with the C-
terminal hydrophobic motif within PKCζ and phosphorylates the T410 residues within the 
activation loop. This leads to exposure of its kinase active site and subsequent 
autophosphorylation of T560 in the turn motif, which is essential for PKCζ catalytic activity 
(Le Good et al., 1998). 
PKCζ is reported to be implicated in cell polarity, p70S6-protein kinase signaling 
cascade, NF-kB activation and the mitogen-activated protein kinase cascade (Reyland, 2009). 
Besides the canonical PKCζ isoform, a shorter isoform lacking the N-terminal regulatory 




PKMζ is constitutively active and has an essential role in the maintenance of long-term 
memory (Sacktor, 2012).  
PKC negatively regulates autophagy via inactivation of the PI3CA/AKT-mTOR 
signaling pathway (Qu et al., 2016). However, the roles of atypical PKCs in autophagy is not 
well understood. 
 
NIMA-related Kinase 9 (NEK9) 
Genetic screening in Aspergillus nidulans for cell cycle mutants lead to the 
identification of never-in-mitosis A (NIMA), a serine-threonine kinase (Oakley and Morris, 
1983). The deletion of NIMA kinase was found to be associated with G2 cell cycle arrest, 
whereas overexpression leads to premature entry into mitosis (Osmani et al., 1988). 
Subsequently, NIMA related kinases were found in a wide range of organisms. The human 
genome contains 11 genes that encode NEK1-NEK11 compared to Aspergillus nidulans which 
has a single gene. All members of this kinase family contain an N-terminal kinase domain, with 
exception of NEK10 having a centrally located kinase domain. The kinase domain contains a 
His-Arg-Asp (HRD) motif which is positively regulated by phosphorylation (Johnson et al., 
1996). In addition, the kinase activity is regulated by phosphorylation of serine or threonine 
residues within the activation loop (Roig et al., 2005). The human NEK consensus motif for 
substrate phosphorylation is F/L XX S/T (where xx denote any residue), with a preference for 
hydrophobic residues preceding the phosphorylation site (Alexander et al., 2011; Lizcano et al., 
2002).  The domain structure of human NEK9 is shown in (Figure 12).  
Figure 12: Schematic diagrams of NEK9 domain structure comprising N-terminal kinase domain, 6 
repeats of regulator of chromosome condensation 1(RCC1) domain and a C-terminal coiled-coil domain. 
The functions of NEKs are associated with mitotic spindle assembly, centrosome 
separation, chromatin condensation, disassembly of the nuclear pore complex and breakdown 
of the nuclear envelope (Quarmby and Mahjoub, 2005). Knockdown of NEK6, NEK7, and 
NEK9 leads to a defect in centrosome separation and formation of a weak mitotic spindle 
(Sdelci et al., 2011). NEK9 acts as an upstream kinase that phosphorylates both NEK6 and 
NEK7 and thereby activates their kinase activity (Roig et al., 2005). The role of NEKs in 




NEK9 with the human ATG8 family proteins, indicating its potential as a regulator of 

























Aims of the study 
The autophagy process is tightly regulated and induced upon various types of cellular 
stresses. Furthermore, the activity of many autophagy proteins is regulated by subcellular 
localization. For example, the most recognized autophagy marker protein LC3B is enriched in 
the cell nucleus under normal cellular conditions. However, when mTOR activity is impaired 
due to starvation conditions, LC3B is redistributed to autophagy structures in the cytoplasm. 
The main hypothesis of this work was that the interaction of LC3 with LIR-containing proteins 
is regulated by posttranslational modifications induced by cellular stress. 
To test this hypothesis, the following aims of the study were defined: 
i) Identify protein kinases that have the capacity to modulate LDS-LIR 
interactions by phosphorylation events. 
ii) Identify the mechanisms involved in the subcellular regulation of TP53INP2 
which has been reported to act as a LC3B chaperone facilitating nuclear export 
of LC3B upon mTOR inhibition. 
















Summary of papers 
 
Paper I 
Birendra Kumar Shrestha Mads Skytte Rasmussen, Yakubu Abudu Princely, Jack-
Ansgar Bruun, Kenneth Bowitz Larsen, Endalkachew A. Alemu, Eva Sjøttem, Trond 
Lamark & Terje Johansen (2019)  
Phosphorylation of LC3B at threonine-50 inhibits selective autophagy. Manuscript 
In this study, we showed that four serine-threonine kinases mediate phosphorylation of LC3B 
at the T50 residue in vitro. Various binding assays showed that three of these, STK3, PKCζ and 
NEK9, bound to the ATG8 proteins via LIR motifs within the kinases. A phospho-mimicking 
T50E mutant of LC3B displayed reduced binding to various autophagy-related proteins. 
Furthermore, reconstitution of the phospho-mimicking LC3B T50E mutant in LC3B KO cells 
resulted in reduced selective autophagy compared to wild type cells. Importantly, and in 
contrast to STK3, ablation of NEK9 lead to enhanced autophagic flux. This indicates that NEK9 
has the potential to regulate selective autophagy by mediating phosphorylation of LC3B at T50.  
Paper II 
Birendra Kumar Shrestha, Eva Sjøttem, Aud Øvervatn, Hanne B Brenne, Jack-Ansgar 
Bruun, Trond Lamark & Terje Johansen (2019)   
Subcellular localization of TP53INP2 is regulated by acetylation. Manuscript  
Here we show that the subcellular localization of TP53INP2 is regulated by acetylation events 
in an mTOR dependent manner. TP53INP2 is a nuclear protein under normal cellular 
conditions, and we mapped a nuclear localization signal (NLS) encompassing a nucleolar 
localization signal (NoLS) sequence within the C-terminal part of TP53INP2. Deletion of the 
NLS leads to cytoplasmic accumulation and degradation of TP53INP2 via the autophagy 
pathway. Similarly, inactivation of mTORC1 leads to cytoplasmic accumulation of TP53INP2. 
We found that this was due to acetylation of K187 within the NLS leading to inhibition of 
nuclear import of TP53INP2. Moreover, mTOR inhibition leads to ablation of nuclear 
TP53INP2, and we show that this is regulated by facilitated proteasomal degradation of 
TP53INP2. We identified that acetylation of the residues K159 and K204 within TP53INP2 is 






Mads Skytte Rasmussen, Stéphane Mouilleron, Birendra Kumar Shrestha, Martina 
Wirth, Rebecca Lee, Kenneth Bowitz Larsen, Yakubu Abudu Princely, Nicola O'Reilly, 
Eva Sjøttem, Sharon A. Tooze, Trond Lamark & Terje Johansen (2017) 
ATG4B contains a C-terminal LIR motif important for binding and efficient cleavage of 
mammalian orthologs of yeast Atg8. Autophagy 13: 834-853. 
 
In this study, we show that human ATG4B contains an LC3 interacting region (LIR) motif in 
its C-terminal region. We solved the crystal structure of GABARAPL1 in complex with a 
peptide containing the ATG4B C-terminal LIR motif, revealing the essential residues that 
mediated the LIR-LDS interaction. These residues were further confirmed by mutation analysis. 
By in vitro and in cell studies we found that the ATG4B C-terminal LIR motif is important for 
efficient cleavage and delipidation of the ATG8 family protein. In addition, we found that the 
C-terminal LIR motif stabilizes unlipidated GABARAP and GABARAPL1 by preventing them 






























In this thesis, we set out to study the regulation of the ATG8-LIR interactions by 
posttranslational modifications mediated by stress signaling pathways. An earlier publication 
showed that phosphorylation of LC3B threonine-50 (T50) by STK3/STK4 positively regulated 
autophagy (Wilkinson et al., 2015). We sought for kinases with potential to phosphorylate the 
T50 residue and identified NEK9 and PKCζ as additional candidates (Paper I). We further 
investigated whether phosphorylation of T50 in LC3B, a site close to the LDS region, affected 
the interaction of LC3B with various autophagy proteins. The autophagic activity of LC3B is 
also regulated by nucleo-cytoplasmic shuttling, reported to be chaperoned by the nuclear 
protein TP53INP2 (Huang et al., 2015). The subcellular localization of TP53INP2 itself is 
regulated by cellular stresses like starvation (Nowak et al., 2009), and in Paper II we found that 
this is mediated by acetylation events on specific lysine residues within TP53INP2. We revealed 
that the subcellular redistribution of TP53INP2 involved cytoplasmic retention and nuclear 
degradation in an mTOR dependent pathway. This will shed more light on the regulation of 
LC3B localization upon autophagy induction. In Paper III, we looked into the regulation of 
LC3B by proteolytic cleavage mediated by the protease ATG4B. We identified a C-terminal 
LIR motif in ATG4B important for efficient cleavage and delipidation of LC3B.  
In this chapter, the work conducted in the three papers will be discussed separately and put into 
context. For a more detailed discussion of the individual results, please consult the discussion 
sections of the respective papers. 
 
Regulation of the LC3B by phosphorylation of threonine-50 (Paper I) 
A previous work on the ATG8 interactome by Christian Behrends and colleagues 
identified several kinases with potential to bind ATG8 proteins. Here we set out to verify these 
interactions further and to determine their biological relevance (Behrends et al., 2010). 
We confirmed that the STK3, PKCζ, and NEK9 serine-threonine kinases interacted with 
human ATG8s. In contrast, we could not find any direct interaction of STK4 with the ATG8s. 
STK3 displayed very strong binding to LC3C and GABARAP but surprisingly the interaction 
with LC3B was weak. The strong preference for LC3C suggested that the interaction might 
involve a C type LIR motif. This was in line with the finding that interaction of STK3 with 
LC3C F58A, an LDS mutant, completely impaired binding. Furthermore, we identified a CLIR-
like motif ‘‘MVI’’ in STK3 mediating the strong interaction with LC3C and GABARAP. It is 




confirmed in our study.  The functional relevance of this phosphorylation was shown to be 
enhanced autophagosome lysosomal fusion and elimination of pathogens (Wilkinson et al., 
2015). Our finding that STK3 displays strong preference towards LC3C, combined with the 
knowledge on important roles of LC3C in xenophagy via NDP52 interactions, could indicate 
that STK3 also plays a role in xenophagy via phosphorylation of LC3C. Interestingly, we found 
that the phospho-mimicking LC3C T56E mutant had reduced the ability to interact with 
NDP52. This suggests that STK3 may be a negative regulator of xenophagy. Whether STK3 
phosphorylates LC3C in vivo and thereby regulates xenophagy will be an important question to 
address in future studies. 
We found the atypical serine-threonine kinase, PKCζ, to interact with all the human 
ATG8s homologues, with a preference for GABARAP. Both in vitro and in vivo association 
assays showed that PKCζ strongly interacts with GABARAP. Binding assays using LC3B and 
GABARAP LDS mutants suggested that the interaction was mediated by LIR motifs, and we 
identified a canonical LIR motif located within the C-terminal part of the kinase. Interestingly, 
the LIR motif completely overlapped with a hydrophobic motif known to mediate PKCζ 
interaction with its activating kinase, PDK1 (Parekh et al., 2000). This hydrophobic motif is 
essential for the activation of PKCζ by PDK1. It will be interesting to investigate whether 
interactions mediated by these overlapping motifs differentiate the roles of PKCζ in autophagy 
and other cellular processes. The PB1 domain of PKCζ mediates interaction with the autophagic 
receptor p62, which adds another dimension to its possible role in autophagy. By in vitro kinase 
assays, we found that PKCζ has the potential to phosphorylate LC3B at T50. An important 
question to address in future studies will be the effect of KD/KO of PKCζ on basal autophagy. 
NEK9 is previously reported to interact with the ATG8 proteins (Behrends et al., 2010),  
but its role in the regulation of autophagy is not well understood. Here we found that NEK9 
interacts with all human ATG8s homologues both in in vitro and in vivo binding assays. The 
interaction was LIR-LDS-mediated since the NEK9 interaction with a GABARAP LDS mutant 
was impaired. We screened all potential LIR motifs within NEK9 and identified that mutation 
of the residues W967 and L970 reduced its interaction with the ATG8s. This LIR motif is 
preceded by a stretch of acidic aspartic residues (D963 and D965) and serine residues (S964 
and S966) and followed by an acidic aspartic residue (D973), threonine (D972) and serine 
(S974) residues. Phosphorylatable amino acid residues are often associated with the regulation 
of LIR-LDS-interactions (Birgisdottir et al., 2013). We observed increased ATG8 binding of a 




substituted with glutamic acids, suggesting phosphorylation-mediated regulation of the NEK9 
LIR-LDS interaction. Interestingly, in vitro kinase assay showed that NEK9 has the ability to 
phosphorylate LC3B at T50, while siRNA mediated knockdown of NEK9 resulted in increased 
autophagic flux indicated by enhanced degradation of the autophagic receptor proteins p62 and 
NBR1. These results were supported by analysis of autophagic flux in a CRISPR/CAS9 NEK9 
KO cell line. Hence, our results suggest that a possible mechanism for NEK9 to regulate 
selective autophagy implicates phosphorylation of LC3B T50. 
 
The phospho-mimicking T50E mutant of LC3B regulates LIR-LDS 
interactions (Paper I) 
PTMs act as switches in the regulating of protein-protein interactions and thereby 
regulation of protein function. LC3B interacts with several autophagy-related proteins via LIR-
LDS interactions (Birgisdottir et al., 2013). Interestingly, the LC3B LDS contains two lysine 
residues (K49 and K51) and one threonine residue (T50) indicating possible regulation of 
function via PTMs. Recently, it was shown that under nutrient-rich condition, nuclear LC3B is 
acetylated at the K49 and K51 residues by the acetyltransferases p300 and CBP (Huang et al., 
2015).  These acetylations inhibit interaction with TP53INP2 and thereby prevents the nuclear 
export of LC3B. Upon starvation or mTOR inactivation, SIRT1 deacetylates nuclear LC3B K49 
and K51 residues and restores its interaction with TP53INP2 leading to nuclear export of LC3B. 
In the cytoplasm, this nuclear LC3B protein pool interacts with autophagy-related proteins to 
initiate autophagosome formation (Huang et al., 2015). The STK3/STK4 kinases are previously 
reported to phosphorylate the T50 residue regulating autophagosome-lysosome fusion 
(Wilkinson et al., 2015). We set out to investigate the functional effects of the T50 
phosphorylation using a phospho-mimicking LC3B T50E mutant. To avoid possible effects of 
endogenous LC3B, we used CRISPR/Cas9 to KO endogenous LC3B and later reconstitute the 
KO cell line with Myc tagged LC3B WT, LC3B T50A, T50E, and the LDS mutant F52A/L53A. 
The LC3B KO cells showed reduced autophagic flux, indicated by increased accumulation of 
p62 and NBR1 (Maruyama et al., 2014), which was restored by reconstitution with LC3B WT. 
Interestingly, reconstitutions with LC3B T50E and F52A/L53A lead to increased inhibition of 
autophagic flux compared to the LC3B KO cell line, suggesting negative regulation of 
autophagy via T50 phosphorylation. These results were supported by reconstitution of the 
LC3B KO cells with mCherry-EYFP-LC3B WT and T50E, showing that mCherry-EYFP-




mimicking mutant is that it is constitutively mimicking phosphorylation. In cells, 
phosphorylation is a dynamic process often acting as a switch to turn on or off interaction or 
activities regulated by specific kinases and phosphatases. To further investigate the 
consequences of LC3B T50 phosphorylation, we performed various binding assays with 
autophagy-related proteins containing LIR motifs. Importantly, we revealed that binding of the 
LC3B T50E mutant with autophagic receptors such as p62 and NBR1 is significantly reduced 
compared to the wild type protein. Moreover, the interactions with ATG4B and with ATG7 
were both severely reduced. Interestingly, the LC3B-ATG7 interaction was not affected by the 
LC3B F52A/L53A mutation, indicating that the interaction of LC3B with ATG7 does not 
involve the LDS site directly, but rather electrostatic interactions. This displays similarity with 
a previous study showing that Lamin B1 interacts with LC3B via electrostatic interactions with 
the R10 and R11 residues (Dou et al., 2015). From the predicted structure (Paper I, Figure 
6A), phosphorylation of LC3B T50 inhibits such electrostatic interactions. Altogether, these 
results show that phosphorylation of LC3B T50 can affect the cleavage and lipidation steps. 
Furthermore, we observed reduced interaction of the LC3B T50E mutant with FYCO1, 
indicating that completed autophagosomes might have reduced capacity to be transported to 
perinuclear lysosomal compartments for lysosomal fusion. The LC3B interaction partner 
syntaxin 17 is associated with autophagosome-lysosome fusion (Itakura et al., 2012). It is 
published that the LC3B-syntaxin 17 interaction is LIR-LDS mediated (Kumar et al., 2018). 
We found reduced interaction of LC3B T50E with syntaxin 17 compared to wild type LC3B, 
indicating that the phosphorylation may negatively regulate the autophagosome lysosomal 
fusion process. Thus, phosphorylation of LC3B T50 seems to have a negative effect on LIR-
LDS interactions in general and may be an important site for regulation of the autophagic 
activity of LC3B. 
 
Acetylation regulates subcellular localization and degradation of TP53INP2 
(Paper II) 
TP53INP2 is in a previous study showed to act as a LC3B chaperone, mediating nuclear 
export of LC3B upon starvation conditions (Huang et al., 2015). The study showed that nuclear 
export of TP53INP2 itself is regulated by 4 major factors: mTOR activity, a nuclear export 
signal, interactions with ATG8s via an LIR motif, and ATG5 (Nowak et al., 2009; Sancho et 
al., 2012). In this paper, we report several conflicting results to these studies. Instead of nuclear 
export, we found that upon mTOR inactivation, the relocalization of TP53INP2 is due to 




proteins. These findings were supported by the absence of a functional NES motif in TP53INP2, 
failure of the CRM1 inhibitor LMB to restrict TP53INP2 inside the nucleus, reduced interaction 
of TP53INP2 with importin under mTOR inhibition, and finally FRAP experiments showing 
no export of nuclear proteins. Furthermore, analysis in ATG5 KO cells showed similar 
localization of TP53INP2 as the WT cells under cellular stress conditions, indicating that the 
redistribution of TP53INP2 is independent of autophagy.  To conclude, our study does not rule 
out nuclear export of deacetylated LC3B upon mTOR inhibition, but our data strongly suggest 
that TP53INP2 does not act as a scaffolding protein for this process.   
The role of TP53INP2 in autophagosome formation is well recognized, recruiting LC3B 
and the BECN1 complex to the forming autophagosome (Nowak et al., 2009). The recruitment 
of LC3B to the autophagosome structure is mediated by a direct LIR motif dependent 
interaction, whereas the BECN1 complex is recruited by VMP1 interactions (Nowak et al., 
2009). Furthermore, TP53INP2 is reported to contribute to autophagosome formation by 
facilitating the interaction of LC3 with ATG7 (You et al., 2019). However, this study failed to 
prove the contribution of TP53INP2 in autophagosome formation, as KD of TP53INP2 did not 
affect the formation of autophagosomes. In line with this study, we did not detect any significant 
effect of TP53INP2 KO on basal autophagy or starvation-induced autophagy. However, we 
cannot rule out the possibility that TP53INP1 and TP53INP2 may have redundant functions in 
autophagosome formation. This has to be addressed by future studies in a TP53INP1/TP53INP2 
double KO cell model. Furthermore, our data also suggest that the recruitment of TP53INP2 
into autophagosome structures observed in previous studies might be the result of 
overwhelming the regulation of TP53INP2 for degradation by the proteasomal pathway - 
leading to cytoplasmic overexpression and degradation by a compensatory autophagy pathway. 
This is based on our finding that an expression level of TP53INP2 close to endogenous level 
(which we obtained by reconstituting TP53INP2 KO cells with EGFP-TP53INP2), failed to co-
localize with LC3B positive structures in the cytoplasm. However, over-expressed EGFP-
TP53INP2 colocalized with cytoplasmic LC3B positive structures. Furthermore, deletion of the 
NLS signal in TP53INP2 resulted in cytoplasmic over-expression and co-localization with 
cytoplasmic LC3B dots. Thus, according to our results, the cytoplasmic degradation of 
TP53INP2 is regulated by C-terminal lysine residue modification. During the overexpression 
of TP53INP2, such regulation is overridden. As mentioned above, we could not see any effect 
of KO of TP53INP2 in autophagic flux, lead to raising a question for a novel functional role of 




in death receptor signaling was reported (Ivanova et al., 2019). This study showed that 
TP53INP2 sensitizes various cell lines to death receptor-induced apoptosis by increasing the 
activation of caspase 8 upon TRAF6 dependent K63 ubiquitination (Ivanova et al., 2019). 
Hence, TP52INP2 seems to have functional roles in the cytoplasm unrelated to the regulation 
of the autophagy pathway. The nuclear role of TP53INP2 is well understood. Under the 
nutrient-rich condition, TP53INP2 is localized to both nucleus and nucleoli where it facilitates 
the transcription activity of the thyroid hormone receptor and of RNA polymerase I important 
for biogenesis of the ribosomes (Baumgartner et al., 2007). These observations are in line with 
our study, as TP53INP2 KO cells displayed reduced cell proliferation and transcription of 
rDNA.  
Several transcription factor’s subcellular localization is regulated by posttranslational 
modifications.  For example, the nuclear-cytoplasmic shuttling of TFEB, a master regulator of 
lysosomal biogenesis, is controlled by phosphorylation of two key serine residues (S142 and 
S211)(Roczniak-Ferguson et al., 2012; Settembre et al., 2011). Under mTOR inactivation, these 
serine residues are dephosphorylated leading to nuclear import. With this in mind, we 
investigated the potential role of phosphorylation events in regulating nuclear-cytoplasmic 
shuttling of TP53INP2. However, deletion of serine/threonine residues did not display any 
effect on nuclear import. Instead, the mutation of lysine residue K187 completely inhibited 
nuclear import of TP53INP2, indicating that acetylation could be involved in the regulation of 
the nuclear-cytoplasmic localization. Mass spectrometry data indicated that all three-lysine 
residues in the C-terminal, K165, K187, and K204, undergo acetylation under starvation. 
Mutation of K165 and K204 resulted in accumulation of TP53INP2, suggesting that acetylation 
of these residues enhances degradation of nuclear TP53INP2 under starvation. This fits with its 
anabolic role under nutrient-rich conditions, facilitating ribosomal biogenesis. Unlike other 
autophagy-related proteins, such as ATG7, ATG8, and ATG12 which are deacetylated upon 
starvation (Lee and Finkel, 2009), TP53INP2 undergoes acetylation upon starvation. However, 
acetylation is observed for other proteins like tubulin, which undergoes hyperacetylation under 
starvation conditions (Geeraert et al., 2010). Interestingly, a study showed that AMPK mediates 
p300 dependent acetylation of importin α1 and thereby regulates the nuclear import of the RNA 
binding protein, Hu-antigen R (Wang et al., 2004). P300 mediated acetylation of the histone 
deacetylase HDAC6 blocks its interaction with importin α and thereby inhibits HDAC6 nuclear 




acetylation of all three-lysine residue in TP53INP2 and thereby regulate both nuclear 
degradation and nuclear import of TP53INP2.  
In contrast to TP53INP1 which undergoes lysosomal degradation under nutrient-rich 
conditions (Seillier et al., 2012), our data indicate that TP53INP2 can be degraded by a 
nucleolar ubiquitin-independent proteasomal pathway. The nucleolar ubiquitin-independent 
proteasomal pathway is not well characterized. Recently, a protein interacting with carboxyl 
terminus 1 (PICT1), a nucleolar ribosomal protein and regulator of p53, was shown to be 
degraded by a nucleolar ubiquitin-independent proteasomal pathway (Maehama et al., 2014). 
Interestingly, under starvation, we observed increased levels of TP53INP2. This increased level 
was not only due to cytoplasmic retention but predominantly resulted from new protein 
synthesis. Inhibition of protein synthesis by cycloheximide treatment of cells exposed to 
starvation showed no increased accumulation of TP53INP2. Interestingly, a study has shown 
that the expression of p53, an inducer of TP53INP2, is increased in hepatic tissue under 
starvation. This was required for gluconeogenesis and amino acid catabolism, and dependent 
on AMPK signaling (Prokesch et al., 2017). Moreover, a study performed proteomic profiling 
of de novo protein synthesis under starvation-induced autophagy was recently published (Wang 
et al., 2016a),  pointing towards increasing interest on proteins that are stabilized ant hence may 
serve important roles in starving cells.  Thus, the functional role of starvation-induced 
stabilization of TP53INP2 will be an important subject for future research. 
 
ATG4B-mediated regulation of ATG8s via LIR-mediated binding (Paper 
III) 
The functional roles of the cysteine protease ATG4B for initial cleavage of pre-ATG8s 
and later delipidation of ATG8s from membrane structures, are well established (Kabeya et al., 
2004; Kirisako et al., 2000). The structure of the ATG4B-LC3B complex has been solved by 
x-ray crystallography,  which has explained the mechanisms involved in LC3B processing and 
delipidation (Satoo et al., 2009). The ATG4B protein used in the structure analysis lacked the 
C-terminal region (355-393) because of high flexibility. Thus, the structure failed to provide 
the contribution of the C-terminal region of ATG4B for binding and cleavage activity. 
However, the published structure predict the LIR motif in the N-terminal part of ATG4B might 
mediate interaction with adjacent non-substrate LC3Bs (Satoo et al., 2009). This LIR motif, 
LIRN, lacks any preceding acidic residues which are often involved in electrostatic interactions 




in vitro and in vivo binding and cleavage assays to delineate the roles of each LIR motif for 
LC3B binding and processing.  Interestingly, we found that strong binding between ATG4B 
and LC3B or GABARAP is mediated by two main interaction sites: the catalytic domain 
interaction and the LIRC -LDS interaction. Our modeled structure suggests that such two-
surface interactions are possible by a long and flexible linker between the catalytic domain and 
LIRC. The requirement of ATG4B LIRC motif for efficient cleavage of its substrate was further 
supported by an independent study of ATG4B in Xenopus Laevis (Frey and Gorlich, 2015). In 
this study, the cleavage efficiency of ATG4B was significantly affected by deletion of the 
ATG4B C-terminal part (Δ345-384) rather than the N-terminal part (Δ1-14). However, they did 
find a reduced activity when a longer region (1-25) was deleted (Frey and Gorlich, 2015). By 
combining these three studies, we could interpret the ATG4B-LC3B interaction as a three-
surface interaction. First, LIRN may play a role by trans-interaction with an adjacent membrane 
conjugated LC3B, thereby opening the active site of ATG4B. Secondly, this change in the 
ATG4B confirmation, allows the catalytic site to interact with the ATG8s in a non LIR-LDS 
manner. Thirdly, the ATG4B LIRC motif mediates cis-interaction with its substrate LC3B for 
efficient binding and cleavage. This kind of cis-trans-interaction might be involved in vivo for 
efficient cleavage and delipidation of LC3B on membranous structures. In contrast to human 
ATG4B, yeast ATG4 displayed a unique type of interaction with ATG8. Yeast ATG4 contains 
four putative LIR motifs, of which three were found to be functional (Abreu et al., 2017). The 
yeast LIR motif 102FVPI105 was essential for mediating interaction with lipidated ATG8 and is 
called the ATG8-PE associated region (APEAR). The specific interaction with lipidated ATG8 
indicated a specific role in the deconjugation step as deletion of the APEAR motif resulted in 
defects in cleavage and delipidation. We predict that the human ATG4B LIRC is functional 
related to the yeast APEAR since mutation of LIRC only affected the binding with the ATG8s, 
while cleavage and autophagic flux was unaltered (Abreu et al., 2017). In contrast, a study in 
human cells showed that de-lipidation by ATG4B is not a prerequisite for autophagosome 
formation and fusion with lysosomes. In this study, overexpression of pre-primed LC3B(LC3B 
with exposed C-terminal glycine) in ATG4B KO cells recused the autophagic flux (Agrotis et 
al., 2019). 
LIR-LDS interactions are often regulated by phosphorylation of adjacent residues 
(Birgisdottir et al., 2013). During our study, another research group reported the regulation of 
ATG4B activity by phosphorylation of two serine residues flanking each side of the ATG4B 




to be increased upon mTOR inactivation mediated by Rapamycin, and thereby lead to increased 
ATG4B cleavage activity (Yang et al., 2015). In support, another study showed that MST4 
mediated phosphorylation of ATG4B at S383 leads to enhanced ATG4B activity and autophagy 
flux in glioblastoma cells.  Our GABARAPL1-ATG4B LIRC structure, however, revealed that 
phosphorylated S392 is facing toward the solvent and phospho-mimicking mutants of these 
residues (S383 or S392E) did not significantly affect binding. Recently, a study showed that 
ULK1-mediated phosphorylation of S316 residues within the kinase domain of ATG4B 
negativity regulates its catalytic activity (Pengo et al., 2017). 
Delipidation of ATG8-PE from the autophagosome membrane is essential for providing 
an unlipidated pool of ATG8s and for efficient autophagosome lysosomal fusion (Nair et al., 
2012).  Studies in yeast have shown that for a continuous supply of unlipidated ATG8s, ATG4 
dependent delipidation of ATG8-PE from nonPAS membranous structures is required (Yu et 
al., 2012). Other studies have shown that overexpression of ATG4B stabilizes unlipidated 
GABARAP and GABARAPL1 sequestering it from delivery to ATG7 (Fujita et al., 2008). In 
line with these studies, we observed reduced amounts of unlipidated GABARAP and 
GABARAPL1 in ATG4B KO cells reconstituted with the EGFP-ATG4B LIRC mutant or the 
EGFP-ATG4B ΔLIRC. This result indicates that ATG4 LIRC motif is required for the formation 
of a stable complex with GABARAP and GABARAPL1 mediating efficient delipidation. In 
cells lacking ATG4B, stabilization of the ATG8s was impaired due to rapid proteasomal 
degradation resulting in a reduced availability of unlipidated ATG8s for autophagosome 
formation. The strong binding to the ATG8 proteins mediated by the ATG4B LIRC motif may 
sequester them from ATG7, and thereby inhibit autophagosome formation. Hence, despite 
enhancing binding affinity and cleavage efficiency, the ATG4B LIRC may be associated with 
negative regulation of autophagy. This negative regulatory effect is probably dependent on the 
expression level of ATG4B, as observed in another study where overexpression of ATG4B WT 
had a negative effect on autophagosome formation (Fujita et al., 2008). However, at the low 
endogenous expression level of ATG4B, the LIRC may have a positive effect on autophagosome 







In our study, we used CRISPR/Cas9 technology to generate various KO cell lines. For 
this purpose, we cloned specific guide RNA sequences targeting the gene of interest into a 
plasmid expressing Cas9 WT. The Cas9 WT makes double-stranded DNA cut after recognition 
of PAM sequence and binding of guide RNA with its specific target gene sequence. The guide 
RNA is normally 21 nucleotides long and can potentially bind to non-target genes leading to 
off-target effects (Fu et al., 2013). The specificity of CRISPR/Cas9 can be increased using a 
mutant form of Cas9, which makes single-stranded DNA nicks and requires binding of two 
guide RNA target sequences for generating a staggered double-stranded DNA cut (Ran et al., 
2013). The KO cells generated in this study were made using wild type Cas9, so we cannot rule 
out possible off-target effects and artifacts due to clonal selection. In paper I, we observed 
decreased autophagic flux in the LC3B KO cells, leading to accumulation of autophagy 
receptors such as p62 and NBR1. However, the decreased autophagic flux was restored to 
normal levels when the LC3B KO cells were reconstituted with myc-tagged LC3B. This 
strongly indicated that the reduced autophagy flux was a phenotype due to ablation of LC3B, 
and not due to off-target effects.  
The use of double-tagged mCherry-EYFP LC3B could affect the function of LC3B, as 
a study has shown that the use of EGFP tagged ATG8s failed to rescue ATG8 KO cells (Nguyen 
et al., 2016). Hence, we do not know to what extent double tagged LC3B punctate structures 
mimic endogenous LC3B. 
We applied the Flp-In T-REx system for reconstitution of LC3B/TP53INP2 KO cells. 
This system is based on the tetracycline-inducible expression of the gene of interest. Hence, the 
level of gene expression can be regulated by titration of the inducing agent. However, an 
expression level completely similar to the endogenous expression levels is hard to obtain. 
Furthermore, the gene of interest is not under the control of the endogenous promoter, but 
instead a CMV promoter in the FlpIn system. Hence, a main drawback with the reconstituted 
KO cells is that the expression of the reconstituted protein is not at the same level or regulated 
in the same way as the endogenous protein. Thus, if the protein of interest is tightly regulated 
by the endogenous promoter, higher or lower expression levels could have detrimental 
functional effects such as in the case of ATG4B where overexpressed ATG4B inhibits 
autophagosome formation (Fujita et al., 2008).  In our ATG4B study, we observed a clear effect 
of ATG4B on the stabilization of unlipidated GABARAB. Hence, we cannot rule out the 




(Joachim et al., 2015). Similar to the negative effect of higher expression of ATG4B, our study 
suggests that overexpression of TP53INP2 performed in many other studies can override the 
regulation by PTMs and turn on activation of an alternative degradation pathway. 
The use of a phospho-mimicking LC3B T50E construct is not a true reflection of the 
phosphorylation of T50. Phosphorylation is a dynamic process which is switched on and off at 
a precise time point, while reconstitution with a phospho-mimicking mutant creates a 
constitutively active phosphorylation state. Furthermore, glutamic acid does not completely 
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Human Atg8 orthologues are involved in all steps of the autophagy pathway, and their lipidation 
is essential for autophagosome formation. Lipidated Atg8 orthologues anchored to the outer 
surface of the phagophore serve as scaffolds for the binding of other core autophagy proteins 
and various effector proteins involved in trafficking or fusion events, while those at the inner 
surface are needed for the assembly of selective autophagy substrates. The scaffolding role of 
Atg8 orthologues depends on specific interactions formed between the LC3 interacting region 
(LIR) docking site (LDS) of the Atg8 orthologues and LIR motifs in various interaction 
partners. LC3B was recently reported to be phosphorylated at threonine 50 (T50) within the 
LDS by serine/threonine-protein kinases STK3 and STK4. Here we identify LIR motifs in 
STK3 and in the serine/threonine kinases atypical protein kinase C (PKC) and never in 
mitosis A (NIMA)-related kinase NEK9. All three kinases mediate phosphorylation of LC3B 
T50 in vitro. Knock-down and knock out of NEK9 resulted in enhanced degradation of the 
autophagic substrate p62. Introduction of a phospho-mimicking mutation at the T50 position in 
LC3B caused impaired binding of several LIR-containing proteins, such as ATG4B, p62, 
NBR1, and FYCO1. Reconstitution of LC3B KO cells with the phospho-mimicking mutant 
LC3B T50E lead to inhibition of autophagic degradation of the selective autophagy receptors 













Macroautophagy (hereafter referred to as autophagy) is an evolutionarily conserved pathway 
for degradation of cytosolic components (1). Autophagy begins with the formation of a double 
membrane structure termed the phagophore. The phagophore grows to envelope cytosolic 
content resulting in the formation of a closed double membrane structure surrounding the 
content, the autophagosome. The autophagosome might fuse with late endosomes before 
ultimately fusing with lysosomes forming an autolysosome, in which the content is degraded 
(2). Autophagy can either be nonspecific i.e. degradation of long-lived cytosolic proteins, 
termed bulk autophagy or selective, i.e. targeted the degradation of specific proteins and 
organelles (3). Selective autophagy is involved in the degradation of a diverse range of cytosolic 
components including mitochondria (mitophagy), peroxisomes (pexophagy), protein 
aggregates (aggrephagy), bacteria (xenophagy) and the ER (reticulophagy)(4). Selective 
autophagy relies on a number of cargo receptors of which the most well studied is p62/SQSTM1 
(sequestosome-1) (5,6). These cargo receptors interact with ATG8 proteins through the LC3-
interacting-region (LIR) motif, which tethers the cargo receptors, along with their cargo, to the 
phagophore (7).   
| Core to the autophagic pathway is the ATG8 family of proteins that, except for an N-
terminal arm, structurally resemble the ubiquitin family of proteins (8). The mammalian ATG8 
family consists of 7 members subdivided into 2 families: MAP1LC3/LC3 (microtubule-
associated protein 1 light chain 3) -A, -B, -B2 and -C and GABARAP (gamma-aminobutyric 
acid receptor-associated protein), GABARAPL1 (gamma-aminobutyric acid A receptor-
associated protein-like 1) and GABARAPL2. The ATG8s are first cleaved by the cysteine 
protease family ATG4 exposing a C-terminal glycine (9). In a manner analogous to the 
ubiquitin system, ATG8s are first activated by ATG7 (E1-like), transferred to ATG3 (E2-like), 
before finally becoming covalently attached to phosphatidylethanolamine (PE) by the action of 
the ATG12-ATG5-ATG16 complex (E3-like), enabling membrane attachment (10). ATG8s are 
released from the phagophore, and from the outer membrane of the autophagosome, by ATG4-
mediated cleavage of the ATG8-PE bond thereby restoring free ATG8 (11). The ATG8s have 
been shown to be involved in the nucleation, expansion (12), and closure of the phagophore 
(13). 
The ATG8s coat the inner and outer membrane of the phagophore (14), and function as 
anchoring points for the autophagic machinery as well as recruitment of cargo receptors to the 
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phagophore (7). A growing number of protein interactions involving ATG8s have been shown 
to be mediated through a LIR motif on the binding partner of ATG8, which interacts with the 
LIR-docking-site (LDS) on ATG8 (15). The LDS consists of two hydrophobic pockets (HP1 
and -2) capable of encompassing the core residues of the consensus LIR sequence separated by 
two variable amino acids ([W/F/Y]-X-X-[L/I/V])(16). Another type of LIR motif termed C-
type LIR (CLIR) has also been shown to bind LC3C through interaction with HP2 (17). LIR 
motifs are very often flanked N-terminally by acidic residues that interact with basic residues 
in the N-terminal alpha helix of ATG8s (15). The variation within the LIR motif sequence 
determine preferential binding to individual ATG8 family members and determine binding 
affinity and thereby competitive interaction with other LIR motif-containing autophagic 
proteins. Such binding specificity might regulate the autophagy pathway (15). The autophagy 
pathway is tightly regulated by several autophagy-related proteins. Among such regulatory 
proteins are kinases such as ULK1 (unc-51 like autophagy activating kinase 1) and -2 and 
mTOR (mechanistic target of rapamycin) (18). Several other serine-threonine kinases were 
identified as interactors of ATG8 family proteins in a human autophagy interactomics study 
(19). NEK9 belongs to the NIMA (Never in Mitosis A)-related kinase family. Members of the 
NIMA family are associated with cell cycle-related function during mitosis. Specifically, NEK9 
plays an essential role in the assembly of spindle fibers early in mitosis (20). STK3 
(Serine/threonine-protein kinase 3) and STK4 play an essential role in the Hippo signaling 
pathway. STK3 and STK4 act as negative regulators of transcription co-activators YAP1 (Yes-
associated protein 1) and WWTR1 (WW domain containing transcription regulator 1 
(WWTR1). YAP1 and WWTR1 are associated with genes that regulate cell proliferation, 
survival, and differentiation (21). Besides its role as a tumor suppressor, loss of STK4 leads to 
high susceptibility toward infection likely due to loss of immune cells (B and T lymphocytes) 
(22,23). STK4 was first reported as a negative regulator of autophagy. STK3 was shown to 
negatively regulate autophagy via phosphorylation of Beclin 1 at T108, thereby promoting 
interaction between Beclin 1 and Bcl-2 (24). The role of atypical protein kinase C in autophagy 
is less understood. Recently, protein kinase C iota (PKC) was shown to negatively regulate 
autophagy via direct phosphorylation-mediated activation of PI3 kinase-AKT-mTOR signaling 
pathway (25). 
Several post-translational modifications (PTMs) have been reported in LC3B both 
surrounding the core LDS as well as in the N-terminal arm (26). Phosphorylation of threonine-
6 (T6) and T29 in the N-terminal arm of LC3B by PKC has been reported but was found to 
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have no effect on overall autophagy or LC3B processing (27). Several other studies have 
reported PTMs near the LDS including phosphorylation of T50 (28), as well as acetylation of 
lysine-49 (K49) and K51(29). Phosphorylation of T50 by STK3 and -4 is reported to be required 
for proper autophagosome-lysosome fusion (28). Furthermore, STK3+/-/STK4-/- knockout cells 
display deficient xenophagy, as these cells are unable to efficiently clear intracellular bacteria 
(28). Acetylation of K49 and K51 is reported to cause nuclear retention of LC3B in full medium. 
Upon starvation, LC3B is deacetylated by SIRT1 and transported out of the nucleus by 
DOR/TP53INP1. This shuttling was found to be crucial for the ability of LC3B to form puncta, 
most likely representing autophagosomes, in the cytosol (29).  
Given the proximity to the LDS, we hypothesized that phosphorylation of T50 could 
regulate, the interaction between LC3B and LIR-containing proteins. To this end, we used 
CRISPR/Cas9 technology to establish a Flp-In T-Rex HEK293 LC3B knockout (KO) cell line. 
By stably reconstituting the LC3B KO cell line with LC3B WT, -T50A, -T50E and LC3B 
F52A/L53A (LDS mutants) we found that selective autophagic flux was strongly inhibited by 
both T50E and F52A/L53A mutations. Furthermore, the phospho-mimicking LC3B T50E 
mutant displayed significantly reduced interaction with several essential autophagy-related 
proteins such as p62/SQSTM1(sequestosome-1), ATG7, ATG4B, FYCO1, and Syntaxin-17. 
By in vitro phosphorylation assays, we identified NEK9 as a potential kinase that mediates 
phosphorylation of LC3B T50. Interestingly, the KO of NEK9 led to enhanced autophagic flux. 
This suggests that NEK9 may regulate autophagy involving LC3B by phosphorylation of T50 
within the LDS.  
 
Materials and methods 
Plasmids  
The Gateway entry clones used in this study are listed in the table below. QuickChange site-
directed mutagenesis kit (Stratagene) was used to create desired point mutation which was 
verified by DNA sequencing (BigDye sequencing kits, Applied Biosystems). For a generation 





Gateway cloning vectors 
Plasmid Description Source 
pENTR1A, 2B,3C Gateway entry vectors Invitrogen 
pDest 3XFlag mammalian triple flag tagged expression vector, CMV  (30) 
pDestEGFP-C1   mammalian EGFP tagged expression vector, CMV (31) 
pDest15 Bacterial GST tagged expression vector, T7 promoter Invitrogen 
pDestYFP-Flp-In Mammalian Flp-In expression vector, Tet-inducible, CMV (32) 
 
Gateway entry vectors 
Plasmid Source 
pENTR -STK3 This study 
pENTR -STK4 This study 











pENTR -STK3 (1-357) This study 
pENTR -STK3 (1-411) This study 
pENTR -STK3 (1-404) This study 
pENTR -STK3 (F402A/K405A) This study 
pENTR -STK3 (323-491) This study 
pENTR -STK3 Δ405-411 This study 
pENTR -STK3 D146N This study 
pENTR -STK3 MVI365-367AAA This study 
pENTR -STK4 D149N This study 
pDONOR223-NEK9 D179N This study 
pENTR -GABARAP Y49A (35) 
pENTR -LC3C F58A This study 
pENTR-LC3B T50A This study 
pENTR-LC3B T50E This study 
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pENTR-LC3B F52A/L53A This study 
pENTR-NBR1 D50R ΔCC (31) 
pDONOR223-NEK9 W718A/I721A This study 
pDONOR223-NEK9 Y845A/L848A This study 
pDONOR223-NEK9 W967A/L970A This study 
pENTR-ATG7 This study 
pENTR- PKCζ This study 
pENTR- PKCζ F37A/L40A This study 
pENTR- PKCζ F252A/I255A This study 
pENTR- PKCζ W434A_L454A This study 
pENTR- PKCζ W575A/I578A This study 
pENTR-LC3C T56A This study 
pENTR-LC3C T56E This study 
 
Gateway expression clones 
Plasmid Source 
pDestmcherry YFP-Flp-In-LC3B  This study 
pDestmcherry YFP-Flp-In-LC3B T50A This study 
pDestmcherry YFP-Flp-In-LC3B T50E This study 
pDestmcherry YFP-Flp-In-LC3B F52A/L53A This study 
pDestmyc-Flp-In-LC3B  This study 
pDestmyc-Flp-In-LC3B T50A This study 
pDestmyc-Flp-In-LC3B T50E This study 
pDestmyc-Flp-In-LC3B F52A/L53A This study 
pDestMyc ATG4B (36) 
pDestMyc ATG7 This study 
pDestMyc NBR1 D50R ΔCC1 (37) 
pDestMyc NEK9 This study 
pDestMyc NEK9 W718A/I721A This study 
pDestMyc NEK9 Y845A/L848A This study 
pDestMyc NEK9 W967A/L970A This study 
pDest3XFlag-NEK9 D179N This study 
pDestMyc-STK3 1-357 This study 
pDestMyc -STK3 1-411 This study 
pDestMyc -STK3 1-404 This study 
pDestMyc -STK3 F402A/K405A This study 
pDestMyc -STK3 323-491 This study 
pDestMyc -STK3 Δ405-411 This study 
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pDestMyc -STK3 D146N This study 
pDestMyc -STK3 MVI365-367AAA This study 
pENTR-STK4 D149N This study 







pDestMyc-PKCζ This study 
pDestMyc-PKCζ F37A/L40A This study 
pDestMyc-PKCζ F252A/I255A This study 
pDestMyc-PKCζ W434A_L454A This study 
pDestMyc-PKCζ W575A/I578A This study 
pDestMyc-LC3C T56A This study 
pDestMyc-LC3C T56E This study 
 
Cell culture  
HEK-293 cells were cultured in DMEM (Sigma-Aldrich, D6046) supplemented with 10% fetal 
bovine serum (Biochrom, S 0615) and 1% streptomycin-penicillin (Sigma-Aldrich, P4333). 
HEK-293 FlpIn T-Rex cell lines were cultured as above but with cultured in high glucose 
DMEM (Sigma-Aldrich, D5671). For amino acid and serum starvation, Hanks’ Balanced Salt 
solution was used (Sigma-Aldrich, H9269).  
 
Generation of stable cell lines  
LC3B KO HEK293 FlpIn T-Rex cells were used to make stable LC3 mutant cell lines. The 
mCherry-YFP or myc-tagged LC3B WT, LC3B phospho-mimicking mutant (T50E), T50A and 
LC3B LDS mutant (F52A-L53) were cloned into pcDNA 3.1 FRT/TO plasmid. The generation 
of a stable cell line was made in accordance with the manufacturer's instructions (Invitrogen, 
V6520-20). Briefly, transfection of different mutants of LC3B expressing pcDNA 3.1 FRT/TO 
plasmids was transfected into LC3B KO cells. Following 48 hours of transfection, colonies of 
cells with the gene of interest integrated into the FRT site were selected with 150ng/ml of 
hygromycin (Calbiochem, 400051). The expression of the gene was induced with 1µg/ml of 





To construct the LC3B/NEK9 guide RNA the CRISPR/Cas9 plasmid, sense and antisense 
oligonucleotide encoding the selection guide sequence were annealed and then inserted into 
plasmid pSpCas9(BB)-2A-Puro (PX459). For a generation of CRISPR/Cas9 KO cells, 
approximately 30,000 of HEK293 Flp-In T-Rex cells were seeded into 24 well plates and then 
500 ng of plasmid PX459 per well were transfected using Metafectene Pro (Biontex, T040). 
The clonal selection was achieved by puromycin treatment 24 hours after transfection for 48-
72 hours. Later, single cells were sorted into 96 well plate via FACS sorting. The clones were 
allowed to grow for 7-10 days and each clones were screened for KO by both western blot and 
DNA sequencing of PCR products amplified from the targeted region in the genome. 
 
Peptide arrays 
Peptides were synthesized on cellulose membranes using a MultiPep automated peptide 
synthesizer (INTAVIS Bioanalytical Instruments AG, Cologne, Germany), as described 
previously. Membranes were blocked using 5% nonfat dry milk in Tris-buffered saline 
containing 0.1% Tween 20. The membrane was probed by overlaying with 1 µg/ml of either 
GST-GABARAP for 2 hours at RT. Membranes were washed three times in Tris-buffered 
saline containing 0.1% Tween 20. Bound protein was detected with HRP-conjugated anti-GST 
antibody (GE Healthcare, RPN1236) 
 
Antibodies and reagents  
The following antibodies were used: Rabbit anti-LC3B (Novus, NB100-2220), mouse anti-p62 
(BD Bioscience ,610833), rabbit anti-CALCOCO2 (Abcam, AB68588), mouse anti-NBR1 
(Santa Cruz Biotechnology, sc-130380), rabbit anti-GFP (Abcam, AB290), rabbit anti-ACTIN 
(Sigma-Aldrich, A2066), mouse anti-FLAG (Sigma-Aldrich, F3165), rabbit anti-ATG7 (Cell 
signalling, 8558), rabbit anti-ATG4B (Santa Cruz Biotechnology, sc-130968) mouse anti-Myc 
(Cell signalling, 2276), NEK9 (Abcam,ab138488), rabbit anti-FYCO1 (Sigma-Aldrich, 
HPA0355526), horseradish peroxidase-conjugated goat anti-mouse (BD Biosciences, 554002) 
and anti-rabbit (BD Biosciences, 554021) secondary antibodies. Other reagents used were 
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Bafilomycin A1 (BafA1; (Santa Cruz Biotechnology, sc-201550) and [35S] methionine 
(PerkinElmer, NEG709A500UC).  
 
Protein purification and GST affinity isolation experiments 
GST-tagged proteins were expressed in Escherichia coli BL21 (DE3). GST-(Atg8-family 
proteins) fusion proteins were purified on glutathione-Sepharose 4 Fast Flow beads (GE 
Healthcare, 17513201) followed by washing with NET-N buffer (100 mM NaCl, 1 mM EDTA, 
0.5% Nonidet P-40 (Sigma-Aldrich, 74385), 50 mM Tris-HCl, pH 8) supplemented with 
cOmplete Mini EDTA-free protease inhibitor mixture tablets (Roche Applied Science, 
11836170001). GST-tagged proteins were eluted with 50 mM Tris, pH 8, 200 mM NaCl, 5 mM 
L-glutathione reduced (Sigma-Aldrich, G425). GST affinity isolation assays were performed 
with 35S-labeled proteins cotranscribed and translated using the TNT Coupled Reticulocyte 
Lysate System (Promega, L4610) as described previously. For quantifications, gels were 
vacuum dried and 35S-labeled proteins detected on a Fujifilm bioimaging analyzer BAS-5000 
(Fujifilm, Tokyo, Japan).  
 
Kinase assay 
Kinase assays were performed in 25 μl final volume, containing 50 ng recombinant active 
kinases, 1-2 μg substrate proteins, 60 μM ATP, 2 μCi/sample [γ32P]ATP in 35.5 mM Tris-HCl 
(pH 7.5), 10 mM MgCl, 0.5 mM EGTA (pH 8.0), 0.1 mM CaCl2. The kinase reaction was 
stopped by addition of 5X SDS-loading buffer followed by boiling for 5 min. Commercially 
available his-tagged kinases were used unless otherwise stated (PKCζ: Millipore,14-525M. 
STK3: Millipore, 14-524. STK4: Millipore, 14-624). FLAG-tagged kinases were obtained by 
transient expression of HEK cells with WT or KD kinases, after immunoprecipitation of the 
FLAG-tag different amount of eluted kinase were run in the kinase assay as above. Expression 
of kinases from cells was verified with western blot.  Proteins were resolved by SDS-page and 
stained with Coomassie blue and gels were vacuum dried and 32P-labeled proteins detected on 







Gel bands containing GST-LC3 were excised and subjected to in-gel reduction, alkylation, and 
tryptic digestion using 2–10 ng/μl trypsin (V511A; Promega). Peptide mixtures containing 
0.1% formic acid were loaded onto a nanoACQUITY UltraPerformance LC (Waters), 
containing a 3-μm Symmetry C18 Trap column (180 μm × 22mm; Waters) in front of a 3-μm 
Atlantis C18 analytical column (100 μm × 100 mm; meters). Peptides were separated with a 
gradient of 5–95% acetonitrile, 0.1% formic acid, with a flow of 0.4 μl/min eluted to a Q-TOF 
Ultima Global mass spectrometer (Micromass/Waters). Each sample was run in MS and data 
dependent tandem MS mode. Peak lists were generated from MS/MS by the ProteinLynx 
Global server software (version 2.1; Waters). The resulting pkl files were searched against the 
Swiss-Prot 51.6 protein sequence databases using an in-house Mascot server (Matrix Sciences). 
Peptide mass tolerances used in the search were 100 ppm, and fragment mass tolerance was 0.1 
Da. Mascot analysis confirmed that the sample contained GST-LC3. Data from MS mode was 
manually inspected to find potential phosphorylated peptides. 
 
Western blot and immunoprecipitation experiments 
For western blotting experiments, cells were washed in PBS (137 mM NaCl, 2.7 mM KCl, 4.3 
mM Na2HPO4, 1.47 mM KH2PO4, pH 7.4.) followed by lysis directly in SDS-PAGE loading 
buffer (2% SDS, 10% glycerol 50 mM Tris-HCl, pH 6.8) and boiled for 10 min. Protein 
concentration was measured followed by addition of bromophenol blue (0.1%) and DTT (100 
mM). Samples (20 µg) were run on 10-16% gradient- or 10%- SDS-polyacrylamide gels and 
blotted on Hybond nitrocellulose membranes (GE Healthcare, 10600003) followed by Ponceau 
S staining. Blocking was performed in 5% nonfat dry milk in PBS-Tween 20 (0.1%). Primary 
antibody was diluted in PBS-Tween 20 containing 5% nonfat dry milk and incubation was 
performed overnight at 4°C. Secondary antibody incubation was performed at room 
temperature for 1 h in PBS-Tween 20 containing 5% nonfat dry milk. Membranes were washes 
3 times prior to the addition of secondary antibody and development using LAS-300 (Fujifilm, 
Tokyo, Japan). Immunoprecipitations were performed by use of either GFP-trap_A system in 
accordance with the manufacturer’s instructions (Chromotek, gta-20) or anti-FLAG Affinity 
Gel (Sigma-Aldrich, A2220). For immunoprecipitations of FLAG-tagged proteins, cells were 
grown and transfected with 2 µg of the plasmid in 6 cm dishes, after 24 hours cells were washed 
and lysed in RIPA buffer followed by centrifugation to remove cell debris. After removal of 
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input control, the lysate was incubated with FLAG affinity gel overnight. The gel was washed 
five times in RIPA buffer and analyzed by western blotting. For GST pulldowns using cell 
extracts FLAG-tagged kinases were eluted by addition of FLAG-peptide (100 µg/ml) (Sigma-
Aldrich, F3290) and the eluate evenly divided to tubes containing GST-tagged ATG8s prepared 
as described above.      
 
Bioinformatics and statistics 
Data in all figures are shown as mean ± SEM from at least 3 independent experiments unless 
otherwise stated. Statistical significance was evaluated with one-way ANOVA followed by the 
Tukey multiple comparison test performed in PRISM (Graphpad) (ns P > 0.05, *P ≤ 0.05, **P 
≤ 0.01, ***P ≤ 0.001). 
 
Results 
LC3B is phosphorylated in vitro by STK3, STK4, NEK9, and PKCζ   
The pioneering proteomic analysis of the autophagy interaction network in human cells by 
Behrends et al. revealed several kinases interacting with ATG8s including STK3, STK4, NEK9 
and PKC(19). Recently, the hippo kinases STK3 and STK4 were shown to phosphorylate 
LC3B on T50 leading to enhanced autophagosome-lysosome fusion (28). Previously only 
STK3 and -4 have been reported to phosphorylate LC3B on T50 and this phosphorylation was 
found to be important for the fusion of autophagosomes with lysosomes (28). However, several 
other protein kinases have been reported to bind to ATG8s (19). Besides STK3 and -4, these 
include ULK1 and -2 (32), the yeast orthologue Atg1 (38), and the atypical PKCι (19). NEK9 
has also been reported to bind ATG8s and positively regulate autophagy (19). Thus, we asked 
if other kinases binding to LC3B are similarly able to phosphorylate LC3B at T50. We chose 
to focus on NEK9 and PKCζ. PKCζ is the homolog of PKCι and has not previously been tested 
for binding to ATG8s. Neither of these three kinases have been reported to mediate 
phosphorylation of LC3B. First, we validated that NEK9 and PKCζ bound to LC3B in vivo. 
NEK9, PKCζ and STK3 and -4 were transiently co-expressed with GABARAP or LC3B in 
HEK293 cells. The kinases were immunoprecipitated and co-precipitated ATG8s detected by 
western blotting (Fig. 1A). For this purpose, we used both a functional kinase (WT) and a 
kinase-deficient mutant (KD). Previously, mutations in the Mg2+ binding motif (DFG) or the 
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ATP binding motif (VAIK) of PKCs, which both abolish ATP binding, have been shown to 
cause apoptotic effects in vivo (39). We, therefore, choose to mutate the aspartic acid (D) of the 
His-Arg-Asp (HRD) motif necessary for proton transfer from the serine/threonine residue (Fig. 
1B). The ATG8s co-immunoprecipitated with all the tested kinases independent of their kinase 
activity. Albeit the kinase-dead variants of STK3 and NEK9 bound slightly less to both 
GABARAP and LC3B in the experiments shown (Fig. 1A and B), this was not consistently 
observed. Of note, co-expression of the GFP tag alone with the kinases caused apoptosis leading 
to a low yield of STK-3 and -4, PKCζ and NEK9, as previously reported (40). Next we asked 
if PKCζ and NEK9 were able to phosphorylate LC3B in vitro, and furthermore, if PKCζ and 
NEK9 also phosphorylated LC3B at position T50. STK3 and -4 were included as positive 
controls. We constructed a GST-LC3B T50A non-phosphorylatable mutant and conducted an 
in vitro kinase assay. PKCζ as well as NEK9 were able to phosphorylate LC3B and interestingly 
exhibited less phosphorylation when probed against LC3B T50A (Fig. 1C and D). As 
previously reported (28), both hippo kinases were able to phosphorylate LC3B and displayed 
reduced phosphorylation of LC3B T50A (Fig. 1C and D). To validate that PKCζ phosphorylates 
LC3B at T50 and that the reduced phosphorylation of LC3B T50A is not a result of interference 
with the structural integrity of LC3B we choose to employ mass spectroscopy. We performed 
an in vitro kinase assay on GST-tagged LC3B and analyzed the phosphorylated product by 
MS/MS (Fig. 1E). We detected a peptide of 985.6 m/z (1969.2 Da) in the phosphorylated LC3B 
sample but not in the unphosphorylated control LC3B. A peptide of 1889.2 Da was detected in 
both samples, corresponding to a difference of 80 Da between the two, indicating a phosphate 
group. The 1889.2 Da peptide corresponds to a peptide encompassing residues 50 to 65 (50-
TKFLVPDRVNMSELIK-65). Notably, both T50 and S61 are phosphorylatable residues in this 
peptide and therefore the MS/MS did not exclude the possibility of phosphorylation on S61. 
However together with the LC3B T50A kinase assay, this strongly suggests phosphorylation of 
LC3B at T50 by PKCζ in vitro.   
 
STK3 interacts with LC3C and GABARAP via a C-type LIR (CLIR)  
To further characterize the interaction between the kinases and ATG8 family proteins we first 
addressed the interactions between the hippo kinases and ATG8 family proteins. To this end, 
GST-pulldown assays using in vitro translated STK3 showed that STK3 interacted directly with 
several of the ATG8s, but most strongly with LC3C and GABARAP and more weakly with 
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GABARAPL1 (Fig. 2A and B). However, STK4 interacted very weakly with the ATG8s (Fig. 
2C). STK3 contains an N-terminal kinase domain followed by an unstructured region important 
for inhibition of the kinase activity by covering the active site. In the far C-terminal region 
resides the SARAH domain, which is important for dimerization(41) (Fig. 2D). A caspase-3 
cleavage site (D322) is located at position D322 which, if cleaved, produces a C-terminally 
truncated, activated version of STK3 (42). To map the binding site for ATG8 on STK3 we 
established expression constructs corresponding to the fragment produced by caspase cleavage 
in vivo as well as various C-terminally deleted constructs (Fig. 2D). GST pulldown assays using 
the various deletion constructs of STK3 identified the interaction to be mediated by the 
fragment encompassing the C-terminal region from amino acid position 323, and not the N-
terminal part (from position 1 to 357) (Fig. 2E). GABARAP was used as interaction partner in 
these LIR mapping experiments since it bound strongly to STK3. However, because STK3 also 
bound strongly to LC3C, we searched the C-terminal part of STK3 for C-type LIRs (CLIR) 
with the consensus ΦΦΦ where Φ is an aliphatic amino acid. A candidate CLIR, ‘MVI’ was 
located at positions 365-367, reminiscent of the CLIR previously described for the interaction 
between CALCOCO2/NDP52 AND LC3C(43). Strikingly, mutation of this CLIR motif to 
AAA abolished binding between STK3 and LC3C (Fig. 2F). Consistently, the mutation of the 
LDS in LC3C F58A resulted in strongly decreased binding to STK3 (Fig. 2G). GST-pulldown 
assays using extracts from HeLa cells expressing FLAG-STK3 or FLAG-STK3 MVI/AAA 
CLIR mutant verified the strong binding of FLAG-STK3 to GABARAP and LC3C whereas the 
CLIR mutant FLAG-STK3 MVI/AAA did not show significant binding. The GABARAP 
Y49A LDS mutant lost almost all binding to FLAG-STK3 (Fig. 2H). Taken together, the results 
show that the CLIR motif in STK3 mediated LDS-dependent binding to both LC3C and 
GABARAP.  
  
PKCζ binds to GABARAP and GABARAPL1 via a LIR motif overlapping with the AGC 
kinase docking motif  
GST-pulldown assays with in vitro translated PKCζ (Fig. 3A), or lysates from HEK293 cells 
transfected with FLAG-PKCζ (Fig. 3B), showed that PKCζ has a binding preference for 
GABARAP and GABARAPL1.  PKCζ does not interact with LC3C, indicating that the binding 
is not mediated by a CLIR-like motif. The interaction with LC3B in vitro is very weak (Fig. 
3A), although LC3B is efficiently immunoprecipitated with PKC from cell extracts (Fig. 1A). 
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This suggests that either PTMs of LC3B or PKC are required for efficient binding, or the 
association is not direct i.e. they are part of a larger complex. To study the regions or motifs in 
PKC required for binding the ATG8s in vitro, we chose to use the high-affinity binder 
GABARAP for in vitro interaction assays. The atypical PKCs contain a C-terminal kinase 
domain whose activity is regulated by the N-terminal region composed of an N-terminal Phox 
and Bem1p (PB1) domain, followed by a C1-like zinc finger domain which is preceded by a 
pseudosubstrate peptide (Fig. 3C). We conducted a peptide array screen to probe the entire 
PKCζ for any LIR-like motifs (44). Three candidate motifs were identified (Fig. 3D). Since 
there are no 3D structures available for PKCζ we used the structure of PKCι (PDB:3A8W) to 
assess whether the motifs that were positive hits from the peptide array were likely to be 
exposed on the surface of PKC. The motif “DIDWVQ” is located in a solvent-exposed part of 
the kinase domain of PKCζ/ι, in an -helical structure with the aromatic tryptophan pointing 
inwards towards the ATP binding pocket. “WDLL” (WDMM in PKCι) is located just C-
terminal to the kinase domain and is solvent exposed in the structure, however tryptophan is 
facing inwards between two -helices. The motif showing the strongest binding in the peptide 
array “FEYI” overlaps with the AGC Kinase docking motif (FEGFEYI), important for the 
binding and activation of PKCζ/ι by PDK1(45), and is located in a solvent-exposed region in 
the far C-terminal part of PKCζ/ι. However, again the aromatic phenylalanine is pointing 
inward in the structure. Mutation of the aromatic F residue in the FEYI core sequence in a 
peptide covering the C-terminal part of PKCζ prevented the interaction with GABARAP and 
mutation of the hydrophobic I residue strongly reduced binding (Fig. 3E). This supports that 
FEYI might be a functional LIR motif. This was confirmed by GST-pulldown assays with full-
length PKCζ with both the aromatic and hydrophobic residues in the core LIR mutated to 
alanines which strongly inhibited binding to the ATG8s (Fig. 3F).   
 
NEK9 interacts with ATG8s via a C-terminal LIR motif 
NEK9 comprises an N-terminal kinase domain, a RCC1 (regulator of chromatin condensation)-
like -propeller domain with 6 RCC repeats followed by a C terminal domain with an 
unstructured region that binds to NEK6 and a coiled-coil region (Fig. 4A). To identify putative 
LIR motifs within NEK9, we employed the iLIR prediction server (46) and peptide array 
screening methods (44). The iLIR server predicted 3 putative C terminal LIR motifs; 
718WHTI751, 845YEEL848, and 967WCLL970, while the peptide array revealed only the most C 
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terminal LIR motif as a candidate ATG8 binding domain (Fig. 4B). To determine if any of the 
predicted LIR motifs mediated the ATG8s interaction, the aromatic and hydrophobic residues 
of the putative core LIRs were mutated to alanine in the three predicted LIRs. NEK9 WT and 
the three mutants were assayed for GABARAP binding in a GST-pulldown assay. The NEK9 
W967A/L970A mutant displayed strongly reduced binding with GST GABARAP while the 
other mutations did not affect binding at all (Fig. 4C). The strong NEK9 mediated 
phosphorylation of LC3B (Fig. 1C and D) could suggest a strong binding of NEK9 to this ATG8 
family protein contrary to what we found for STK3 and PKC. Indeed, GST-pulldown assay 
with in vitro translated NEK9 showed that NEK9 interacted very well with all ATG8s. The LIR 
mutant almost completely lost all binding to the ATG8s (Fig. 4D). A similar binding pattern 
was seen in GST- pulldown assays, where whole cell lysate from Hela cells transiently 
transfected with myc-tagged NEK9 WT and NEK9 LIR mutant constructs were incubated with 
recombinant GST or GST-ATG8s beads and NEK9 detected with immunoblotting using NEK9 
antibody. All ATG8 proteins bound well while the LIR mutation abolished binding (Fig. 4E). 
Co-immunoprecipitation of GFP-LC3B or GFP-GABARAP from cells co-transfected with 
FLAG-NEK9 wild-type or kinase-dead showed that NEK9 interaction with the ATG8s is not 
dependent on an active kinase (Fig. 1A). In conclusion, NEK9 contains a C-terminal LIR motif 
with the core LIR sequence 967WCLL970.  
 To further analyze the sequence requirements for binding to GABARAP of the C 
terminal LIR of NEK9, a two-dimensional peptide array mutation analysis was performed. Each 
position of an 18-mer NEK9 peptide encompassing amino acids 960-977 was substituted with 
all 19 alternative amino acids and the array was probed with GST-GABARAP (Fig. 4F). The 
results confirm the absolute requirements of an aromatic residue at position 0 and either Leu 
(L), Ile (I) or Val (V) at the hydrophobic position +3. Tyr is not as efficient in replacing Trp 
(W) as Phe (F) at position 0. Apart from the invariant aromatic and hydrophobic positions of 
the core LIR, the intermediate +1 and +2 position also show clear preferences for allowed 
substitutions. The rather unusual Cys (C) in position +1 is most effectively replaced by E (Glu), 
V or T (Thr) while the Leu (L) in +2 is only productively substituted by the hydrophobic I or 
V and the aromatic residues (W, F, Y). As almost always seen (15,32), basic residues (R, K) 
and proline (P) and glycine (G) are selected against in the core LIR. Interestingly, there are 
serines at the -1 and -3 positions suggesting that LIR binding can be positively regulated by 
phosphorylation. There are also acidic residues at position -2 and -4 which are often involved 
in electrostatic interactions with N terminal residues of the ATG8s (15). Position -1 shows a 
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preference for either acidic, S, T, P or G residues. These residues are most often found at this 
position (15,47). Position -2 also shows a strong preference for acidic (D, E) or Ser residues.  
At position +4 C-terminal to the core LIR, Cys, aromatic and hydrophobic residues (L, I, V) 
are detrimental to the binding. There is a tendency for counterselection of these residues in the 
following +5 to +7 positions as well. A recent study of determinants regulating the selective 
binding of autophagy adapters and receptors to ATG8 proteins allow us to speculate that the 
fact that NEK9 binds so well to LC3B may perhaps be explained by favorable residues for 
LC3B binding located at +2 and -1 and -2 of the NEK9 LIR (47).   
 
NEK9 inhibits the selective autophagic degradation of p62 andNBR1 
The efficient NEK9-mediated phosphorylation of LC3B in vitro raised the question of whether 
NEK9 could impact selective autophagy. To address this, we knocked down NEK9 and 
observed an increased turnover of p62 in full medium (Fig. 5A-C). To further validate the NEK9 
knockdown data, we generated HeLa NEK9 KO cells (Suppl. Fig. S1A and B). In HeLa NEK9 
KO cells we also observed increased autophagic degradation of p62 and NBR1 (Fig. 5D). 
Hence, our results suggest that NEK9 inhibits autophagic degradation of p62 and NBR1. This 
inhibition may be mediated by phosphorylation of LC3B at T50E.  
 
A phospho-mimicking T50 mutant of LC3B inhibits LIR-LDS binding 
Phosphorylation of LC3B at Thr50 (T50) has been reported to be crucial for the fusion of the 
autophagosome with the lysosome (28). T50 is located close to Arg10 (R10) in the N-terminal 
arm of LC3B which forms part of the LDS (Fig. 6A). The R10 residue is involved in electrostatic 
interactions with several LIR containing proteins, including the Asp336 (D336) residue at 
position -2 of the p62 LIR (48)(Fig. 6A). Phosphorylation of T50 can be suspected to impose a 
steric hindrance for LIR-LDS interactions where R10 of LC3B is engaged in binding an acidic 
residue N-terminal to the core LIR, such as in p62. We tested this first for the p62-LC3B LIR-
LDS interaction. We employed myc-p62 with a mutated PB1 domain, unable to form polymers 
(31). The phospho-mimicking T50E mutant of LC3B exhibited a 60% reduced binding to p62 
compared to WT in an in vitro GST-pulldown assay. The LC3B F52A/L53A double mutant 
affecting both hydrophobic pockets (HP1 and -2) of the LDS completely lost binding to p62. 
(Fig. 6B and C). Furthermore, endogenous p62 co-precipitated with GFP-LC3B from HeLa cell 
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extracts bound with less affinity to LC3B T50E compared to WT LC3B (Fig. 6D). Similar 
results were obtained for endogenous p62 from HeLa cell lysates when bound to GST-LC3B 
WT, GST-LC3B T50A, GST-LC3B T50E and GST-LC3B F52A/L53A (Fig. 6E). These results 
clearly show that introducing a phospho-mimicking T50E mutation in LC3B reduces its affinity 
for the cargo receptor p62. Next, the binding of LC3B T50E to the autophagy receptor NBR1 
was analyzed. Whole cells extract from HeLa cells was subjected to pulldown assays with WT, 
T50A, T50E or F52A/L53A mutants of GST-LC3B and bound endogenous NBR1 detected by 
immunoblotting with NBR1 antibody. The phospho-mimicking mutant T50E mutant showed a 
45% reduction in binding with endogenous NBR1 compared to WT LC3B (Fig. 6F).  
T50 is conserved in the LC3 subfamily of ATG8s, but not present in the GABARAP 
subfamily. The kinesin adaptor and Rab7 effector FYCO1 transports autophagosomes along 
microtubules in the plus end direction and has a clear preference for binding to LC3A and –B 
(49). The LC3B T50E mutation strongly reduced binding to endogenous FYCO1 in GST-
pulldown assays and also when co-immunoprecipitated with myc FYCO1 (Fig. 6G, H and I). 
It is important to note that both NBR1 and FYCO1 also displayed a slight reduction in binding 
with LC3B T50A, indicating that this substitution also affects LIR-LDS binding, albeit slightly.     
The cysteine protease ATG4B is required for processing of LC3B before conjugation to 
phosphatidylethanolamine (PE) and for delipidation and recycling of LC3B(50). To test if T50E 
would compromise efficient binding of ATG4B, we conducted a GST pulldown assay with in 
vitro translated ATG4B probed against GST-LC3B WT, T50A, T50E, and the LDS double 
mutant F52A/L53A. Importantly, ATG4B displayed less affinity for LC3B T50E than for WT 
LC3B (Fig. 7A). In GST-pulldown assays with endogenous ATG4B from HeLa cell lysates 
LC3B T50E showed 74% reduction in binding with ATG4B compared to LC3B WT and very 
little binding to the LDS mutant (Fig. 7B and C).  
Efficient conjugation of LC3 to PE requires sequential interaction of LC3 with ATG3 
and ATG7 (51,52). To investigate whether the interaction of LC3B with ATG7 was affected by 
the T50E mutant GST pulldown with endogenous ATG7 was done. The phospho-mimicking 
mutant LC3B T50E almost lost all binding to ATG7 while LC3B T50A and LC3B F52A/L53A 
(LDS) bound similarly to WT (Fig. 7D and E).  
ATG8s family protein is essential both for efficient autophagosome biogenesis and 
fusion with lysosomes (13). The role of ATG8s in the fusion of autophagosomes with 
lysosomes has been shown via its interaction with syntaxin 17 (STX17)(53) and 
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PLEKHM1(54). Both STX17 and PLEKHM1 are known to interact with ATG8s via LIR motifs 
(53,54). Consistent with the results obtained for interaction with the other LIR-containing 
ATG8 interactors tested here LC3B T50E showed strongly reduced binding affinity for STX17. 
Almost no binding of STX17 was seen for the LDS mutant LC3B F52A/L53A, and there was 
also reduced binding to LC3B T50A (Fig. 7F and G). 
Taken together all these results show that binding of LIR-containing protein to LC3B 
T50E is compromised. This can be explained by steric hindrance and charge repulsions 
occurring due to the close proximity of T50 to the LDS. Phosphorylation of T50 will most likely 
exaggerate the effects observed with T50E, having an even stronger impact on LIR-LDS 
interactions. 
 
The LC3B T50E phospho-mimicking mutant impairs selective autophagic flux  
To investigate the importance of the phosphorylation of LC3B on T50 we established a LC3B 
knockout (KO) cell line to avoid the influence of endogenous LC3B. We employed the 
CRISPR/Cas9 system targeting exon 2 of the human LC3B gene on chromosome 16 to generate 
a Flp-In T-Rex HEK293 cell line lacking expression of LC3B (Suppl. Fig. 1C and D). The 
LC3B KO cells showed accumulation of the selective autophagy receptors p62/SQSTM1 and 
NBR1 compared to wild type cells (Fig. 8A and B). To avoid any overexpression artefacts, we 
employed stable reconstitution of the LC3B KO cells by use of the Flp-In system under the 
control of a tetracycline-inducible promoter. LC3B KO cell lines with reintroduced Myc-LC3B 
WT, Myc-LC3B T50A, Myc-LC3B T50E, and the LDS mutant F52A/L53A were established 
(Fig. 8C). Reduced lipidation was observed for T50E and no lipidation was seen for the LDS 
mutant (Fig. 8C). The reconstitution of LC3B KO cells with Myc-LC3B WT restored the 
autophagic flux as indicated by a reduced level of p62 and NBR1. Interestingly, reconstitution 
of Myc-LC3B T50E and Myc-LC3B F52A/L53A led to strongly reduced autophagic 
degradation of p62 and NBR1 (Fig. 8D). To further investigate the autophagic turnover of the 
LC3B T50 mutations in the KO cells, we reintroduced mCherry-YFP-LC3B wild type and 
mutants. The mCherry-YFP tag allows for monitoring entry into acidic structures such as the 
lysosome since YFP fluorescence is rapidly lost in acidic structures, leaving only mCherry as a 
functioning fluorophore (35). First, we quantitated the amount of LC3B-containing puncta 
(indicative of autophagosomes) per cell. We scored the ability of the different cell lines to 
produce LC3B puncta during starvation. While more than 90% of LC3B WT (n=550) and T50A 
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cells (n=710) contained LC3B puncta, the T50E cell line (n=680) exhibited puncta in 75% of 
the cells. We had to exclude the LC3B F52A/L53A cell line since, as expected, only a few cells 
produced LC3B puncta. Only by actively searching for LC3B puncta containing cells were we 
able to identify cells with LC3B puncta (less than 15%; n=220) (Fig. 8E). Next, we focused on 
the cells containing LC3B puncta in WT, T50A, and T50E cell lines. Looking at the number of 
puncta per cell volume, we found slightly fewer LC3B puncta in the T50A cell line when 
compared with LC3B WT (Fig. 8F) and more so during starvation (Fig. 8G). LC3B T50E 
expressing cells displayed a strongly reduced amount of LC3B-containing puncta, both when 
grown in full medium and when starved in Hanks medium (Fig. 8F and G). Hence, either fewer 
LC3B-containing puncta are produced when LC3B T50E is expressed, or LC3B T50E puncta 
are more readily removed thus having a higher turnover-rate. To discriminate between these 
two possibilities we determined the ratio of red-only to yellow puncta. When grown in full 
medium LC3B T50E displayed a slightly reduced fraction of red only puncta compared to 
LC3B WT and T50A, strongly indicating that T50E positive puncta do not have a higher 
turnover rate (Fig. 8H). In conclusion, the lower total amount of puncta in the T50E cell line is 
caused by a reduced ability of LC3B T50E to become lipidated. Notably, the lower fraction of 
red-only puncta under basal conditions may indicate that not only formation but also maturation 
of LC3B positive puncta is affected by the T50E mutation (Fig. 8H). However, when starved, 
there was no statistically significant difference in the fraction of red-only puncta between the 
cells (Fig. 8H).  
 
Discussion 
The hippo kinases have previously been reported to phosphorylate LC3B at T50 (28). Here we 
show that in vitro PKCζ and NEK9 are also able to phosphorylate this residue. Furthermore, 
we mapped an atypical C-type LIR motif mediating binding to LC3C and GABARAP in STK3, 
a GABARAP-preferring LIR motif overlapping with the AGC kinase docking motif in PKCζ, 
and a C-terminal LIR motif in NEK9 mediating efficient binding to both LC3 and GABARAP 
subfamily members of the ATG8 family proteins. Knock down and KO experiments showed 
that NEK9 may be acting to inhibit the selective autophagic degradation of p62 and NBR1. It 
is likely that this inhibition can be mediated via phosphorylation of T50 in LC3B. This 
reasoning is based on our findings that the LC3B T50E phospho-mimicking mutant impaired 
selective autophagic flux by inhibiting LIR-LDS binding to a number of autophagy-related 
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proteins. These include the selective autophagy receptors p62 and NBR1, the basal autophagy 
proteins important for conjugation and delipidation of LC3B ATG7 and ATG4B, FYCO1 
involved in microtubule-dependent transport of autophagosomes and lysosomes, and the 
SNARE STX17 implicated both early and late in the process of autophagosome formation and 
maturation.  
We were unable to detect in vitro binding of STK4 to ATG8s. STK3 therefore clearly 
seems to have the strongest affinity for ATG8s of the two hippo kinases. STK4 has previously 
been shown to bind to ATG8s in vitro. However, the binding appeared weaker than the binding 
of STK3 to the ATG8s (19). It is entirely likely that STK4 binds ATG8s in vivo. However, this 
binding is apparently not strong enough to be detected by the in vitro methods employed in this 
study. Interestingly, knockdown of STK3 was recently shown to have the most dramatic effect 
on autophagy measured as an increased basal level of p62 and increased LC3B lipidation (28). 
In addition to influencing basal autophagy, STK3 was also shown to stimulate xenophagy by 
enhancing the clearance of bacteria via phosphorylation of the LC3B T50 site (28). The 
xenophagy receptor NDP52 has been shown to rely on binding to LC3C (17,43). Here we show 
that STK3 has a preference for binding to GABARAP and LC3C and we identified a C-type 
LIR (MVI) in STK3. Consistent with our finding that the phospho-mimicking mutant T50E 
negatively affects its LIR-LDS-mediated interactions the LC3C T56A/E mutants significantly 
reduced its interaction with NDP52 (Suppl. Fig. 1E and F). Clearly, this link to the regulation 
of xenophagy warrants further studies. 
Interestingly, the CLIR of STK3 and surrounding residues have been identified as a 
nuclear export signal (55). Furthermore, the STK3 substrate MOB1 has been shown to bind to 
STK3 dependent on several phosphorylated threonines, with T364 (next to the LIR) being the 
most crucial for this binding (56), indicating a possible competition for this site in STK3.  
Previously, PKCζ has only been indirectly implicated in the phosphorylation of LC3B 
(27). However, it has long been known that PKCζ/bind p62 (31), and thereby might co-localize 
with LC3B in vivo. The atypical PKCi, which is very similar to PKC, has been shown to 
negatively regulate autophagy via PIK3CA/AKT-MTOR signaling (25). The LIR motif we 
mapped in PKCζ overlaps completely with AGC kinase docking motif, a hydrophobic motif 
known to mediate PKCζ interaction with its activating kinase, PDK1 (57). This hydrophobic 
motif is essential for the activation of PKCζ by PDK1. In future studies, it will be interesting to 
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investigate whether interactions mediated by these overlapping motifs may affect the roles 
played by PKCζ, or PKC, in autophagy and other cellular processes.  
Except for the pioneering study of Behrends et al. (19), NEK9 has not been implicated 
in autophagy processes or the regulation of autophagy before. In the Behrends et al. paper NEK9 
was scored among the positive regulators of autophagosome formation based on a reduced 
amount of LC3-positive puncta formed upon siRNA-mediated KD of NEK9. We also see 
reduced lipidated LC3B upon KO of NEK9, but this can also be interpreted as increased 
turnover (Fig. 5D). This would then be consistent with our findings of an inhibitory role of 
NEK9 on selective autophagy. We found that NEK9 interacts strongly with all ATG8s 
compared to PKCwhich showed preferential binding towards GABARAPs.  
 We show that the T50 phospho-mimicking mutant displays a strongly reduced binding 
to several autophagic related proteins. A phosphorylatable residue in the LDS of LC3B is 
intriguing as it might function as a dynamic “switch” governing which proteins bind to LC3B. 
Regulation of LDS binding by phosphorylation/dephosphorylation might be executed at a 
certain stage(s) of autophagosome formation and maturation adding another regulatory layer.  
An intriguing idea is that LC3B on a fully matured autophagosome becomes phosphorylated at 
T50. This causes canonical LIR-binding proteins to dissociate, leaving ATG4B to delipidate 
LC3B from the autophagosome. Such a model might also explain why we observed less II-form 
of LC3B T50E. If LC3B T50E is unable to bind effectively to cargo receptors such as p62 on 
the inside of the phagophore, LC3B might be exposed for ATG4B-mediated delipidation. This 
way LC3B T50E is delipidated, removed from the autophagosome before maturation, and thus 
no longer sequestered inside the autophagosome, hence the lower amount of LC3B-II. 
Importantly, phosphorylation is assumed to have a greater effect on all the interactions and 
functions of LC3B, due to the more negatively charged and bulky phosphate compared to our 
phosphor-mimicking glutamic acid. One of the limitations of using a phospho-mimicking T50E 
mutant is that it is mimicking a constitutively phosphorylated state. So, the phospho-mimicking 
T50E mutant behaves as a constitutively dominant negative on LIR-LDS interactions which 
might affect both autophagosome formation and autophagosome-lysosomal fusion. Such an 
effect is supported by our results where the selective autophagic flux is reduced as well as the 
formation of autophagosomes (fewer puncta).  
Interestingly, during starvation, the LC3B T50A cell line was also less able to make 
puncta than LC3B WT (Fig. 8E and G). This may indicate that phosphorylation of T50 is 
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important for autophagosome formation. However, as previously noted, LC3B T50A displayed 
slightly reduced binding to several LIR-containing proteins (Fig. 1). Hence, puncta formation 
might be inhibited and this might be more evident during the fast protein turnover occurring 
during starvation. We saw no consistent difference between the myc-tagged versions of LC3B 
WT and T50A neither in the amount of p62 nor the band pattern of LC3B. Furthermore, there 
was no difference between LC3B WT and T50A in the fraction of red-only puncta between full 
medium and starvation. This indicates that the slightly negative effect of T50A is occurring 
during autophagosome formation.  
The reduced ability of LC3B T50E to become lipidated may seem surprising when 
considering the reported positive effect on the fusion of autophagosomes and lysosomes (28). 
However, neither our in vitro binding data nor in vivo data support a pro-autophagic role of the 
phosphorylation of T50. There are, however, important differences between the studies. First, 
the study by Wilkinson et al. (28) is based on the transient overexpression of LC3B harboring 
T50 mutations. Second, they did not use a LC3B knockout cell line. Our cell lines mimic global 
phosphorylation, which might retard a dynamic process depending on only a fractional pool of 
phosphorylated LC3B at any one time. Our data support that LC3B lipidation is impaired and 
that interactions of LC3B with effector proteins on the inner or outer surface of the 
phagophore/autophagosome is strongly reduced. Furthermore, roles not directly related to 
autophagy have been reported for LC3B (58), such as the regulation of endocytic pathways 
(59), and the Rho signaling pathway (60). How the phosphorylation of T50 affects these 
pathways in vivo was not addressed. Since these interactions are reported to be LIR-mediated 
it is likely that the phosphorylation also affects these interactors. Recently, acetylation of 
residues in the LDS was shown to have a drastic effect on LC3B causing LC3B to be unable to 
produce puncta (29). We show that the phospho-mimicking T50E mutant also strongly affects 
LC3B function strengthening the notion of a potent regulator of the LDS by PTMs. Both 
acetylation and phosphorylation sites in the LDS region are conserved within the LC3 
subfamily of ATG8 proteins.  
Recent KD and KO studies of ATG8 family members show that GABARAPs are critical 
facilitators of autophagic flux (61-63). LC3 family proteins are not required for non-selective, 
bulk degradation of cytosolic proteins whereas GABARAPs are required (62). A similar 
conclusion was reached for some forms of selective autophagy based on triple KOs of LC3 or 
GABARAP subfamily members (61,63). However, studying cells only KO for LC3B we did 
see an effect on the turnover of p62 and NBR1, although it was not very strong. The T50E 
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mutant had a stronger effect, most likely because it also has a dominant negative effect. More 
studies will be required to determine the relative contributions of the different ATG8 family 
members to different forms of selective autophagy. We have also just begun to elucidate how 
PTMs may regulate LIR-LDS interactions and the effects mediated on different steps of the 
autophagy pathway.  
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Figure 1. NEK9, PKC and STK3/4 associate with ATG8s in vivo and phosphorylate LC3B in 
vitro. (A) HEK293 cells were transiently co-transfected with the indicated FLAG-tagged 
kinases, wild type (WT) or kinase dead (KD), and either GFP-LC3B or GFP-GABARAP. Cell 
lysates were immunoprecipitated with FLAG antibodies and analyzed by western blotting. (B) 
GST-STK3 and FLAG-tagged PKC or NEK9 were expressed and purified from HEK293 cells 
and analyzed for kinase activity when incubated with myelin basic protein (MBP) and [γ-
32P]ATP. (C) GST-tagged LC3B or LC3B T50A were incubated with the indicated kinases in 
the presence of [γ-32P]ATP. Of note, FLAG-NEK9 was purified from HEK293 cells while the 
other kinases were obtained from commercial vendors. Incorporation of radioactive labeled 
phosphate was detected by autoradiography (AR), and immobilized GST or GST-tagged 
proteins visualized by Coomassie Brilliant Blue staining (CBB). (D) Quantifications of 
STK4/NEK9 (n=2) and STK3/PKCζ (n=5). Relative phosphorylation of LC3B WT/T50A 
normalized to the autophosphorylation of the kinase. (E) GST-tagged LC3B was incubated or 
not with PKCζ in the presence of ATP and the product was resolved by SDS-PAGE. The GST-
LC3B band was excised and analysed by LC-MS/MS. Shown are the MS spectra from LC-MS 
without PKCζ (top) and with PKCζ (bottom). Peptides are shown above the spectra. Note that 
this LC3B construct contained a mutation in residue H57 to R57.    
 
Figure 2. STK3 interacts with LC3C and GABARAP via a C-type atypical LIR motif. (A) 
Myc-tagged STK3 kinase constructs were in vitro translated in the presence of [35S]methionine, 
and analyzed in GST affinity isolation experiments for binding to the indicated ATG8s fused 
to GST. Bound proteins were detected by autoradiography, and immobilized GST or GST-
tagged proteins visualized by Coomassie Brilliant Blue staining. (B) Quantification of STK3 
binding shown in (A), based on three independent experiments. (C) Myc-tagged STK4 kinase 
construct was in vitro translated in the presence of [35S]methionine, and analyzed in GST 
affinity isolation experiments for binding to the indicated ATG8s fused to GST. (D) Schematic 
drawing of the domain organization of STK3 with the kinase domain, the LIR motif and the 
SARAH domain indicated. The extent of deletion mutants and the location of MVI/AAA LIR 
mutation are shown below the domain cartoon. (E) GST pulldown analyses of binding of the 
myc-tagged STK3 deletion constructs shown in (D) to GST-GABARAP. The deletion 
constructs were in vitro translated in the presence of [35S]methionine. (F and G) GST pulldown 
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analyses of binding of myc-tagged STK3 WT and LIR mutant in vitro translated in the presence 
of [35S]methionine to GST-LC3C (F) or myc-tagged STK3 WT in vitro translated in the 
presence of [35S]methionine to GST-LC3C or GST-LC3C F58A (G). The F58A mutant inhibits 
binding to the LDS of LC3C. (H) HEK293 cells were transiently transfected with FLAG-tagged 
constructs of STK3 WT and LIR mutant (MVI/AAA) and whole cell lysates were incubated 
with recombinant GST or GST-ATG8s family proteins. The bound FLAG-tagged STK3 protein 
was detected by western blot using anti-FLAG antibodies and immobilized GST or GST-tagged 
proteins visualized by Ponceau S staining. AR, autoradiography; CBB, Coomassie Brilliant 
Blue. 
 
Figure 3. PKCζ binds to GABARAP and GABARAPL1 via a LIR motif overlapping with the 
AGC kinase docking motif. (A) Myc-tagged PKCζ was in vitro translated in the presence of 
[35S]methionine, and tested in GST affinity isolation experiments for binding to human ATG8 
family proteins. Bound proteins were detected by autoradiography (AR), and immobilized GST 
or GST-tagged proteins by Coomassie Brilliant Blue staining (CBB). (B) HEK293 cells were 
transiently transfected with FLAG-tagged PKCζ expression construct and whole cell lysate was 
incubated with recombinant GST or GST-ATG8 family proteins including the LDS mutants 
GABARAP Y49A and LC3B F52A/L53A. The bound FLAG-tagged PKCζ protein was 
detected by western blot using anti-FLAG antibodies and immobilized GST or GST-tagged 
proteins visualized by Ponceau S staining. (C) Schematic diagram of the domain organization 
of PKCζ with the N-terminal PB1 domain involved in heterodimerization, the pseudosubstrate 
sequence (PS), the zinc finger domain (ZnF), the kinase domain and the overlapping AGC 
kinase docking- and LIR motifs. (D) Identification of GABARAP-binding putative LIR motifs 
in PKCζ. An array of 20-mer peptides covering full-length PKCζ (each peptide shifted three 
amino acids relative to the previous) was mixed with GST-GABARAP (1 g/ml) and binding 
detected using ant-GST antibodies. The extension of the most strongly interacting peptides are 
indicated of which the overlapping peptides harboring the FEYI core LIR motif clearly bound 
most strongly. (E) Peptide array of FEYI where the core F (phenylalanine) and/or I (isoleucine) 
residues are mutated to alanine. Peptide array performed as in (D) but with the 20-mer harboring 
the FEYI motif with or without mutations. (F) GST pulldown assay performed as in (A) with 
Myc-tagged PKCζ WT and LIR mutant F575A/I578A in vitro translated in the presence of 
[35S]methionine, and tested in GST affinity isolation experiments for binding to human ATG8 
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family proteins. Bound proteins were detected by autoradiography (AR), and immobilized GST 
or GST-tagged proteins by Coomassie Brilliant Blue staining (CBB). 
 
Figure 4. NEK9 interacts with ATG8s via a C-terminal LIR motif. (A) Schematic diagram of 
NEK9 domain structure comprising the N-terminal kinase domain, regulator of chromosome 
condensation 1(RCC1) repeats, a NEK6-binding region, a coiled coil domain (CC) and the C-
terminal LIR motif. (B) Identification of a GABARAP-binding LIR motifs in the C terminus 
of NEK9. An array of 20-mer peptides, moved increments of 3 amino acids, covering the entire 
979 amino acid long sequence of NEK9 was probed with GST-GABARAP (1 g/ml) and 
binding detected using ant-GST antibodies. The sequences of the overlapping peptides giving 
a positive signal are shown below the array with the core LIR motif WCLL indicated. (C) Myc-
tagged NEK9 LIR mutant constructs were in vitro translated, labelled with [35S]methionine and 
analyzed for binding to GST-GABARAP. (D) GST pulldown assays with in vitro translated 
and [35S]methionine-labelled Myc-tagged NEK9 WT and LIR mutant W967A/L970A and 
GST-ATG8 proteins. Bound proteins were detected by autoradiography (AR), and immobilized 
GST or GST-tagged proteins by Coomassie Brilliant Blue staining (CBB). (E) GST pull down 
assay, where Myc-tagged NEK9 WT and NEK9 LIR mutant constructs were transiently 
transfected into HeLa cells. The whole cell lysates were incubated with recombinant GST or 
GST-ATG8s beads and bound NEK9 was detected by immunoblotting using anti-NEK9 
antibody. The GST and GST-ATG8 proteins were visualized by Ponceau S staining. (F) Two 
dimensional peptide array to investigate effects of single amino acid substitution at all position 
of an 18-mer peptide from NEK9 (960-977) harboring the LIR motif. The array was probed 
with GST-GABARAP (1 g/ml) and binding detected using ant-GST antibodies. 
 
Figure 5. NEK9 inhibits the selective autophagic degradation of p62 and NBR1. (A and B) 
Western blot analysis of p62 in HeLa cells with control siRNA and NEK9 smartpool siRNA. 
Actin was used as loading control. (C) Quantification of p62 levels following siRNA-mediated 
knockdown of NEK9 in full medium based on three biological replicates. (D) Western blots of 
cell extracts from HeLa WT and HeLa NEK9 KO cells with antibodies against NEK9, NBR1, 
p62 and LC3B with -actin as loading control. 
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Figure 6. The phospho-mimicking T50E mutant of LC3B inhibits LIR-LDS interactions. (A) 
Structure of LC3B and p62 (PDB: 2ZJD) in which T50 is substituted by a glutamic acid (E). 
The p62-LIR peptide is shown with a black backbone. The core p62 LIR residues W338 and 
L341 (both purple) are shown docking into HP1 and HP2, respectively. The structure shows 
the side-chain of R10 (green) of LC3B interacting with D336 (yellow) of p62. T50E (red) is 
very close to R10. (B) Myc-tagged p62 R21A/D69A (monomeric mutant) was in vitro 
translated and tested for binding to LC3B fused to GST with or without mutations at T50 or the 
LDS of LC3B. Bound proteins were detected by autoradiography (AR), and immobilized GST 
or GST-tagged proteins by Coomassie Brilliant Blue staining (CBB). (C) Quantification of p62 
binding shown in (B), based on three independent experiments. (D) HEK293 cells were 
transiently transfected with the indicated GFP-tagged LC3B constructs. Cell lysates were 
immunoprecipitated with GFP antibodies and endogenous p62 was analyzed by western 
blotting. (E) Recombinant GST or GST LC3B with or without mutation of T50 and LDS 
mutation were incubated with RIPA buffer cell lysate from HeLa cells. The bound endogenous 
NBR1 was detected by immunoblotting with NBR1 antibodies. (F) Quantification of NBR1 
binding shown in (E), based on three independent experiments. (G) Recombinant GST or GST 
LC3B with or without mutation of T50 and LDS mutation were incubated with RIPA buffer 
cell lysate from HeLa cells and bound endogenous FYCO1 detected by immunoblotting. (H) 
Quantification of binding affinity of endogenous FYCO1 based on three independent replicates. 
(I) HEK293 cells were transiently transfected with myc-FYCO1 and FLAG-LC3B. Cell lysates 
were immunoprecipitated with anti-FLAG antibodies and analyzed by western blotting. 
 
Figure 7. The T50E mutant of LC3B inhibits LIR-LDS interactions with ATG4B, ATG7 and 
syntaxin-17 (STX17). (A) Myc-tagged ATG4B was in vitro translated in the presence of 
[35S]methionine and subjected to GST pulldown assays with recombinant GST-LC3B WT, 
T50A, T50E, and the LDS double mutant F52A/L53A. Bound proteins were detected by 
autoradiography (AR), and immobilized GST or GST-tagged proteins by Coomassie Brilliant 
Blue staining (CBB). (B) GST pulldown assays using RIPA buffer cell lysate from HeLa cells 
with recombinant GST-LC3B WT, T50A, T50E, and the LDS double mutant F52A/L53A. The 
bound endogenous ATG4B was detected by immunoblotting. (C) Quantification of binding 
affinity of endogenous ATG4B based on three biological replicates. (D) HeLa cell lysates were 
used in GST pulldown assays as in (B) except that ATG7 binding was analyzed by 
immunoblotting of the bound fraction. (E) Quantification of ATG7 binding affinity from three 
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independent experiments. (F) Hela cells were transfected with EGFP-Syntaxin 17 (GFP-
STX17) and cells were lysed with RIPA buffer. The cell lysate was incubated with recombinant 
GST or GST LC3B with or without the indicated mutations. Bound GFP-STX17 was detected 
by western blot with EGFP antibody. (G) Quantification of binding affinity of GFP-STX17 
based on three biological replicates.  
 
Figure 8. The phospho-mimicking T50E mutation inhibits autophagic flux of the selective 
autophagy receptors p62 and NBR1. (A) Western blot analysis of p62 and NBR1 levels in 
HEK293 WT and HEK293 LC3B KO cells. Actin was probed as a loading control. (B) 
Quantification of p62 and NBR1 levels in WT and LC3B KO cells from three biological 
replicates. (C)  Western blots of Myc-LC3B in cell lysates from HEK293 LC3B KO cells 
reconstituted with Myc-LC3B -WT, -LC3B T50A, -LC3B T50E, and Myc-LC3B F52A/L53A 
and grown in full medium only, or in full media first and then incubated for 4 hours in Hanks 
balanced salt solution (HBSS), or for 4 hours in HBSS with Bafilomycin A1 (HBSS+BAF). 
The blot was developed using anti-Myc antibodies and PCNA was used as loading control. (D) 
Western blots of p62 and NBR1 in cell lysates from HEK293 WT and LC3B KO cells 
reconstituted with Myc-LC3B -WT, -LC3B T50A, -LC3B T50E, and Myc-LC3B F52A/L53A 
and grown in full medium. Actin was used as a loading control. (E-H) Under basal conditions 
(full medium) both formation and maturation of LC3B positive puncta (autophagosomes) are 
negatively affected by the T50E mutation. (E) Representative confocal fluorescence 
microscopy images of starving cells expressing the different mCherry-YFP-LC3B constructs 
used in (F-H). The indicated LC3B cell lines expressing mCherry-YFP-LC3B WT, -LC3B 
T50A, -LC3B T50E, and mCherry-YFP-LC3B F52A/L53A were induced with tetracycline (1 
µg/ml) for 24 hours and grown in full mediun or buffered Hanks balanced salt solution for 2 
hours after which the cells were fixed and analyzed by confocal microscopy. Individual cells 
were marked and LC3B-containing puncta were plotted as a function of cell volume for cells 
grown in full medium (F) or in Hanks balanced salt solution for the final 2 hours (G). Total 
number of cells scored is indicated above the plots. Note only cells positive for LC3B puncta 
are included. Results represent three independent experiments (H) The ratio of red-only to 
yellow puncta from the experiment shown in (F and G) was analyzed for the different cell lines. 
Mean +/- SEM of 3 independent experiments, NS P > 0.05, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 
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SUPPLEMENTARY FIGURE LEGENDS 
Supplementary Figure S1. Generation of CRISPR/CAS9-mediated HEK293 FlpIn LC3B  KO 
cells and HeLa NEK9 KO cells and GST pulldown analyses of NDP52 binding to T50 mutants 
of LC3C. (A) The genomic sequence from exon 16 of NEK9 targeted by gRNA. (B) Western 
blot of various clones from the KO experiments probed with antiNEK9 antibodies. Clone B7 
was used for our studies. (C) The genomic sequence from exon 2 of MAP1BLC3B targeted by 
guide RNA. (D) Western blot analysis of various clones from the KO experiments. Clone 7 was 
used for our studies. (E) Whole cell lysates from HeLa cells were subjected to GST pulldown 
assays to analyze binding of endogenous NDP52 to recombinant GST or GST-LC3C with or 
without mutations. The bound endogenous NDP52 was detected by immunoblotting with ant-
NDP52 antibodies and GST and GST-ATG8 proteins were visualized by coomassie blue 







































































































CRISPR/CAS9 KO of MAP1LC3B in HEK293 FlpIn cells
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TP53INP2/DOR (tumor protein p53 inducible nuclear protein 2)/ (diabetes and obesity-related) 
is a multifunctional protein acting as a coactivator of thyroid receptor-mediated transcription in 
the nucleus, as a facilitator of ribosome biogenesis in the nucleolus, and as an enhancer of 
starvation-induced autophagy. In this study, we uncover novel mechanisms for regulation of 
the subcellular localization and stability of TP53INP2. TP53INP2 is a nuclear protein under 
normal cellular conditions. Here, we identified a nuclear localization signal (NLS) and 
nucleolar localization signal (NoLS) in the C terminal part of TP53INP2. Upon mTOR 
inactivation such as starvation, TP53INP2 was stabilized and accumulated strongly in the 
cytoplasm. FRAP experiments revealed that this redistribution of TP53INP2 was due to 
cytoplasmic retention combined with an enhanced nuclear degradation rate. This result was 
supported by the lack of functional NES motifs in TP53INP2. Interestingly, the cytoplasmic 
retention of TP53INP2 during starvation was mediated by acetylation of lysine 187, impairing 
its interaction with importins. Furthermore, the rapid nuclear degradation of TP53INP2 was 
regulated by lysine’s 165 and 204. Starvation-induced acetylation of these residues led to 
proteasomal degradation of TP53INP2.  Hence, here we provide novel evidence that the 
subcellular localization of TP53INP2 is regulated by its three C-terminal lysine residues. mTOR 
inhibition mediated their acetylation leading to impaired nuclear import and proteasomal 














Lysine acetylation has been extensively studied in the context of transcription regulation. In  
the past decade, it has become clear that non-histone proteins are frequently acetylated 
regulating key cellular processes such as gene transcription, DNA damage repair, cell 
division, signal transduction, protein folding, autophagy, and metabolism. Acetylation may 
affect protein function through various mechanisms, including impact on protein stability, 
subcellular localization and by controlling protein-protein interactions1. Several studies have 
reported that acetylation plays an important role in the regulation of autophagy. 
Acetyltransferase TIP60 acetylates and thereby stimulates the activity of ULK1, required for 
autophagy induction2. Acetyltransferase CBP/p300 mediates acetylation of the autophagy 
proteins ATG5, ATG7, ATG8 and ATG12, and thereby inhibits autophagy activity3. The 
ATG8 family protein LC3B is reported to shuttle between the nucleus and the cytoplasm4,5. 
Upon nutrient deprivation, nuclear LC3B becomes deacetylated at K49 and K52 by Sirt1. 
This is reported to allow LC3B to bind to nuclear TP53INP2/DOR (tumor protein p53 
inducible nuclear protein 2)/(diabetes and obesity-related), which then mediates transport of 
LC3B out of the nucleus5. Cytoplasmic LC3B binds to ATG7, undergoes lipidation that 
converts soluble LC3B to the membrane-bound form and thereby recruits LC3B interacting 
proteins to the growing phagophore. Recently it was reported that cytoplasmic localized 
TP53INP2 is recruited to early autophagic membranes by LC3B, where it promotes the 
interaction between LC3B and ATG7 thereby facilitating autophagosome formation6. 
TP53INP2 was originally identified as a nuclear protein highly expressed in tissues with 
high metabolism level. In addition to its role in autophagy, it acts as a transcription coactivator 
of thyroid hormone receptor and regulates thyroid hormone function7. In a transgenic mouse 
model, muscle-specific overexpression of TP53INP2 led to reduced muscle mass and deletion 
of it led to muscle hypertrophy8. TP53INP2 is also linked to adipose cell differentiation. It acts 
as a negative regulator of adipogenesis by promoting sequestration of GSK3β in an ESCRT 
dependent pathway9. Nuclear TP53INP2 is enriched in the nucleolus, where it facilitates the 
formation of the RNA polymerase I preinitiation complex on rDNA promoters, and thereby 
promotes ribosome biogenesis when mTOR is active10. The complete redistribution of 
TP53INP2 from the nucleus to the cytoplasm upon mTOR inhibition has raised the question of 




 In this study, we mapped the amino acid residues directing nuclear (NLS) and nucleolar 
(NoLS) localization of TP53INP2. Using CRISPR/Cas9, we established TP53INP2 knock out 
(KO) cells reconstituted with inducible expression of various EGFP-TP53INP2 constructs. To 
our surprise, we found that TP53INP2 is not exported out of the nucleus upon mTOR inhibition. 
In contrast, nuclear import of newly synthesized TP53INP2 is inhibited while the nuclear-
localized TP53INP2 is degraded by the proteasome. Mass spectrometry analyses showed that 
three C-terminal lysine residues, K187, K165, and K204, were acetylated upon amino acid 
starvation. Acetylation of K187 impaired importin binding and nuclear import, while 
acetylation of K165 and K204 facilitated nuclear degradation. Autophagy flux was not affected 
by TP53INP2 KO, and TP53INP2 was not degraded by autophagy. However, over-expression 
of TP53INP2 in the cytoplasm leads to recruitment to LC3B dots and degradation by autophagy.  
 
Materials and methods 
Plasmids  
The Gateway entry clones used in this study are listed in the table below. QuickChange site-
directed mutagenesis kit (Stratagene) were used to create desired point mutation which was 
verified by DNA sequencing (BigDye sequencing kits, Applied Biosystems). For a generation 
of Gateway destination plasmid, Gateway LR and BP recombination kit from Invitrogen was 
used. 
Gateway entry vectors 
Plasmid Source 
pENTR -TP53INP2 Ref. 11 
pENTR -TP53INP2 W35A/I38A Ref. 11 
pENTR -TP53INP2 K165R This study 
pENTR -TP53INP2 K187R This study 
pENTR -TP53INP2 K204R This study 
pENTR -TP53INP2 K165R/K204R This study 
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pENTR -TP53INP2 K165R/K187R/K204R This study 
pENTR -TP53INP2 E97K/D98K Ref. 11 
pENTR -TP53INP2 Δ24-40 This study 
pENTR -TP53INP2 Δ189-211 This study 
pENTR -TP53INP2 Δ201-204 This study 
pENTR -TP53INP2 Δ201-204 This study 
pENTR -TP53INP2 W35A/I38A/Δ189-211 This study 
pENTR -TP53INP2 1-143 This study 
pENTR -TP53INP2 1-165 This study 
pENTR -TP53INP2 1-189 This study 
pENTR -TP53INP2 1-211 This study 
pENTR -TP53INP2 143-211 This study 
pENTR -TP53INP2 143-165 This study 
pENTR -TP53INP2 165-189 This study 
pENTR -TP53INP2 189-211 This study 
pENTR -TP53INP2 Δ6-14 This study 
pENTR -TP53INP2 Δ43-65 This study 
pENTR -TP53INP2 Δ70-80 This study 
pENTR -TP53INP2 Δ93-114 This study 
pENTR -TP53INP2 Δ121-141 This study 
pENTR -TP53INP2 S185A This study 
pENTR -TP53INP2 S198A This study 
pENTR -TP53INP2 S207A/S208A This study 
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pENTR -TP53INP2 S203A This study 
 
Gateway expression plasmids 
Plasmid Source 
pDest EGFP-Flp-In-TP53INP2 This study 
pDest EGFP-Flp-In-TP53INP2 W35A/I38A This study 
pDest EGFP-Flp-In-TP53INP2 K165R This study 
pDest EGFP-Flp-In-TP53INP2 K187R This study 
pDest EGFP-Flp-In-TP53INP2 K204R This study 




pDest EGFP-Flp-In-TP53INP2 E97K/D98K This study 
pDest EGFP-Flp-In-TP53INP2 Δ24-40 This study 
pDest EGFP-Flp-In-TP53INP2 Δ189-211 This study 
pDest EGFP-Flp-In-TP53INP2 Δ201-204 This study 




pDest EGFP -TP53INP2 1-143 This study 
pDest EGFP -TP53INP2 1-165 This study 
pDest EGFP -TP53INP2 1-189 This study 
pDest EGFP -TP53INP2 1-211 This study 
pDest EGFP -TP53INP2 143-211 This study 
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pDest EGFP -TP53INP2 143-165 This study 
pDest EGFP -TP53INP2 165-189 This study 
pDest EGFP -TP53INP2 189-211 This study 
pDest EGFP-Flp-In-TP53INP2 Δ6-14 This study 
pDest EGFP-Flp-In-TP53INP2 Δ43-65 This study 
pDest EGFP-Flp-In-TP53INP2 Δ70-80 This study 
pDest EGFP-Flp-In-TP53INP2 Δ93-114 This study 
pDest EGFP-Flp-In-TP53INP2 Δ121-141 This study 
pDest EGFP-Flp-In-TP53INP2 S185A This study 
pDest EGFP-Flp-In-TP53INP2 S198A This study 
pDest EGFP-Flp-In-TP53INP2 S207A/S208A This study 




Rev 1.4 EGFP Ref. 12 
Rev 1.4 NES EGFP Ref. 12 
Rev 1.4 TP53INP2 NES1 EGFP  This study 
Rev 1.4 TP53INP2 NES1 EGFP  This study 
 
Cell culture  
HeLa Flp-In T-Rex cells (Invitrogen, R714-07 were cultured in Eagle’s minimum essential 
medium with 10% serum (Biochrom, S0615) and 1% streptomycin-penicillin (Sigma-Aldrich, 
P4333). All HeLa FlpIn cell lines with EGFP-TP53INP2 integrated at FRT site were maintained 
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in the same medium with additional selection antibiotics 100 g/ml hygromycin (Calbiochem, 
400051) and 7.5 g/ml blasticidin S (Invitrogen, R210-01). 
 
Generation of stable cell lines  
HeLa FlpIn T-Rex cells were used to make stable TP53INP2 cell lines. The N-terminal EGFP-
tagged TP53INP2 cDNAs were cloned into pcDNA 3.1 FRT/TO plasmid. The generation of 
stable cell lines was performed in accordance with the manufacturer's instructions (Invitrogen, 
V6520-20). Briefly, 48 hours after transfection of different mutants of TP53INP2 cloned into 
pcDNA 3.1 FRT/TO plasmids, colonies of cells with the gene of interest integrated into FRT 
site were selected with 200 ng/ml of hygromycin (Calbiochem, 400051). Gene expression was 
induced with 1µg/ml of tetracycline for 24 hours. 
MEF ATG5 KO and WT cells were kindly provided by N. Mizushima13. Stable MEF 
cell lines expressing EGFP-TP53INP2 cell line were made by retroviral transfer. First, 
Platinium Retroviral Packaging Cell Line-E (Cell Biolabs, RV-101) was transfected with a 
pMXs retroviral plasmid containing EGFP-TP53INP2 cDNA. After 24 hours of transfection, 
viral supernatant was harvested, filtered through a 0.45 M filter and mixed with 8 g/ml of 
Polybrene (Sigma-Aldrich, H9268) before being added to cells. The viral transduction 
procedure was repeated again for the next 48 and 72 hours posts transfection. After the last viral 
transduction, MEF cells were selected with 5 g/ml of blasticidin S HCL (Thermo Fisher 
Scientific R2210-01).  
 
CRISPR/Cas9  
To construct the specific TP53INP1/TP53INP2 guide RNAs the CRISPR/Cas9 plasmid, sense- 
and antisense oligonucleotides encoding the selection guide sequence were annealed and then 
inserted into plasmid pSpCas9(BB)-2A-Puro (PX459). For a generation of CRISPR/Cas9 KO 
cells, approximately 30,000 of HeLa Flp-In T-Rex cells were seeded into 24 well plates and 
then 500 ng of plasmid PX459 per well were transfected using Metafectene Pro (Biontex, 
T040). The clonal selection was achieved by 500 ng/ml puromycin treatment, 24 hours after 
transfection for 48-72 hours. Later, single cells were sorted into 96 well plates via FACS 
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sorting. The clones were allowed to grow for 7-10 days and each clone was screened for KO 
by DNA sequencing of PCR products amplified from the targeted region in the genome. 
 
Fluorescence Recovery After Photobleaching (FRAP) 
HeLa Flp-In cells expressing EGFP-TP53INP2 WT or various mutants were grown on Lab-
Tek chambered cover glass (Thermo Scientific, Cat.no. 155411,) and imaged at 37° C and 5% 
CO2 on an LSM780 confocal microscope (Carl Zeiss Microscopy) equipped with a 40X 1.2NA 
water immersion lens. FRAP analysis was performed by drawing regions of interest (ROIs) 
around the nucleus and photobleaching the GFP signal inside the ROI to 100% of its initial 
value using 5 iterations of unattenuated 488 nm laser light. Fluorescence recovery was then 
monitored. An ROI placed inside a neighboring cell was monitored to control for 
photobleaching during image acquisition.  
 
Antibodies and reagents  
The following antibodies were used: Rabbit anti-LC3B (Novus, NB100-2220)  mouse anti-
GABARAP (MBL, M135-3), mouse anti-p62 (BD Bioscience, 610833), rabbit anti-NDP52 
(Sigma, HPA023195), mouse anti-NBR1 (Santa Cruz Biotechnology, sc-130380), rabbit anti-
GFP (Abcam, AB290), rabbit anti-ACTIN (Sigma-Aldrich, A2066), mouse anti-
GABARAP(MBL, M135-3),  horseradish peroxidase-conjugated goat anti-mouse- (BD 
Biosciences, 554002) and anti-rabbit (BD Biosciences, 554021) secondary antibodies. For 
confocal imaging following antibodies were used: rabbit anti LC3B (Sigma, L7543), guinea pig 
anti p62 (Progen, GP62-C), rabbit anti-Fibrillarin (Santa Cruz Biotechnology, sc-25397), Alexa 
Fluor® 555-conjugated goat anti-rabbit IgG (Life Technologies, A-21428), Alexa Fluor® 647-




Bafilomycin A1 (Sigma, B1793), MG132 (Sigma, C2211), Cycloheximide (Sigma, C7698), 
C646 (Sigma, C646), Torin 1 (Santa Cruz Biotechnology, sc-396760), Trichostatin A (Sigma, 
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T9033), Nicotinamide (Sigma, N3376), (Leptomycin B (Sigma, L2913), [35S]-methionine 
(PerkinElmer, NEG709A500UC). 
 
Real-Time PCR  
The total RNA was isolated using GenElute Mammalian Total RNA Miniprep Kit (Sigma, 
RTN70) and reverse transcribed using Transcriptor Universal cDNA master mix (Roche, 
Cat.no. 05893151001). The Realtime-PCR was performed using FastStart Universal SYBR 
Green Master Mix (Roche, Cat.no. 04913850001) on a LightCycler® 96 Real-Time PCR 
system (Roche). The primers used were as follows: 47S rRNA: forward primer 
TGTCAGGCGTTCTCGTCTC, reverse primer GAGAGCACGACGTCACCAC and Actin: 
forward primer TGACGGTCAGGTCATCACTATCGGCAATGA, Reverse primer 
TTGATCTTCATGGTGATAGGAGCGAGGGCA.  
 
Cell proliferation assay 
HeLa FlpIn TP53INP2 KO cells and HeLa FlpIn T-Rex control cells were seeded with four 
different concentrations (2000, 4000, 5000 and 6000 cells), two parallels of each concentration, 
in 100 μl DMEM (Sigma, D6046) on E-Plate L16 PET readers (ACEA Biosciences Inc, 
#2801185). xCELLigence® Real-Time Cell Analysis (RTCA) (ACEA Biosciences) were used 
to measure the cell proliferation over a time of 96 hours with recording at 1hr intervals.   
 
Protein purification and GST affinity isolation experiments 
GST-tagged proteins were expressed in Escherichia coli BL21 (DE3). GST fusion proteins 
were purified on glutathione-Sepharose 4 Fast Flow beads (GE Healthcare, 17513201) followed 
by washing with NET-N buffer (100 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40 (Sigma-
Aldrich, 74385), 50 mM Tris-HCl, pH 8) supplemented with cOmplete Mini EDTA-free 
protease inhibitor mixture tablets (Roche Applied Science, 11836170001). GST-tagged 
proteins were eluted with 50 mM Tris-HCl pH 8, 200 mM NaCl, 5 mM reduced L-glutathione 
(Sigma-Aldrich, G425). GST affinity isolation assays were performed with 35S-labeled proteins 
co-transcribed and translated using the TNT Coupled Reticulocyte Lysate System (Promega, 
L4610) as described previously14. For quantifications, gels were vacuum dried and 35S-labeled 
proteins detected on a Fujifilm bioimaging analyzer BAS-5000 (Fujifilm, Tokyo, Japan).  
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Acetylation modification and mass Spectrometry 
The total level of TP53INP2 acetylation under starvation and nutrient-rich condition was 
detected by Signal SeekerAcetyl-Lysine Detection Kits (Cat. # BK163, Cytoskeleton, Inc). The 
cells were harvested, and immunoprecipitations performed using manufacturer protocols. For 
mass spectrometry, cells were lysed with lysis buffer containing 20 mM Tris-HCl, pH 7.4, 1% 
NP-40, 137 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 10% Glycerol,1 M Trichostatin A (TSA), 
5 mM nicotinamide (NAM) and cOmplete Mini EDTA-free protease inhibitor mixture tablets. 
The inhibitors were added just before the lysis of cells. The MACS GFP isolation kits 
(Miltenyi Biotec) was used for immunoprecipitation of EGFP-TP53INP2 from cell lysate. The 
gel band containing EGFP-TP53INP2 was precisely cut and subjected to in-gel reduction, 
alkylation, and endopeptidase digestion using 4 ng/µl of Arg-C, sequencing grade (cat. no 
11370 529001, Roche) protease. OMIX C18 tips (Varian) were used for sample cleanup and 
concentration.  Peptide mixtures containing 0.1% formic acid were loaded onto a Thermo Fisher 
Scientific EASY-nLC1200 system. Samples were injected to a trap column (Acclaim PepMap 
75 μm × 2 cm, C18, 3 μm, 100 Å; ThermoFisher) for desalting before elution to the separation 
column (EASY-Spray column,  C18,  2  μm,  100  Å, 50 μm, 50 cm; ThermoFisher). Peptides 
were fractionated using a 4–40 % gradient of increasing amounts of 80% acetonitrile in water 
over 60 min at a flow rate of 300 ml/min. The mobile phases contained 0.1% formic acid. 
Separated peptides were analyzed using an Orbitrap Fusion Lumos mass spectrometer. The 
mass spectrometer was operated in a data-dependent mode with the precursor scan in the 
orbitrap over the range m/z 350–1500. The most intense ions were selected for ETD or CID 
fragmentation using 3 sec between each master scan. Dynamic exclusion was set to 30s. The 
Orbitrap AGC target was set to 4E5 and the MS2 scans in the Ion Trap were set to 1E4 with 
maximum injection times 50 and 100 ms, respectively. Precursor ions with charge 3+ in the 
m/z range 350-650 and 4+ or 5+ ions in the m/z range 350-900 was fragmented with ETD. All 
ions with 6+ or higher were also fragmented using ETD. The rest of the precursor ions were 
fragmented using CID. Protein identification and PTM mapping were done using the Proteome 
Discoverer 2.2 software (ThermoFisher). 
 
Western blot and immunoprecipitation experiments 
For western blotting experiments, cells were washed in PBS (137 mM NaCl, 2.7 mM KCl, 4.3 
mM Na2HPO4, 1.47 mM KH2PO4, pH 7.4.) followed by lysis directly in SDS-PAGE loading 
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buffer (2% SDS, 10% glycerol 50 mM Tris-HCl, pH 6.8) and boiled for 10 min. Protein 
concentration was measured followed by addition of bromophenol blue (0.1%) and DTT (100 
mM). Samples (20 µg) were run on 10-16% gradient- or 10%- SDS-polyacrylamide gels and 
blotted on Hybond nitrocellulose membranes (GE Healthcare, 10600003) followed by Ponceau 
S staining. Blocking was performed in 5% nonfat dry milk in PBS-Tween 20 (0.1%). Primary 
antibody was diluted in PBS-Tween 20 containing 5% nonfat dry milk and incubation was 
performed overnight at 4°C. Secondary antibody incubation was performed at room 
temperature for 1 h in PBS-Tween 20 containing 5% nonfat dry milk. Membranes were washes 
3 times prior to the addition of secondary antibody and development using LAS-300 (Fujifilm, 
Tokyo, Japan).  
 
Bioinformatics and statistics 
The prediction of nucleolar localization signal (NoLS) and Nuclear export signal was performed 
using online servers: http://www.compbio.dundee.ac.uk/www-nod/ and 
(http://www.cbs.dtu.dk/services/NetNES/), respectively. Secondary structure predictions were 
performed using the PSIPRED server: http://bioinf.cs.ucl.ac.uk/. Helical wheel projections 
were made using HeliQuest: http://heliquest.ipmc.cnrs.fr/. Data in all figures are from 
experiments performed at least twice unless otherwise stated.  
 
Results  
The autophagic flux is unaffected by CRISPR/CAS9-mediated knock-out of TP53INP2 in 
HeLa cells 
The multifaceted roles of TP53INP2, acting as a transcriptional coactivator in the cell nucleus, 
as a promoter of rRNA transcription in the nucleolus, and as a regulator of autophagy in the 
cytoplasm, seem to be regulated by subcellular localization10,15. In order to reveal the molecular 
mechanisms regulating TP53INP2 localization and autophagic activity, we first established 
CRISPR/Cas9 mediated HeLa FlpIn knock-out (KO) cells of TP53INP2 and its homologue 
TP53INP1. KO of the genes was verified by genomic DNA sequencing since their expression 
levels in the HeLa FlpIn cells were too low to be detected by commercial antibodies (Fig. S1A 
and B). To measure the autophagic flux in the KO cells, the level of the autophagy receptors 
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p62, NBR1 and NDP52, and the lipidation of LC3B and GABARAP, under normal and starved 
conditions, were analyzed by Western blotting (Fig. S2A and B). Surprisingly, no differences 
were observed in the KO cell lines compared to wild type (WT) cells. This suggests that 
TP53INP2, and its homologue TP53INP1, does not have a detectable impact on the regulation 
of autophagy flux during normal and starved conditions in the HeLa cells applied in this study. 
However, we cannot rule out that they are redundant in function, and that knocking out both 
TP53INP1 and TP53INP2 might have affected the autophagy pathway. Recently, TP53INP2 
was shown to have a role in ribosomal biogenesis and cell proliferation10. In order to, confirm 
that the TP53INP2 KO cells have a similar phenotype, the cell proliferation of the KO cells was 
analyzed and compared to wild type cells (Fig. S2C). In line with previous reports, we observed 
that the TP53INP2 KO cells have a slower proliferation rate than the wild type cells and a 
decreased transcription of 47S rRNA (Fig. S2D).  
 
TP53INP2 is degraded by the proteasome in the nucleus and accumulates in the cytoplasm 
upon inhibition of mTOR   
Previous studies have shown that TP53INP2 redistributes to the cytoplasm upon mTOR 
inhibition. To determine which factors or modifications of TP53INP2 that mediates this 
redistribution, we reconstituted the HeLa FlpIn TRex TP53INP2 KO cells with EGFP-
TP53INP2. The expression of EGFP-TP53INP2 was induced by tetracycline treatment and kept 
at a low level to obtain a situation as close to endogenous as possible. Confocal fluorescence 
microscopy analysis of the reconstituted cells under normal conditions and upon mTOR 
inhibition by starvation or Torin 1 treatment, revealed that redistribution of EGFP-TP53INP2 
from the nucleus to the cytoplasm is regulated by mTOR activity (Fig. 1A and Fig. S2E). 
Surprisingly, EGFP-TP53INP2 retained diffusible cytoplasmic staining and did not form any 
puncta structures in the cytoplasm during starvation. The autophagy receptor p62 and the 
autophagosome marker protein LC3B formed punctate structures that increased upon starvation 
and treatment with the lysosomal inhibitor Bafilomycin A1 (BafA1), indicating that the 
autophagy process acts as normal in the cell line. In contrast, when we over-expressed EGFP-
TP53INP2 in the KO cells by transient transfection, EGFP-TP53INP2 formed punctate 
structures in the cytoplasm upon starvation (Fig. S3). This suggests that overexpression of 
TP53INP2 may impair its normal subcellular localization pattern. To determine whether EGFP-
TP53INP2 is an autophagic substrate, the level of EGFP-TP53INP2 upon starvation and BafA1 
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treatment was measured by Western blotting. To our surprise, the expression level of EGFP-
TP53INP2 was strongly increased upon starvation and unaffected by BafA1 treatment (Fig. 
1B). In contrast, inhibition of the proteasomal degradation pathway by MG132 treatment led to 
increased expression of EGFP-TP53INP2 (Fig. 1B). Furthermore, confocal microscopy 
imaging showed accumulation of EGFP-TP53INP2 in the nucleolus (Fig. 1C). Proteins are 
degraded by ubiquitin-dependent and -independent pathways. To test this, we mutated all three 
lysines (K) residues in TP53INP2 to arginines (R) and reconstituted KO cells with the K3R 
triple mutant. Interestingly, also the K3R mutant displayed increased accumulation of 
TP53INP2 in the nucleoli upon MG132 treatment indicating ubiquitin-independent degradation 
(Fig. 1D and E). Similar to our result, PICT1, a nucleolar ribosomal protein is also degraded 
inside the nucleolus in a ubiquitin-independent manner16. Altogether, these results show that 
mTOR inhibition leads to cytoplasmic accumulation of EGFP-TP53INP2 and that the nuclear 
pool of TP53INP2 is degraded by the proteasome.   
 
Partial overlapping NLS and NoLS signals are located in the C-terminal region of 
TP53INP2  
To facilitate the nuclear pore complex (NPC) mediated import of a protein requires a nuclear 
localization signal (NLS) that interacts with importin proteins. The first described NLS motif 
was identified in SV40 T antigen (PKKKRKV)17. To map the NLS directing nuclear import of 
TP53INP2 we made several deletions constructs of TP53INP2 fused to EGFP (Fig. 2A). These 
expression constructs were transfected into HeLa cells and the subcellular localization of the 
various constructs was analyzed by confocal fluorescence microscopy (Fig. 2B). The N-
terminal part of TP53INP2 (amino acids 1-143, 1-165 and 1-189) displayed a localization 
pattern similar to EGFP alone (Fig. 2B). However, extending the expression construct to 
include the region 189-211 resulted in a dominant nuclear localization. This suggested the 
presence of an NLS motif within the region 189-211. The localization of an NLS in this region 
was further validated by deleting this region from full-length TP53INP2. This led to reduced 
nuclear localization compared to the WT protein (Fig. 2B). Moreover, fusing the 189-211 
region to EGFP resulted in complete nuclear localization of EGFP (Fig. 2B). Together with 
bioinformatics tools and a recent publication that predicted an NLS within the 144-221 region 
of TP53INP26, our results clearly have identified the 189-211 region of TP53INP2 to direct 
nuclear localization.   
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A recent report showed that endogenous TP53INP2 is enriched in the nucleoli where it plays a 
role in ribosome biogenesis10, and that the 191-211 region constitutes a nucleolar localization 
signal (NoLS)10. In line with this, we observed nucleolar enrichment of EGFP-TP53INP2 both 
upon transient transfection and in the EGFP-TR53INP2 reconstituted KO cell line (Fig. 1A, C 
and Fig. 2B). The consensus sequence based on several proteins with NoLS is designated as 
R/K-R/K-X-R/K18. Sequence analysis predicted a putative NoLS sequence in the 201-204 
region, partially overlapping the NLS. Deletion of the 201-204 region from full-length 
TP53INP2 prevented localization of TP53INP2 in the nucleolus (Fig. 2B) and clearly identified 
the NoLS of TP53INP2. Together with our results and previously published data identify partial 
overlapping NLS and NoLS signals in the C-terminal region of TP53INP2. 
 
Deletion of the TP53INP2 NLS motif leads to protein accumulation and partial 
autophagic degradation  
Exogenously over-expressed TP53INP2 forms punctate structures in the cytoplasm co-
localized with ATG8s upon induction of autophagy by starvation15(Fig. S3) . However, 
confocal fluorescence microscopy analysis of our TP53INP2 KO cell line reconstituted with 
EGFP-TP53INP2 expressed at a low level, did not display any puncta formation in the 
cytoplasm during starvation (Fig. 1A). Moreover, treatment of the cell line with the lysosomal 
inhibitor BafA1 did not stabilize EGFP-TP53INP2, while the proteasomal inhibitor MG132 
caused strong stabilization (Fig. 1B). This suggests that over-expression of TP53INP2 may 
overload the regulation mechanisms for nuclear import of TP53INP2 leading to cytoplasmic 
accumulation and may potentiate TP53INP2 as an autophagic substrate. To clarify this, we 
generated a HeLa FlpIn cell line with inducible expression of EGFP-TP53INP2 lacking the 
NLS and NoLS sequences (Δ189-211). Interestingly, deletion of the NLS-NoLS motif led to 
the formation of cytoplasmic puncta that co-localized with LC3B under basal conditions. The 
number of cytoplasmic puncta co-localizing with LC3B increased upon inhibition of lysosomal 
degradation and even more upon starvation (Fig. 3A). Monitoring the expression level of 
EGFP-TP53INP2(Δ189-212) by Western blotting revealed that there was no significant 
stabilization upon starvation of the NLS-NoLS mutant (Fig. 3B) as found for WT TP53INP2 
(Fig. 1B). There was a small stabilization by BafA1 while proteasomal inhibition gave a 
profound stabilization. Together this suggests that the nuclear pool of TP53INP2 is degraded 
by the proteasome while the smaller cytoplasmic pool may be degraded by autophagy. Mutation 
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of the LIR motif in the TP53INP2(Δ189-211) constructs impaired the recruitment of TP53INP2 
to the cytoplasmic LC3B dots (EGFP-TP53INP2 NLS+LIR in Fig 3A), confirming previous 
studies based on transient over-expression15. These results suggest that TP53INP2 is more 
stable when localized in the cytoplasm than in the nucleus. This is consistent with previously 
published data showing that TP53INP2 is very unstable with a half-life of about 4 hours19. 
TP53INP2 which has accumulated in the cytoplasm is recruited to LC3B-positive structures via 
its LIR motif and can undergo degradation via the autophagic-lysosomal pathway as published 
for TP53INP120. However, normally TP53INP2 is a substrate for proteasomal degradation in 
the nucleolus. 
 
The starvation-induced cytoplasmic localization of TP53INP2 is independent of ATG5 
and NES motifs 
TP53INP2 is reported to mediate transport of nuclear LC3B to the cytoplasm to promote 
autophagy under starvation5. Translocation of TP53INP2 from the nucleus to the cytoplasm 
upon starvation required a functional LIR motif11. A nuclear export sequence (NES) was 
identified in the region amino acids 25-47 encompassing the LIR motif at positions 35-3811. 
Together these studies indicate a mutual role of ATG8s and TP53INP2 in facilitating each 
other’s export out of nucleus upon mTOR inactivation. Furthermore, it is reported that 
autophagy-deficient cells lacking ATG5 display impaired nucleocytoplasmic shuttling of 
TP53INP215.  To study this more closely as we first applied bioinformatics tools to predict 
putative NES motifs in TP53INP2. In addition to the published NES1 (25-
VSEEDEVDGWLIIDLPDSYAAP-47), another NES2 motif (87 GPARLQSSPLEDLLIEH 
104) was predicted. To test their functionality in mediating nuclear export in isolation, both 
motifs were cloned into the Rev 1.4 plasmid vector21. The positive control REV NES motif 
directed REV-EGFP out of the nucleus (Fig. 4A). However, both the NES1 and the NES2 
motifs failed to export the REV-EGFP protein out of the nucleus (Fig. 4B). Furthermore, when 
the HeLa FlpIn EGFP-TP53INP2 cells were starved and treated with leptomycin B (LMB) for 
2 hours, EGFP-TP53INP2 was still localized in the cytoplasm and not retained in the nucleus 
as p62 (Fig. 4C). p62 is continuously shuttling between the nucleus and the cytoplasm21. LMB 
inhibits CRM1-mediated export from the nucleus to the cytoplasm. These results indicate that 
NES1 and NES2 in TP53INP2 are not functional NES motifs and that TP53INP2 nuclear export 
is not mediated by CRM1 (also called exportin 1). Interestingly, similar to TP53INP2, LMB 
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treatment is not able to restrict LC3B to the nucleus4, suggesting that the two proteins use a 
similar mechanism for directing cytoplasmic localization. Therefore, we analyzed the 
importance of the LIR motif in TP53INP2 for nucleocytoplasmic shuttling by establishing a 
HeLa FlpIn EGFP-TP53INP2 W35A/I38A (LIR mutant) expressing cell line. Surprisingly, and 
in contrast to previous studies11, we found that the mutation of the LIR motif did not impact 
TP53INP2 localization (Fig. 4D). Deletion of the complete NES1 encompassing the LIR motif 
(TP53INP2 Δ24-40) (Fig. S4A), or mutation of the residues E97 and D98 previously reported 
to be important for TP53INP2 shuttling11, did not affect localization either (Fig. S4B). Hence, 
the nuclear export of TP53INP2 seems not to be mediated by the previous published NES motif 
or by interaction with the ATG8 proteins. Our next question was therefore whether ATG5 and 
autophagy activity had any impact on TP53INP2 localization. To this end, we generated WT 
MEF and ATG5 KO MEF cell lines constitutively expressing EGFP-TP53INP2. In contrast to 
previous reports15, we found that the ATG5 KO MEF EGFP-TP53INP2 cell line showed similar 
nuclear-cytoplasmic shuttling as the MEF wild type cells (Fig. 5A and B). This suggests that 
the autophagy process does not impact directly on the TP53INP2 nuclear-cytoplasmic shuttling. 
 
mTOR inactivation mediates acetylation and cytoplasmic retention of TP53INP2 
Our failure to identify a functional NES in TP53INP2 together with the lack of nuclear retention 
upon LMB treatment raised the question whether the cytoplasmic accumulation of TP53INP2 
is regulated by inhibition of nuclear import and not a consequence of nuclear export. To 
investigate this, we performed fluorescence recovery after photobleaching (FRAP) on the FlpIn 
TP53INP2 KO cell line reconstituted with EGFP-TP53INP2. The nuclear EGFP-TP53INP2 
was completely photoed bleached and then the cells were starved in HBSS for 1 hour. During 
this period, the localization of EGFP-TP53INP2 was followed by live cell imaging. Despite 
photobleaching of the entire nuclear pool of EGFP-TP53INP2, we still observed cytoplasmic 
accumulation similar to the unbleached cells, upon starvation (Fig. 6A). This shows that the 
cytoplasmic accumulation takes place without contribution from the nuclear EGFP-TP53INP2 
fraction. Thus, the newly synthesized EGFP-TP53INP2 is restricted to the cytoplasm upon 
mTOR inhibition while the nuclear EGFP-TP53INP2 fraction is degraded by nuclear 
proteasomes. To test this further, we checked if the interaction between TP53INP2 and the 
importin family of proteins is modulated upon starvation. For nuclear import, proteins interact 
with the nuclear pore complex whereby the importin family of proteins plays an essential role. 
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First, we assayed the interaction of TP53INP2 with importin family proteins by GST pulldown 
assay (Fig. 6B). Since TP53INP2 bound best to importin 1, GST-Importin 1 was applied in 
a GST-pulldown assay with cell lysates from the HeLa FlpIn EGFP-TP53INP2 cell line 
exposed to normal medium or starvation medium (HBSS) for 2 hours. Interestingly, EGFP-
TP53INP2 from cells exposed to full medium interacted strongly with GST-Importin 1 while 
EGFP-TP53INP2 from cells exposed to HBSS did not (Fig. 6C). This indicates that mTOR 
inhibition affects the binding of TP53INP2 to Importin and thereby restricts TP53INP2 to the 
cytoplasm. Acetylation of proteins can regulate their subcellular localization1. Importantly, 
nuclear localization of LC3B is shown to be regulated via acetylation of the lysine residues 
K49/K515. This prompted us to investigate if starvation could change the acetylation pattern of 
TP53INP2, and thereby inhibit Importin binding and nuclear translocation. To this end, we 
monitored acetylated EGFP-TP53INP2 in cell extracts from the HeLa FlpIn EGFP-TP53INP2 
cell line exposed to normal or starvation conditions using an acetylation enrichment assay. In 
contrast to what is reported for LC3B, we found that starvation induces strong acetylation of 
TP53INP2 (Fig. 6D). To verify this further, we immunoprecipitated EGFP-TP53INP2 from the 
cells and analyzed post-translational modifications by mass spectrometry. Notably, we found 
that all three residues within the C terminal part of TP53INP2 undergo acetylation upon 
exposure to starvation media (Fig. 6E and Fig. S5A-F). Secondary structure predictions 22 
suggest the presence of two helices in the C-terminal region of TP53INP2. The second helix is 
part of the NLS and projects K187 and two arginines (R191 and R194) on the same side of the 
helix suggesting they may constitute an interaction surface for importin . Acetylation of K187 
may then inhibit this interaction and thereby inhibit the nuclear import of TP53INP2. Taken 
together, and in contrast to previous reports, our results show that starvation-induced mTOR 
inhibition leads to increased acetylation of the three C terminal lysine residues in TP53INP2 
inhibiting binding to the importins and blockage of nuclear translocation of TP53INP2. 
 
Acetylation of TP53INP2 at K187 inhibits nuclear import upon starvation 
To determine the importance of each of the three lysine residues (K165, K187, K204) for 
regulating nuclear localization of TP53INP2, we generated HeLa FlpIn cells expressing each 
of the TP53INP2 mutants EGFP-TP53INP2 K165R, EGFP-TP53INP2 K187R, and EGFP-
TP53INP2 K204R. HeLa FlpIn cells expressing EGFP-TP53INP2 K165R and EGFP-
TP53INP2 K204R displayed a similar localization pattern as wild type EGFP-TP53INP2 (Fig. 
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1A, Fig. 7A, and C). However, cells expressing EGFP-TP53INP2 K187R did not display any 
cytoplasmic retention upon starvation and TP53INP2 K187R remained completely nuclear 
(Fig. 7B). This indicates that K187 regulates the nuclear import of TP53INP2. To rule out the 
possibility of phosphorylation regulating nuclear-cytoplasmic shuttling, we made several cell 
lines expressing EGFP-TP53INP2 with deletions (Fig. S6A-F) or point mutations of serine-
threonine phosphorylatable residues (Fig. S6G-K), but we could not see any effect of any of 
these mutations on subcellular localization. 
 
Inhibition of CBP leads to dysregulated expression of TP53INP2  
Since the MS data showed acetylation of all the three C-terminal lysine residues in TP53INP2, 
we next analyzed the localization of an EGFP-TP53INP2 mutant with all three lysine residues 
mutated, K3R. In a normal medium, the K3R mutant displayed a nuclear localization similar to 
the WT protein (Fig. 8A). However, exposure to starvation conditions led to strong nuclear 
accumulation in addition to the cytoplasmic accumulation typical for the WT protein (Fig. 8A 
and Fig. 1A). This combined phenotype was a surprise because the K3R has the K187R 
mutation allowing unregulated nuclear import. This result clearly suggests that K165 and/or 
K204 also are involved in regulating the localization and/or stability of TP53INP2. To further 
confirm that acetylation of these three lysine residues is important for regulation of subcellular 
localization and degradation, we next exposed the HeLa FlpIn EGFP-TP53INP2 cell line to the 
CBP/p300 inhibitor C646. CBP/p300 is localized both in the cytoplasm and in the nucleus and 
is previously shown to regulate autophagy via acetylation of autophagy-related proteins such 
as ATG5 and LC3B3,5. Notably, starvation of HeLa FlpIn EGFP-TP53INP2 cells that had been 
treated with C646 led to a similar nuclear and cytoplasmic accumulation as the EGFP-
TP53INP2(K3R) mutant (Fig. 8B). This clearly suggests that acetylation of the three C-terminal 
lysine residues in TP53INP2 is important for regulating its subcellular localization and the 
degradation rate upon starvation. 
 
Acetylation of K165 and K240 facilitates nuclear degradation of TP53INP2 upon 
starvation 
Our results so far have shown that the expression of TP53INP2 is strongly enhanced upon 
starvation. At the same time, the nuclear import is inhibited due to acetylation of 
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TP53INP2(K187) and the subcellular localization of TP53INP2 switches from nuclear to 
cytoplasmic. Our FRAP analyses suggested that there is no significant translocation of 
TP53INP2 from the nucleus to the cytoplasm during this period. Hence, the next question was 
if the localization switch was caused by cytoplasmic retention and stabilization of newly 
synthesized TP53INP2, while the nuclear pool of TP53INP2 proteins was directed to 
degradation via the proteasome. To this end, we exposed the EGFP-TP53INP2 wild type and 
mutant cell lines for starvation while we inhibited protein synthesis with cycloheximide and 
followed the localization of the EGFP-TP53INP2 proteins. The subcellular localization of the 
wild type protein was completely switched from nuclear to cytoplasmic within 80 minutes of 
starvation. Inhibition of protein synthesis leads to a strong reduction in the accumulation of 
cytoplasmic EGFP-TP53INP2 protein (Fig. 9A). This shows that the accumulation of 
cytoplasmic TP53INP2 is due to increased synthesis and stabilization by cytoplasmic retention. 
The EGFP-TP53INP2 K187R mutant displayed complete nuclear localization even after 120 
minutes of starvation. Inhibition of protein synthesis led to a strong reduction in the amount of 
TP53INP2 K187R (Fig. 9B). This confirms that acetylation of K187 directs inhibition of 
nuclear import. Furthermore, it shows that newly synthesized EGFP-TP53INP2 K187R is 
continuously imported to the nucleus where it undergoes nuclear degradation. Addition of 
cycloheximide to the EGFP-TP53INP2 K3R mutant, which normally accumulated both in the 
nucleus and in the cytoplasm upon starvation, led to the disappearance of the cytoplasmic 
proteins while the nuclear proteins remained unchanged (Fig. 9C). This confirms that the 
cytoplasmic accumulation upon starvation is due to enhanced protein synthesis of TP53INP2. 
Interestingly, also p53 is stabilized upon starvation in certain cell lines23. Hence, enhanced 
TP53INP2 expression may be mediated by p53. Moreover, it shows that modification of the 
lysine residues K165 and K204 facilitates nuclear degradation upon starvation. When they are 
mutated, TP53INP2 is still expressed in the nucleus under starvation conditions. Altogether, 
our results show that the localization of TP53INP2 is regulated by its three C-terminal lysine 
residues K165, K187, and K204. K187 regulates the nuclear import of the protein, while K165 
and K204 regulate its nuclear degradation rate. Upon starvation, these three residues are 
acetylated, leading to cytoplasmic retention and nuclear degradation, and hence a switch in its 






The major conclusion of this study is that the localization switch of TP53INP2 upon mTOR 
inhibition from the nucleus to the cytoplasm, is regulated by acetylation of three lysine residues 
in its C-terminal region. By establishing TP53INP2 KO cell lines with low expression levels of 
EGFP-TP53INP2, we found that EGFP-TP53INP2 does not shuttle from the nucleus to the 
cytoplasm. Instead, mTOR inhibition led to impairment of nuclear import combined with 
facilitated degradation of nuclear TP53INP2 proteins. A previous study showed data to suggest 
that TP53INP2 shuttles between the cytoplasm and nucleus. During this shuttling, it passes 
through the nucleolus24. Furthermore, TP53INP2 has also been reported to act as a mediator of 
nucleocytoplasmic shuttling of LC3B, binding to deacetylated LC3B in the nucleus and 
facilitating its export to the cytoplasm upon nutrient deprivation5. Our data do not oppose that 
nuclear export of LC3B occurs upon mTOR inhibition, but TP53INP2 is not exported together 
with LC3B. This finding was supported by the lack of a functional NES in TP53INP2, the 
inability of a CRM1 inhibitor to restrict TP53INP2 to the nucleus, and by FRAP data showing 
that TP53INP2 does not move out of the nucleus.  
 Under full media conditions, TP53INP2 is localized in the nucleus, and enriched in the 
nucleolus. It serves roles both as a transcriptional coactivator of the thyroid hormone receptor 
and as a facilitator of RNA polymerase I transcription, respectively7,10. These findings were 
supported by our analysis of the TP53INP2 KO cells, which displayed a lower proliferation rate 
and less rDNA transcription than the wild type cells. We mapped the region encompassing 
amino acids 189-211 to constitute the NLS of TP53INP2, and within this region, we mapped 
the NoLS to be represented by amino acids 201 to 204. Interestingly, immediately preceding 
the mapped NLS we identified the K187 residue that regulated the nuclear import of TP53INP2. 
Starvation-induced acetylation of K187 restricted TP53INP2 to the cytoplasm. K187 is 
predicted to be located on a helix that also projects two R191 and R194 on the same side. 
Acetylation of K187 may compromise binding of the helix with R191 and R194 to importin 
and inhibit nuclear import of TP53INP2. When the nuclear import of TP53INP2 is inhibited 
under nutrient deprivation its stimulating effects on cell proliferation and ribosome biogenesis 
is consequently blocked. Moreover, we also identified the K204 residue within the NoLS and 
K165 to be acetylated under cellular starvation. Acetylation of these residues facilitated nuclear 
degradation of TP53INP2, and hence further ensured that the anabolic roles of TP53INP2 are 
switched off during starvation.  
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 In this study, we found that p300/CBP can mediate acetylation of the three regulatory 
lysine residues in the C-terminal of TP53INP2 with acetylation of K187 inhibiting nuclear 
import. Regulation of subcellular localization by acetylation is already known in the literature1. 
Acetylation of the NLS of S phase kinase-associated protein 2 (SKP2) by p300 promotes its 
cytoplasmic retention and inhibits its degradation25. This is essentially the same mechanism as 
we here report for TP53INP2. Also, acetylation of the NLS of the viral- DNA sensor γ- 
interferon-inducible protein 16 (IFI16) leads to its cytoplasmic localization26. Furthermore, 
AMPK-dependent p300-mediated acetylation of importin α1 is associated with regulation of 
nuclear import of RNA binding protein, Hu-antigen R27. Also, p300 is shown to acetylate 
histone deacetylase 6 (HDAC6) leading to inhibition of interaction with importin α and 
subsequent inhibition of nuclear import 28.  
We found the expression of TP53INP2 to strongly increase upon starvation. Treatment 
with cycloheximide showed that this increase is dependent on protein synthesis, and hence not 
only due to protein stabilization. This shows that TP53INP2 escapes the global downregulation 
of translation that occurs upon mTOR inhibition. Importantly, p53 is shown to be stabilized by 
starvation in hepatic tissue23. The stabilization was obtained by post-transcriptional 
mechanisms and was required for gluconeogenesis and amino acid catabolism in a starved state. 
The role of starvation-induced TP53INP2 expression upon mTOR inhibition will be an 
important question to address in future studies.  
 One suggested a role of cytoplasmic TP53INP2 is the reported role in facilitating 
autophagosome formation, thus acting as a positive regulator of autophagy15. Whether 
TP53INP2, via binding to the vacuole membrane protein 1 (VMP1), functions as a scaffold for 
LC3B recruitment to autophagosomes, or if LC3B recruits TP53INP2 to the phagophore 
structures, has not been clarified5,15,24,29. However, a recent report shows that LC3B recruits 
TP53INP2 to autophagic membranes6, which is in line with our results. Our data suggest that 
cytoplasmic degradation of TP53INP2 is regulated by modifications of the C-terminal lysine 
residues. This regulation is overridden when TP53INP2 is over-expressed by transient 
transfection. Then it is recruited to LC3B-positive structures in a LIR-dependent manner. 
However, when the expression of TP53INP2 is kept at a level closer to the endogenous level, 
TP53INP2 is stabilized in the cytoplasm upon starvation and not detected in LC3B-positive 
structures. Normally, TP53INP2 is degraded by the proteasome19, which we show occurs in the 
nucleus, most likely in the nucleolus, by an ubiquitin-independent pathway. This degradation 
pathway is not much studied and not well understood. Recently, Protein interacting with the 
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carboxyl terminus (PICT), a regulator of p53, was found to be degraded by a nucleolar 
ubiquitin-independent proteasomal pathway16. It is interesting that TP53INP2 may be degraded 
by the same pathway.  
Our measurements of autophagic flux in the TP53INP2 KO out cells revealed no 
difference from WT cells. LC3B lipidation upon starvation was completely normal, and the 
autophagy receptors were not accumulated. This suggests that at least in these cell lines loss of 
TP53INP2 does not affect autophagy flux detectably.  This cannot rule out the possibility of 
functional redundancy between TP53INP1 and TP53INP2.  Another recent study reported that 
TP53INP2 interaction with ATG7 enhanced LC3-ATG7 interaction but did not affect the 
formation of autophagosomes on knockdown of TP53INP26. Consistent with this, TP53INP2-
deficient 3T3-L1 cells did not display any changes in autophagy flux during adipogenesis 
relative to control cells 9. Taken together, this raises the question if TP53INP2 may have other 
roles in the cytoplasm than being a regulator of autophagy activity. Interestingly, a recent paper 
shows that TP53INP2 sensitizes cells to apoptosis induced by death receptor ligands30. 
TP53INP2 was found to bind to caspase‐8 and the ubiquitin ligase TRAF6, and thereby regulate 
TRAF6-mediated activation of caspase‐8. Hence, an important role of TP53INP2 in the 
cytoplasm may be to regulate this death receptor pathway. To conclude, TP53INP2 serves 
important roles in the cytoplasm, nucleus, and nucleolus. We now show that its subcellular 
localization is tightly regulated by acetylation of specific lysine residues in its C-terminal part.  
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Figure 1. TP53INP2 is degraded by the proteasome in the nucleolus but accumulates in 
the cytoplasm upon inhibition of mTOR. (A) TP53INP2 does not co-localize with p62 or 
LC3B puncta upon starvation. TP53INP2 KO cells reconstituted with EGFP-TP53INP2 were 
treated with doxycycline for 24 h to induce expression. Cells were then kept in full medium 
(FM) or treated as indicated, before staining with p62 and LC3B antibodies and analysis by 
confocal fluorescence microscopy. (B) TP53INP2 is mainly degraded by the proteasome but is 
strongly stabilized upon starvation. After induction of EGFP-TP53INP2 with doxycycline, cells 
were treated as indicated and cell extracts analyzed by western blotting using the indicated 
antibodies. (C) EGFP-TP53INP2 accumulates in the nucleolus upon proteasomal inhibition. 
After induction of EGFP-TP52INP2 with doxycycline, cells were treated with MG132 for 8 h, 
stained with fibrillarin antibodies, and analyzed by confocal imaging. (D) Mutation of all 
lysines in TP53INP2 does not prevent its degradation by the proteasome nor its stabilization in 
response to starvation. Cells expressing EGFP-TP53INP2 K3R were treated as in B and cell 
extracts analyzed by western blotting as in B. (E) Mutation of all lysines in TP53INP2 does not 
affect its accumulation in the nucleolus upon proteasomal inhibition. Cells expressing EGFP-
TP53INP2 K3R were treated and analyzed by confocal fluorescence microscopy as in C. Scale 
bars, 10 m. 
 
Figure 2. Partial overlapping NLS and NoLS signals are located in the C-terminal region 
of TP53INP2. (A) Schematic diagram of TP53INP2, showing the extension of deletion 
constructs used to identify nuclear localization signal (NLS) and nucleolar localization signal 
(NoLS) in TP53INP2. The localization of different deletion constructs in the nucleus (N) or 
cytoplasm (C) of transfected cells is indicated to the right. (B) HeLa cells transiently transfected 
with the indicated EGFP-TP53INP2 constructs were analyzed by confocal imaging 24 h post 
transfection. Scale bars, 10 m. (C) Mapping of NLS and NoLS motifs in TP53INP2. The 
extent of the motifs are shown above a sequence alignment indicating evolutionary conservation 
of the NLS and NoLS motifs in higher vertebrates. The green dots indicate the positions of the 
three lysine residues in human TP53INP2. Basic residues are indicated in blue and acidic ones 
in red. The amino acid numbering below the alignment is based on the human TP53INP2 




Figure 3. Deletion of the TP53INP2 NLS motif leads to cytoplasmic protein accumulation 
and partial autophagic degradation. (A) TP53INP2 189-211 is partially cytoplasmic and 
co-localizes with LC3B puncta. After induction of expression of EGFP-TP52INP2 189-211 
with doxycycline, cells were treated as indicated and stained with LC3B or Fibrillarin 
antibodies, before analysis by confocal fluorescence microscopy. Scale bars, 10 m. (B) 
TP53INP2 189-211 is partially degraded by autophagy. After induction of EGFP-TP53INP2 
189-211 with doxycycline, cells were treated as indicated and cell extracts analyzed by 
western blotting using the indicated antibodies.  
 
Figure 4. The starvation-induced cytoplasmic localization of TP53INP2 is independent of 
NES and LIR motifs. (A and B) Predicted NES1 and NES2 motifs in TP53INP2 are unable 
to mediate export of the NES reporter REV-EGFP out of the nucleus. HeLa cells were 
transfected with the indicated REV-EGFP constructs and analyzed by confocal fluorescence 
microscopy. REV1.4 EGFP is a negative control without any NES motif. REV1.4 NES EGFP 
is a positive control containing the NES from the REV protein. (C) Treatment of cells with the 
nuclear export inhibitor leptomycin B (LMB) does not inhibit a redistribution of TP53INP2 in 
response to starvation. HeLa FlpIn cells expressing EGFP-TP53INP2 were treated as indicated 
and stained for endogenous p62 as a positive control for LMB treatment, before analysis by 
confocal imaging. (D) EGFP-TP53INP2 with the LIR motif mutated (W35A/I38A) shows 
similar nuclear cytoplasmic shuttling as wild type in response to starvation. HeLa FlpIn cells 
expressing EGFP-TP53INP2 W35A/I38A were treated as indicated and stained with LC3B 
antibodies, before analysis by confocal imaging. Scale bars, 10 m.  
 
Figure 5. The starvation-induced cytoplasmic localization of TP53INP2 is independent of 
ATG5. (A and B) Stable WT MEFs (A) and ATG5-/- MEFs cell lines expressing EGFP-
TP53INP2 made by retroviral transfer were treated with tetracycline for 24 h to induce 
expression of EGFP-TP53INP2. Cells were then treated as indicated and stained with p62 and 




Figure 6. mTOR inactivation mediates acetylation and cytoplasmic retention of 
TP53INP2. (A) Cytoplasmic accumulation of TP53INP2 upon starvation does not depend on 
the nuclear pool of TP53INP2. Confocal fluorescence microscopy live cell imaging of HeLa 
FlpIn cells expressing EGFP-TP53INP2 under starvation. The nucleus of one of the 
representative cells was photobleached while another cell was left unbleached. After complete 
photobleaching of nuclear EGFP-TP53INP2, cells were treated with HBSS and live cell 
imaging performed. Scale bars, 10 m. (B) TP53INP2 interacts with Importin 1. GFP-tagged 
TP53INP2 was in vitro translated in the presence of [35S]-methionine and tested in GST 
pulldown assays for binding to the indicated recombinant Importin family proteins fused to 
GST. Bound proteins were detected by autoradiography (AR), and immobilized GST fusion 
proteins by Coomassie brilliant blue staining. (C) The binding of TP53INP2 to Importin 1 is 
reduced upon starvation. HeLa FlpIn cells expressing EGFP-TP53INP2 were starved or not for 
2 h, and cell lysates tested in GST pulldown assays for binding of EGFP-TP53INP2 to GST-
Importin 1. Bound EGFP-TP53INP2 was detected with EGFP antibodies and immobilized 
GST-Importin 1 by Coomassie brilliant blue staining. (D) TP53INP2 is acetylated upon 
starvation. HeLa FlpIn cells expressing EGFP-TP53INP2 were starved or not for 2 h, before 
immunoprecipitation of EGFP-TP53INP2 from cell lysates. Total EGFP-TP53INP2 was 
detected by western blotting with EGFP antibodies, while acetylated TP53INP2 was detected 
with the anti-acetylated lysine antibody supplied in the Signal Seeker Acetyl Lysine Detection 
Kit (Cytoskeleton, Inc). (E) Sequence of the C-terminal region encompassing amino acids 161-
220 of TP53INP2 showing PSIPRED secondary structure prediction22,  location of NLS and 
NoLS and the three lysine (K) residues that were shown by mass spectrometry to become 
acetylated upon starvation. A helical wheel projection shows the location of the K187 and the 
two arginine (R) residues to be located on the same side of the helix. Blue squares indicate basic 
residues and red one’s acidic residues.  
 
Figure 7. Acetylation of TP53INP2 at K187 inhibits nuclear import upon starvation. (A, 
B and C) HeLa FlpIn cells expressing EGFP-TP53INP2 with the indicated K to R mutations 
were treated as indicated, stained with LC3B antibodies and analyzed by confocal fluorescence 




Figure 8. Inhibition of CBP/p300 leads to dysregulated expression of TP53INP2. (A) 
TP53INP2 with all three lysines mutated to arginines (K3R) is nuclear in full medium (FM) but 
displays a partial and dysregulated nuclear cytoplasmic shuttling upon starvation. HeLa FlpIn 
cells expressing EGFP-TP53INP2 K3R were treated as indicated, stained with LC3B antibodies 
and analyzed by confocal fluorescence microscopy. (B) TP53INP2 treated with CBP/P300 
inhibitor is nuclear in full medium but displays a partial and dysregulated nuclear cytoplasmic 
shuttling upon starvation. HeLa FlpIn cells expressing EGFP-TP53INP2 were treated as 
indicated with CBP/P300 inhibitors and analyzed by confocal fluorescence microscopy. Scale 
bars, 10 m.  
 
Figure 9. Acetylation of K165 and K240 facilitates nuclear degradation of TP53INP2 upon 
starvation. (A, B and C) HeLa FlpIn cells expressing the indicated EGFP-TP53INP2 
constructs were starved in HBSS with or without cycloheximide (CHX) to block protein 
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SUPPLEMENTAL FIGURE LEGENDS 
Supplementary Figure S1: Generation of CRISPR/CAS9-mediated HeLa FlpIn 
TP53INP1 and TP53INP2 KO cells: (A and B) Genomic sequences of indicated TP53INP1 
and TP53INP2 exons targeted by guide RNAs. Shown are the sequences of two mutated alleles 
in TP53INP1 KO clone 19 (A) and two mutated alleles in TP53INP2 clone 10 (B). For each 
clone, more than 10 sequences were analyzed, and only two different alleles were identified.  
 
Supplementary Figure S2: Effects on autophagic flux and cell proliferation by knock-out 
of TP53INP1 or TP53INP2 in HeLa FlpIn cells: (A and B) Western blot analysis of NBR1, 
p62, NDP52, GABARAP and LC3B in lysates from the indicated cell lines treated or not with 
HBSS and/or bafilomycin A1 (Baf.) as indicated. (C) Proliferation curves of WT and 
TP53INP2 KO cell lines (number of analyzed cells seeded are indicated). The diagram 
represents one of three biological replicates. (D) Relative level of 47S rRNA in WT and 
TP53INP2 KO cell lines. (E) Confocal fluorescence microscopy analysis of EGFP-TP53INP2 
in reconstituted HeLa FlpIn TP53INP2 KO cells after treatment with the mTOR inhibitor Torin 
1 for 6 h. Endogenous p62 and LC3B were detected by immuno-fluorescence. Scale bars, 10 
m.  
 
Supplementary Figure S3: Transiently transfected EGFP-TP53INP2 co-localize with 
LC3B in puncta: HeLa FlpIn cells transiently transfected with EGFP-TP53INP2 were 
subjected to the indicated treatments and analyzed by confocal fluorescence microscopy 24 h 
after transfection. LC3B was detected with LC3B antibodies. Scale bars, 10 m.  
 
Supplementary Figure S4: The nucleocytoplasmic redistribution of TP52INP2 upon 
starvation is independent of its LIR and predicted NES motifs: (A and B) HeLa FlpIn 
TP53INP2 KO cells stably reconstituted with the indicated EGFP-TP53INP2 constructs were 
treated as indicated, stained with LC3B antibodies, and analyzed by confocal fluorescence 




Supplementary Figure S5: Mass spectrometry spectra showing acetylation. HeLa FlpIn 
cells stably expressing EGFP-TP53INP2 cells were treated with HBSS for 2 hours. Cells were 
lysed and EGFP-TP53INP2 immunoprecipitated using EGFP magnetic beads. Following SDS-
PAGE the bands corresponding to EGFP-TP53INP2 were precisely cut out and subjected to in-
gel reduction, alkylation, and endopeptidase digestion using 4 ng/µl of Arg-C before sample 
clean up and MS analyses (see Materials and methods). (A-F) Tables of MS2 fragment matches 
and MS2 spectra of the acetylated peptides showing acetylation on K165, K187 and K204. (A, 
B) ETD fragmented 3+ m/z 399.908 peptide showing the K165 acetylation. (C, D) CID 
fragmented 2+ m/z 561.822 peptide showing the K187 acetylation. (E, F) CID fragmented 2+ 
m/z 892.922 peptide showing the K204 acetylation.  
 
Supplementary Figure S6: Deletion of serine-threonine residues have no effect on 
nucleocytoplasmic shuttling of TP53INP2. (A) TP53INP2 amino acid sequence indicating 
mutated serine residues and the extension of systematic deletions done to identify essential 
serine or threonine residues. (B-J) Confocal fluorescence microscopy of HeLa FlpIn TP53INP2 
KO cells stably expressing the indicated EGFP-TP53INP2 point mutant or deletion constructs, 
treated as indicated and stained with p62 and LC3B antibodies. Scale bars, 10 m.  
 
Supplementary Figure S7: Model explaining the observed regulation of subcellular 
localization and degradation of TP53INP2. (A) In full medium TP53INP2 is completely 
nuclear and degraded by a nucleolar proteasomal pathway. (B) In response to starvation or 
mTOR inactivation, acetylation of K187 in TP53INP2 by CBP/p300 inhibits the nuclear import 
and this results in a stabilization and cytoplasmic accumulation of the protein. Simultaneously 
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#1 a+ a2+ b+ b2+ c+ c2+ Seq y2+ z+1+ z+1²+ #2
1 60.04439 30.52583 88.03930 44.52329 105.06585 53.03657 S 14
2 230.14992 115.57860 258.14483 129.57605 275.17138 138.08933 K-Acetyl 1697.80642 849.40685 1682.79552 841.90140 13
3 344.19285 172.60006 372.18776 186.59752 389.21431 195.11079 N 1527.70089 764.35408 1512.68999 756.84863 12
4 472.25142 236.62935 500.24634 250.62681 517.27289 259.14008 Q 1413.65796 707.33262 1398.64706 699.82717 11
5 559.28345 280.14536 587.27837 294.14282 604.30492 302.65610 S 1285.59938 643.30333 1270.58848 635.79788 10
6 646.31548 323.66138 674.31039 337.65884 691.33694 346.17211 S 1198.56735 599.78732 1183.55645 592.28187 9
7 793.38389 397.19559 821.37881 411.19304 838.40536 419.70632 F 1111.53533 556.27130 1096.52443 548.76585 8
8 906.46796 453.73762 934.46287 467.73507 951.48942 476.24835 I 964.46691 482.73709 949.45601 475.23164 7
9 1069.53129 535.26928 1097.52620 549.26674 1114.55275 557.78001 Y 851.38285 426.19506 836.37195 418.68961 6
10 1197.58986 599.29857 1225.58478 613.29603 1242.61133 621.80930 Q 688.31952 344.66340 673.30862 337.15795 5
11 1294.64263 647.82495 1322.63754 661.82241 1339.66409 670.33568 P 560.26094 280.63411 545.25004 273.12866 4
12 1454.67328 727.84028 1482.66819 741.83773 1499.69474 750.35101C-Carbamidomethyl 463.20818 232.10773 448.19728 224.60228 3
13 1582.73185 791.86956 1610.72677 805.86702 1627.75332 814.38030 Q 303.17753 152.09240 288.16663 144.58695 2






#1 a+ a²+ b+ b²+ c+ c²+ Seq. y+ y²+ z+ z²+ z+2+ z+2²+ #2
1 60.04439 30.52583 88.03930 44.52329 105.06585 53.03657 S 14
2 230.14992 115.57860 258.14483 129.57605 275.17138 138.08933 K-Acetyl 1697.80642 849.40685 1681.78769 841.39748 1683.80334 842.40531 13
3 344.19285 172.60006 372.18776 186.59752 389.21431 195.11079 N 1527.70089 764.35408 1511.68216 756.34472 1513.69781 757.35254 12
4 472.25142 236.62935 500.24634 250.62681 517.27289 259.14008 Q 1413.65796 707.33262 1397.63924 699.32326 1399.65489 700.33108 11
5 559.28345 280.14536 587.27837 294.14282 604.30492 302.65610 S 1285.59938 643.30333 1269.58066 635.29397 1271.59631 636.30179 10
6 646.31548 323.66138 674.31039 337.65884 691.33694 346.17211 S 1198.56735 599.78732 1182.54863 591.77795 1184.56428 592.78578 9
7 793.38389 397.19559 821.37881 411.19304 838.40536 419.70632 F 1111.53533 556.27130 1095.51660 548.26194 1097.53225 549.26976 8
8 906.46796 453.73762 934.46287 467.73507 951.48942 476.24835 I 964.46691 482.73709 948.44819 474.72773 950.46384 475.73556 7
9 1069.53129 535.26928 1097.52620 549.26674 1114.55275 557.78001 Y 851.38285 426.19506 835.36412 418.18570 837.37977 419.19353 6
10 1197.58986 599.29857 1225.58478 613.29603 1242.61133 621.80930 Q 688.31952 344.66340 672.30080 336.65404 674.31645 337.66186 5
11 1294.64263 647.82495 1322.63754 661.82241 1339.66409 670.33568 P 560.26094 280.63411 544.24222 272.62475 546.25787 273.63257 4
12 1454.67328 727.84028 1482.66819 741.83773 1499.69474 750.35101C-Carbamidomethyl 463.20818 232.10773 447.18945 224.09837 449.20510 225.10619 3
13 1582.73185 791.86956 1610.72677 805.86702 1627.75332 814.38030 Q 303.17753 152.09240 287.15881 144.08304 289.17446 145.09087 2
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